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Abstract 
Background: This thesis explores the concept of frailty, as a latent vulnerability 
in older people, with the aim of refining its measurement by generating a new 
measure of frailty - the British Frailty Index (FI). This index was developed and 
validated in a cohort of community-dwelling older women, the British Women's 
Heart and Health Study (BWHHS), in 23 towns in Britain. Findings were 
replicated in another large Medical Research Council (MRC) Assessment of 
Older People study. 
Methods: A systematic literature review examined the evolution of the concept 
and definitions of frailty. A meta-analysis on the prognostic value of current 
frailty measures confirmed extensive heterogeneity in the prediction of all-cause 
mortality despite consideration of age, sex, type of measure and duration of 
follow up. A 'General Specific' model of frailty was derived from factor analysis 
in the BWHHS population and replicated in the MRC cohort. Construct, external 
criterion and predictive validity of the British FI were assessed and its 
performance compared to another widely used index - the Canadian Frailty 
Index - with single indicators of frailty. 
Results: Frailty was explained by seven factors; physical ability, cardiovascular 
and respiratory disease and symptoms, visual impairments, other co-
morbidities, psychological problems and physiological measures. Associations 
with frailty included increased age, female sex, smoking, living alone, not living 
in own home, poor social contact and low socioeconomic position. Frailty was 
an independent predictor of all-cause mortality in both cohorts and predicted 
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hospitalization and institutionalization in the MRC study, performing better than 
the Canadian Index. 
Conclusion: This thesis provides better understanding of the mUlti-dimensional 
domains of frailty in older people. The British FI demonstrates validity in relation 
to adverse outcomes, provides a more reliable measurement tool and its 
application offers further opportunities for the prevention, detection and 
treatment of frailty at a clinical level. 
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Chapter 1: Frailty in older adults 
Background 
The management of the frail older person has been the core of a 
geriatrician's existence since the specialty began. Geriatricians have long 
recognized the heterogeneity of the health status of older people in grappling 
with the complex care of these vulnerable individuals [1, 2]. However, it has 
only been in the past few decades that a special population of older adults 
had become a more prominent 'cause' among public health specialists and 
policy makers. They are known as the 'frail elderly' [3]. Identifying who they 
are, whether on an individual basis or population level, has presented a 
challenge to the care of older people. The numerous frailty measures 
published in recent years give an indication of the many approaches to 
meeting this challenge [4]. However, the drive to provide tangible means of 
defining this population more accurately arises from concerns about 
'population ageing'. 
The phenomenon of 'population aging' is possibly the biggest challenge to 
the world's population today. Underlying population ageing is a process 
known as the 'demographic transition' in which mortality and then fertility, 
decline from higher to lower levels [5]. As fertility rates move towards lower 
levels, mortality decline, especially at older ages, assumes an increasingly 
important role in population ageing. Particularly in developed countries, 
where low fertility has prevailed for a significant period of time, relative 
increases in the older population are now primarily determined by improved 
chances of surviving to old ages [6]. 
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An important aspect of demographic transition is the emergence of the frail 
older population associated with a progressive ageing of the older population 
itself. For most nations, regardless of their geographic location or 
developmental stage, the 80 and over age group is growing faster than any 
of the younger segments of the older population [5](see Figure 1. 1). 
Figure1.1: Distribution of people aged 60 or over by age groups: world, 
1950-2050. 
100 ~--------------------------------. 
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Source: World population aging 1950-2050; Population Division, DESA, United 
Nations 
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In the United Kingdom (UK), it is projected that there will be more people of 
state pensionable age than under-16s (see Figure 1.2). This reflects a 
decline in the number of under-16s, which fell to 18.9 per cent of the 
population, compared with rising numbers of men aged 65+ and women 
aged 60+, who accounted for 19.0 per cent of the population at mid-
2007.The oldest age group (80 and over) is the fastest growing, accounting 
for 5 per cent (2.7 million) of the total population in mid-2007 and has 
increased by more than 1.2 million between 1981 and 2007[7]. The current 
and projected rise in the older United Kingdom population over the coming 
years in three age categories; 65 to 74, 75 to 74 and 85 years and above 
which extends from the 'young old' to the 'oldest old'. 
Figure 1.2: Growth of UK elderly population as a percentage of total UK 
population. 
Percentage 
100% I 
80% 
60% 
40% 
20% 
0% 
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. 0-15 
Source: ONS censuses 1971-2001; National population projections: 2011-
2031. 
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This demographic transition from a younger to older age structure has now 
reached global proportions among the world's populations. As population 
aging is progressing rapidly in developing countries that have lower 
socioeconomic development than their developed counterparts, there is less 
time to adjust to this change and its consequences. This has implications for 
each country's economy and its provisions allocated for health care services 
across all ages not just the old. 
AriSing from this growing and older population is a special group of older 
adults recognized as the 'frail elderly'. I traced their first emergence in the UK 
to the description of the 'frail ambulant' by JH Sheldon in 1960[8].This 
description was coined in the interest of 'administrative tidiness' and the 
hope of discovering the correct authority to provide care for the "enfeebled" 
old persons who were increasing the pressure on hospital beds in acute 
medical departments. Over the years, the types of individuals that make up 
this special group are very much determined by the view or assumption one 
takes on this population. This is related to the reasons for identifying who the 
frail elderly really are. Concepts ranging from "bed-blockers" to "major 
rehabilitation challenges" can be applied to frail elderly people and varies in 
the eyes of clinicians, policy makers, formal and informal carers and even 
among the 'frail' individual themselves. Hence, frailty remains an elusive 
concept despite many efforts over the past decades to define and measure it 
in a standardized manner. What is certain is that frailty is a controversial 
concept and its use in reference to the care of the older person has gained in 
popularity over the past few decades. These relate to particular questions 
such as whether a distinction should be made between frailty and ageing; 
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whether frailty is truly a syndrome or a series of age-related impairments that 
predict adverse outcomes; as well as what are its critical domains. A 
consensus on the concept and definition of frailty would play an important 
role in informing decision makers as to who among the older population are 
to be allocated care/access to health care services. A first step in this 
direction is to untangle the existing definitions of frailty that are used in 
general, among gerontologists and clinicians. This is explored in greater 
detail in Chapter 2 where I present a systematic literature review of the 
evolution of existing frailty definitions. 
Who are the frail elderly?: Untangling the concepts 
The development of the concepts and subsequent measures of frailty has 
been affected by the definition of frailty used. Brown et al[9] describes four 
problems with the way frailty has been used: 
• 'frailty is usually used without definition, and without identifying any 
assumptions that might function as parameters to its use' 
• 'frailty is used in a variety of ways; to fit with the thinking of the 
interests and perspectives of various authors' 
• 'frailty in older persons is thought to be an undesirable state; a 
stigmatized and poorly thought of process; creating a self fulfilling 
prophecy for those considered frail' 
• 'lack of strong instrumentation to measure and assess frailty'. 
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To a certain degree, general meanings of 'frail' and 'frailty' used in the 
context of daily living run in parallel to the world of gerontology and clinical 
practice. The Oxford English dictionary [10] provides a general meaning of 
the adjective 'frail' and the noun 'frailty'. 
'Frail: adjective: weak and delicate, easily damaged or broken' 
'Frailty: noun: the condition of being frail, weakness in character or morals' 
The Webster's Ninth New Collegiate Dictionary 1985 [11] similarly defined; 
'Frail: adjective: easily led into evil (-humanity), easily broken or destroyed; 
fragile, physically weak, slight, unsubstantial'. 
'Frailty: the quality or state of being frail, a fault due to weakness especially 
of moral character'. 
Other meanings along this negative vein are seen in Roget's International 
Thesaurus 4th Edition[12]: 
'Frail: slight, delicate, dainty, delicately weak, puny, lightweight, womanish, 
effeminate ;( informal terms): namby-pamby, sissified, pansyish, fragile, 
breakable, destructible, shattery, crumbly, brittle etc.' 
A Canadian based study investigating the view points of English speaking 
women on their experiences of frailty reported that older women describe 
frailty not only as an observable physical state such as 'looking small and 
skinny' but also as an emotional experience of vulnerability. As a socially 
constructed concept, frailty was related to judgments and negative 
assumptions of powerlessness and dependence(13). These meanings depict 
frailty in actual daily use, as a negative state which introduces an inherent 
social devaluation. It is therefore of no surprise that older adults themselves, 
by and large, do not equate their health status with this general meaning[13). 
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In clinical practice, the identification and management of the frail older 
person has been the mandate of geriatricians who have long embraced the 
complexity of the health status of older adults and perhaps 'it is in the 
management of frailty that the art of geriatrics is best expressed'[14]. 
However, from a clinical/geriatric perspective the frailty concept is not an 
easy one to quantify/translate into a tangible measure/tool. As one author 
explains, perhaps geriatricians 'have not been as good at articulating just 
how we embrace the complexity of our patients[15]. This could be due to the 
fact that frailty does not fit into a particular clinical slot and is often subtle and 
asymptomatic. Hence, it often goes unnoticed by most medical practitioners. 
Symptoms of chronic illness are also treated similarly by older adults and 
their family who tend to relate the changes to the normal aging process. This 
is probably because limitations and disease associated with aging are an 
inseparable part of frailty[16]. As with aging, frailty is an individual and 
qualitative experience. The indistinct line between normal and pathological 
aging (age-related disease) could explain why the experience of frailty differs 
from one person to the next. In fact, the difference between biological and 
chronological age in anyone individual may be explained by their 
susceptibility to frailty. Hence, it has been suggested that using frailty as the 
criterion to select older persons for preventive interventions may be better 
than selecting persons based only on their chronological age[17]. 
Over the past few decades, growing uncertainty about the definition of frailty 
and the underlying reasons for making these measures is certainly reflected 
by the creation of many measures, scales and indices of frailty. Operational 
definitions of frailty vary widely according to the conceptual framework. Some 
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consider frailty in a broad sense (qualitatively), encompassing multiple 
domains of physical, social, cognitive, co-morbidity and psychological. This 
was proposed by Rockwood in the well validated Frailty Index developed for 
older Canadians[18]. This concept was replicated in the Comprehensive 
Geriatric Assessments (CGA)[19].Others define frailty more restrictively, 
(quantitatively) as seen in the well known 'Fried's physical phenotype of 
frailty' which focuses mainly on performance parameters, such as the 
measurement of gait speed, grip strength, weight loss, energy intake and 
physical activity[20). Single physical measures of frailty have also been 
proposed and include the measurements of grip strength[21] and gait 
speed[22]. Although social and psychological domains have not been totally 
excluded from the concept of frailty, their importance has diminished over the 
years, making way for the more quantitatively measured definitions of 
physical frailty, with technological and superficially more objective science of 
measurement. However, there are those that resist a 'frailty equals physical 
frailty' approach. One proposal to operationalize the definition as a clinical 
measure includes several features, such as cognitive, functional and social 
circumstances, that go well beyond just the physical aspects [23]. This view 
is in keeping with the aims of the World Health Organization's International 
Classification of Impairments, Disabilities and Handicaps (ICIDH) 1980, and 
the current International Classification of Functioning, Disability and Health 
(ICF). ICF is a classification of health and its domains that describe body 
functions and structures, activities and participation. [24] The domains are 
classified from individual and societal perspectives. Since an individual's 
functioning and disability occurs in a context, ICF also includes a list of 
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environmental factors, which include the physical, social and attitudinal 
environment in which people live and conduct their lives. The full health 
experience is described using all these components where an individual's 
functioning in a specific domain is an interaction between the health 
condition and contextual factors (i.e. environment and personal factors). 
Disability (now classified as activity limitation), impairment, partiCipation, 
handicap (participation restriction) are key entities that form these 
associations (see Figure 1.3). 
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Figure 1.3: Interactions between the components of the 
International Classification of Functioning, Disability and 
Health (ICF) 
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Source: International Classification of Functioning, Disability and 
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Figure 1.4: Interactions between frailty and the components 
of the International Classification of Functioning, Disability 
and Health (ICF) 
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Conceptually, frailty could certainly be incorporated into the ICF framework. As 
illustrated in Figure 1.4, frailty in an older individual is the result of interactions 
within each of the three ICF domains with the health condition and contextual 
factors. This would suggest that research on frailty should return towards the 
holistic geriatric concept; where the pre-existing ICF could act as a useful 
guide/template for its definition. In the clinical setting, geriatricians already 
conduct Comprehensive Geriatric Assessments on older patients. This 
incorporates disease related and other multi dimensional aspects of the 
assessment and treatment of older people. The recognition of frailty would 
perhaps be a further refinement of this assessment [25]. 
As there is great overlap between frailty, health conditions (co- morbidity) and 
disability, we must question whether they are clearly separate entities. An 
International Academy on Nutrition and Aging (I.A.N.A.) task force combining 
evidence derived from a systematic review of literature along with an expert 
opinion of a European, Canadian and American Geriatric Advisory Panel stated 
that a distinction should be made between outcomes of frailty and frailty itself. 
Although they had found no consensus on a frailty definition or assessment tool, 
it was agreed that frailty be considered as a pre-disability stage as disability was 
an outcome of frailty. It was their view that the frailty syndrome does not 
include functional impairments and therefore these should not be included in 
frailty definitions and assessment tools[26]. The panel however, did not specify 
which type of functional impairments would be excluded from future operational 
definitions. Frailty appears to be a much broader concept as it is due to multiple 
system impairments. Disability, which is defined by impairments giving rise to 
functional limitations, may develop from impairment of just a single system or 
more. The overlap between frailty and disability could perhaps be greater in 
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older people at advanced ages. Therefore, the incorporation of functional 
impairments into a frailty assessment tool should still be a subject for 
debate[20]. 
Why focus on frailty? 
Fortunately, there is unanimous agreement that frail older adults are indeed 
vulnerable and at high risk for a range of adverse health outcomes (acute and 
chronic illness, falls, disability, mortality). Despite the ongoing debate on the 
concept of frailty and its measurement, there is no doubt about the impact of 
frailty, be it on the frail individual, the family or primary caregiver, as well as on 
society as a whole. Identifying frail elderly people in clinical practice or in the 
wider population through various aspects of their health and social status is a 
challenge worth attempting as it would enable pre-emptive action to be taken 
that might avoid serious sequelae at individual and population levels. However, 
a vital step to consider before deciding on a standard measurement of frailty is 
the purpose behind its use [25]. The challenge would be to develop a standard 
frailty measure that could incorporate the different perspectives behind its 
purpose. These perspectives include a clinical, gerontological research or public 
health one. 
A geriatrician's perspective would be for a frailty measure to refine the 
Comprehensive Geriatric Assessments and further improve the decision making 
process in terms of weighing the risk and benefit and cost of curative versus 
rehabilitative/palliative care services in the frail older person. 
A research gerontologist would use a measure of frailty to assess the 
underlying causes of frailty so as to identify a pre-frailty stage and enable its 
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prevention. From a public health perspective, a standardized frailty measure 
could enable a more cost effective use of resources through population 
preventative measures and intervention. Briefly, there are three main reasons 
why it is useful to measure frailty: 
i) To reduce the health care burdens associated with frailty 
Frail older people are the major users of health care worldwide[19]. This is 
evident by their increased utilization of resources in the community, hospital as 
well as long-term care institutions[27]. These all relate to adverse health 
outcomes that commonly accompany frailty. In the United Kingdom, the NHS 
cost per age group is shown in Figure 1.5. The NHS cost rises sharply in the 65 
and over age group, with the highest owing to the 84 and over age group, who 
appear to cost the NHS as much as those just born. 
Figure1.5: Estimated Health and Community Health Service (HCHS) per 
capita expenditure by age group, England, 2002103 
£ per person 
B.-th unde,5 51015161044451064 651074 751084 ove,84 
Source: The Government's Expenditure Plans 1999/00 (Department of Health) 
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A standardized measure of frailty could target the frail elderly people who are at 
increased risk of multiple hospital admissions, institutionalization and death. 
Their detection may reduce the incidence of frailty and the number of years of 
dependency through education, prevention and promotion of healthy lifestyles. 
Measuring frailty would be useful for informing not just clinical practitioners but 
also policy makers on how to detect, prevent and delay the onset of these frailty 
outcomes and enable more effective planning of the future needs, services and 
use of resource for elderly people. 
Currently, the limitations in defining frailty make its prevalence uncertain[28] 
posing a barrier to targeting or allocating appropriate healthcare services to this 
vulnerable group. 
ii) To understand the underlying causes of frailty. 
Understanding the pathways that lead to frailty, its underlying causes and its 
association with ageing could enable the discovery of ways to detect, prevent or 
delay the onset of frailty. Targeted research into this could identify the 'pre-frail 
elderly' or those at high risk of becoming frail. So far, work on the early 
detection and diagnosis of frailty has focused on its hypothesized association 
with multiple impairments in inter-related physiological systems namely the 
immune. neuro-endocrine and muscular systems [29, 30]. This has revealed the 
association of frailty with certain inflammatory, coagulation, metabolic and other 
physiological markers [4, 31, 32]. It is hoped that the growing body of 
knowledge arising from research on the pathophysiology of frailty [32-34] will 
lead us in the right direction in the development of interventions or therapies 
that will either prevent frailty or improve the quality of life of the frail older adult. 
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iii) To target interventions on those who will become frail or those who are 
'high risk frail'. 
Targeting interventions would also be possible with a standardized measure of 
frailty to identify people at an early pre-frailty stage (Le. those at high risk of 
becoming frail) and those who are already frail and therefore at risk of 
complications of frailty (e.g. falls, mortality). Such an approach would help with 
more cost-effective planning of services for older people. 
These services would involve the implementation of specific primary or 
secondary intervention strategies which aim at reducing the chances of 
becoming frail and the adverse outcomes associated with frailty. We must 
acknowledge that much important work on the presentation and/or interventions 
for frailty (e.g.: Frailty and Injuries: Cooperative Studies of Intervention 
Techniques (FICSIT) trials and interventional studies with Tai Chi) has been 
achieved without a precise definition being in place [35-37]. However, a 
standardized, reliable and accurate measure would more likely increase the 
effectiveness and reduce the costs of interventions by providing them to those 
who would really benefit most. 
A successful definition of frailty 
Unfortunately, the daunting array of available measures or scales of frailty in 
older persons pose a significant problem in generalizing or even comparing one 
set of findings to another. Hence, validation which is essentially a process of 
hypothesis testing [38], must be carried out on the various operational 
definitions to determine whether the 'test' is measuring frailty. The assessment 
of the measures used is based on several aspects: 
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Content validity: assesses the theoretical basis and degree to which the 
measure covers all the relevant or important content or domain for frailty e.g. 
multidimensional, dynamic, and is useful across different contexts. 
Face validity: although related to content validity assesses whether a test 
appears to be a good measure or not. Hence judgment is made just on the 
'face' of it 
Construct validity: assesses whether the measure is associated with other 
variables in the expected direction: increased frailty with age, in women, in 
poorer socioeconomic groups, co-morbidity and poor self rated health. Two 
aspects of construct validity are convergent and divergent Idiscriminant 
validity. Convergent validity assesses the degree to which the measure is 
correlated with other measures or other variables of the same construct it 
should be related to. Divergent validity assesses the degree to which the 
measure does not correlate with dissimilar or unrelated variables.[38] 
Criterion validity: assesses the correlation of a measure with ideally a 
reference or a 'gold' standard measure which is widely used and accepted in 
the field. It is usually divided into two types: concurrent and predictive 
validity. Concurrent validity assesses the correlation of the measure with other 
measures/variables of the same construct that are measured at the same time. 
Predictive validity assesses this at a future time, testing the ability of the 
measure to predict adverse health outcomes including death, hospitalization, 
institutionalization, falls, morbidity etc, and whether it provides an age threshold 
that predicts when everyone is frail[15]. 
As a reference standard definition of frailty does not exist, predictive validity 
provided means of evaluating the ability of a frailty measure to demonstrate 
susceptibility to adverse outcomes. 
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The validity of any measure however does not imply its reliability. Reliability 
refers to the degree to which measurements can be replicated. It involves 
making judgements on the adequacy of the measurement by assessing the 
amount of error, both random and systematic[38]. Thus the inclusion of various 
directly observed or objectively measured variables into a frailty measure will 
affect its reliability as the more variables considered, the greater the problems 
of measurement error and missing data. The sources of variance in a measure 
are tested by examining the effect of inter-observer reliability where the error 
results from different observers' perceptions. Variations of the measure within 
an observer are called intra-observer reliability. If there are no observers 
involved in the measurement, which is the case in many self rated questionnaire 
measures, its reliability can be tested using test-retest reliability. This 
approach is concerned with administration of the measure within a sufficiently 
short time interval where it is assumed that what is being measured has not 
changed. The greater reliability of a measure can also be assessed by the 
degree of internal consistency or homogeneity. This 'speaks directly to the 
ability of the clinician or researcher to interpret the composite score as a 
reflection of the test's items'[39], where the variables included in the 'score' 
should be moderately correlated with each other, and each variable should also 
correlate with the total measure's score. 
Hence, a successful operational definition of frailty should (as with any tool) be 
valid and reliable when used in different populations. In keeping with a more 
holistic view of the individual, it would also need to be multi dimensional, 
identifying the domains of the community dwelling older people. 
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Scope of the work 
It is indeed a challenge to compare and validate the various definitions of frailty 
thus far as they were constructed for different purposes and for different elderly 
populations. Given the heterogeneity of this term when applied to older people, 
it is hoped that this compilation of various known definitions of frailty (Chapter 
2.1) and their prognostic value (Chapter 2.2) in large elderly populations will 
help untangle the growing body of knowledge on the concept of frailty and 
perhaps bring us closer to a consensus definition. Chapter 3 introduces the 
British Frailty Index (FI) which is based on a multidimensional concept of frailty 
and developed using factor analysis. This new measure of frailty was developed 
using the BWHHS cohort of women and this process was replicated in both 
men and women of the larger and older cohort of the MRC assessment study of 
older people. Its construct and external concurrent criterion validity were 
assessed in Chapter 4 by examining associations with specific socio-
demographic and lifestyle variables. Predictive validity of the British FI in 
relation to adverse outcomes such as all cause mortality, cause specific 
mortality, hospitalization and institutionalization was examined in Chapter 5. 
Chapter 6 reports results of the comparisons made between the British FI and 
a well known multi-dimensional frailty index-the Canadian Frailty Index - as well 
as single markers of frailty. The last chapter incorporates an overall discussion 
of the findings made from this study, its implications as well as 
recommendations for future work. 
This study has the potential to generate frailty indicators that should not only be 
able to predict death but also indicate the health status, functional decline and 
use of health services in the target population of frail older people. These frailty 
indicators should reflect the multi dimensional domains that relate to the 
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wellbeing and independence of this vulnerable population. Developing a 
prognostic tool for prediction of adverse events, would, if sufficiently accurate, 
aid clinical decisions on place and type of care for older adults at risk (for 
example palliative versus acute care).This would also permit preventive 
targeting of care/services on modifiable risk factors. It should be practical and 
simple for use in a primary care or hospital setting as well as appropriate across 
many cultures and populations 
It is antiCipated that this work will have impact on the direction of future 
intervention and healthcare strategies for frail elderly people. This is in the hope 
of reducing both the burden of suffering in these people and also the economic 
'burden' that the growing elderly populations pose to healthcare services the 
world over. 
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Aim and objectives 
The aim of this study was to generate a measure of frailty that can be used to 
predict adverse events in a community dwelling older population. 
Objectives: 
• To review existing literature on concept of frailty, its measurement and its 
prognostic value in large study populations. 
• To derive a model based measurement of frailty (the British Frailty Index) 
and examine its internal reliability in community dwelling elderly people. 
• To assess the construct and concurrent criterion validity of the developed 
frailty measure i.e. whether the measure provides information on 
expected associations and is correlated with other variables of the same 
construct. 
• To assess the performance of the developed frailty measure in predicting 
all cause mortality in the British Women's Heart and Health Study 
(BWHHS) population. 
• Re-evaluation of the British Frailty Index (FI) in an independent cohort of 
the MRC assessment study of older people. 
• Comparison of the performance of the British FI with a widely used frailty 
index and with simple approaches to measuring frailty in both cohorts. 
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Chapter 2.1: Definitions and concepts of frailty: a 
systematic literature review 
Introduction 
Efforts to quantify the experience of frailty in older people have resulted in a 
wealth of research which requires much appraisal and synthesis. These efforts 
have contributed to our understanding of the pathways to frailty, its aetiology 
and associated risk factors. However, the presence of a huge variety of frailty 
measures also reflects the growing uncertainty about its definition and the 
underlying reasons for making these measures. At present, despite the absence 
of a consensus definition, many conclusions continue to be drawn on 'frail' older 
people deemed at risk of adverse events [20, 40-42]. I embarked on this 
systematic literature review to investigate the rationale behind the concept and 
definition of frailty in older people by tracing its evolution from the earliest 
definition to its current definitions and use. This included assessment of the use 
of similar meanings to the term 'frailty' to include definitions and concepts 
relating to the same population prior to the current popularity of the term "frailty". 
The challenge posed here was to compare and validate the various definitions 
of frailty thus far, as they were constructed for different purposes and for 
different older people populations. It is hoped that this compilation of the various 
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definitions of 'frailty' will provide greater clarity to the growing body of knowledge 
on the concept of frailty. This may bring us closer to a consensus on what 
defines frailty in elderly people; alternatively it may result in questioning the 
necessity for defining a condition that in most instances is self-evident. 
In this chapter I present two systematic reviews: a) the historical development of 
concepts and definitions of frailty; b) the associations of measures of frailty with 
mortality and other adverse outcomes. 
Methods 
A systematic and comprehensive search strategy was designed with an 
information scientist to review the literature. Peer-reviewed journal articles were 
selected from the following databases: MEDLlNE, Psych Info and Age Info 
(1950 to July 2009); EMBASE (1974 to July 2009) and Web of Science (1970 to 
July 2009). Gerontology textbooks were reviewed for earlier definitions and 
concepts of frailty. Citation tracking of key papers was also used. The search 
was limited to English language articles, humans and 'all aged 65 and over'. As 
frailty is yet to be defined, the search terms combined various Medical Subject 
Headings (MeSH) terms for 'frail elderly' to broaden the scope of the search 
population (see Table2.1). 
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Table 2.1: Medical Subject Headings (MeSH) and other terms for frail 
elderly 
exp Frail Elderly/ 
older old.tw. 
(infirm$ adj3 elder$).tw. 
(vulnerab$ adj3 (elder$ or old or older)).tw. 
(weak$ adj3 (elder$ or old or older».tw. 
(function$ adj3 impairS adj3 (elder$ or old or older».tw. 
(debilit$ adj3 (elder$ or old or older)).tw. 
«sick or sicker) adj3 (elder$ or old or older)).tw. 
«disabled$ or disabilit$) adj3 (old or older or elder$)).tw. 
(socia$ adj3 frail$}.tw. 
(physical$ adj3 frail$).tw. 
(mental$ adj3 frail$).tw. 
(psychol$ adj3 frail$}.tw. 
(physiol$ adj3 frail$).tw. 
(frail$ adj3 syndrom$}.tw. 
This produced literature which sought to define, conceptualize or measure frailty 
and its related terms as well as distinguished between theoretical and 
operational definitions of frailty. A proposed pathway to defining frailty is shown 
in Figure 2.1. As frailty in older people comprised of the interplay between 
associated factors, markers and health behaviours, articles which described 
frailty in terms of 'markers', 'associations', 'predictors' or 'contributing factors' 
were seen to be on the pathway to frailty and not truly providing a complete 
definition. Definitions were split into theoretical and operational. 
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Figure 2.1: Pathway to defining frailty 
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Theoretical definitions were those that proposed a hypothesis on the idea or 
concept of frailty. Operational definitions provided measures that defined frailty 
or its associated meanings and identified frail older people either by stating the 
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measures that fulfil the criteria for frailty and/or by providing scales or indices. 
The operational definitions were assessed by whether they fitted into physical. 
physiological. psychological or socially based criteria. Operational definitions 
were grouped into three categories as described by Rockwood et a/ : a) rules-
based b) sum of deficit accumulation c) clinical judgment-based[35]. 
Results 
Figure 2.2 demonstrates the flow of information through the different phases of 
the systematic literature review. The search for the relevant articles using the 
term 'frail elderly' and its associated meanings broadened the scope 
considerably. The combined database search resulted in a total of 22,912 
citations of which only 219 potentially relevant articles were found. A total of 57 
different definitions of frailty were identified (see Table 2.2). Of this total, 47 
articles focused on only defining frailty and 10 additionally validated frailty within 
the same population it was derived from. These definitions were tabulated 
chronologically and divided into theoretical and/or operational definitions (see 
Table 2.3). Although 'frailty' or 'frail' was the major descriptive term used, this 
review revealed that other terms such as 'vulnerable'[43, 44], 'functionally 
impaired', 'functional limitations' or 'functional disability'[22, 45, 46] in older 
people were often used to describe or identify the same frail older population. 
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Figure 2.2: Flow diagram of the search strategy for the systematic 
literature review 
N umber of records identified 
through database searching: 
Medline: 6438 
Embase: 2623 
Psych Info: 1534 
Age Info: 4935 
Web of Science: 7382 
Number of additional records 
identified through other sources 
22,912 
Number of records screened after 
duplicates removed: 17669 
Number offull text articles 
assessed for eliQibility: 219 
Number of articles on definition 
and validation of frailty: 10 
Number of articles on frailty 
defin ition only: 47 
Total: 57 
8 
Numberof 
records excluded 
based on title 
and abstract: 
17450 
Excluded, 
reasons: 
Intervention 
studies: 4 
Reviews: 39 
Other validation studies: 
119 
41 
The measures used to identify these vulnerable, functionally impaired or 
disabled older individuals were often the combination of variables included in or 
even similar to several known frailty measures[20, 22, 47-49]. Hence, 
regardless of the terms used, these measures appeared to have one common 
goal; the identification of the older persons at risk of adverse health outcomes. 
Other MeSH terms were later excluded as the articles screened did not attempt 
to identify or define the concept of frailty in the population under study. 
Manual searching of old Gerontology textbooks [8, 50] unearthed two early 
descriptions from the 1960s which sought to define this subset of the older 
population. These provided broader qualitative and multi-dimensional definitions 
based on physical/functional, psychological and social criteria. Later year 
searches were derived from the databases mentioned. These yielded a varied 
selection of frailty definitions based on single, dual or multidimensional criteria. 
Prior to 1998, the majority of the definitions were theoretical and not validated. 
Operational definitions were mainly accompanied by a measure/test. 
These can be: 
• rules-based/phenotype of frailty, for example, a person may be defined 
as frail if 3 or more symptoms are present[20] 
• Summing up of accumulated deficits (frailty index), is a proportion of all 
potential deficits considered for a given person[51] 
• Reliance on clinical judgment, to interpret the results of history taking and 
clinical examination[41]. 
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Table 2.2: Type of frailty definitions and the individual frailty domains. 
Author Phlsical Phl!iol2Sical Pslcholosical Social Theoretical Operational 
Sheldon 1960 v v v v 
Agate 1963 v v v v 
OBrien,Wagner 1980 v v 
Gadow 1983 v v 
Brocklehurst 1985 v v v v 
Wan 1986 v v v v 
Woodhouse 1988 v v v 
National Institute of Health 1988 v v v v 
Berkman 1989 v v 
lachs 1990 v v v v 
Speechley&Tinetti 1991 v v 
Buchner,1992 v v 
Bortz 1993 v v 
Rockwood 1994 v v v v 
Kaufman 1995 v v 
Brown, R 1995 v v v 
Canpbell1997 v v 
Strawbridge 1998 v v v v v 
Dayhoff 1995 v v v v 
Ranieri 1998 v v 
Fried & Walston 1998 v v 
Carlson 1998 v v v v v 
Rockwood 1999 v v v 
Hanmerman1999 v v v 
Chin 1999 v v v 
Brown,M 2000 v v 
Fried 2001 v v v 
Minitski 2001 v v v v 
Continued 
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Au1hor Ph~ical Ph:r:sioloSical Ps:r:chological Social Theoretical Operational 
Nourhashemi 2001 v v v v 
Saliba2001 v v 
Gill 2001 v v v 
Steverink 2001 v v v v 
Bortz 2002 v v v 
Lipitzs 2002 v v 
Gerdhan 2003 v v 
Klein 2003 v v 
Sydhall2003 v v v 
Fried 2004 v v 
GililM 2004 v v v 
Studenski 2004 v v v v 
Jones 2004 v v v v 
Minitski 2004 v v v 
Cariere 2005 v v v 
Scarcela 2005 v v v v 
Rockwood 2005 v v 
Puts2005 v v v v 
Klein 2005 v v v 
Rolfson 2006 v v v v 
Carr 2006 v v v 
Schultz-larsen 2007 v v v 
Amici 2008 v v v 
Boxer 2008 v v v 
Ensrud 2008 v v v 
Varadhan 2008 v v 
Ravaglia 2008 v v v v 
Guilley2008 v v v v 
Buchman 2009 v v v 
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Table 2.3: Th 
- - --
luti If frailtv definif 
-----
Author/Year Reference Theoretical definitions Operational definitions 
Sheldon JH 1960 8 'frail ambulant' group of elderly 'belonging to the 
later period of old age. beyond 75 years with an 
increasing amount of breakdown in (physical and 
mental )health which is of long duration (chronic); 
who face domestic as well social problems.' 
Agate J ,1963 50 • a state of semi-dependence ... the patient is not 
necessarily ill. and may have no specific disabilities; 
yet she cannot sustain an independent life with 
safety and success. even though willing to try and is 
mentally normal . .' 
O'Brien J & 55 > 75 years of age, living alone with sub-poverty 
Wagner DL 1980 levels of income 
Gadow S,1983 54 'a devalued phenomenon particularly identified with 
aging ... 
Brocklehurst 57 'Model of Breakdown' using a balance between 
J,1985 biomedical and psychosocial factors which were , 
seen as 'assets' or 'deficits' that affect whether a 
person can live independently in the community. 
Wan TTH, 1986 60 measure of need for care conceptualized as 'a first 
i order factor of four unobservable health related 
constructs, including self assessed health status, 
i 
objectively evaluated functional status, perceived 
service needs and instrumental social suPPort' 
Woodhouse,1988 3 'individuals over 65 years of age, dependent on I I 
others for activities of daily living ... • 
National 59 'tend to exhibit great medeal complexity and 
Institutes of vulnerability; have illnesses with atypical and 
Health 1988 obscure presentations; suffer major cognitive, 
affective and functional problems; are especially 
vulnerable to iatrogenesis; are often socially 
isolated and economically deprived; and at high risk 
I for premature or inappropriate institutionalization.' 
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Author1Year Reference Theoretical definitions Operational definitions 
Berkman B, 1989 56 'Failure to Thrive (FTl) ... functional ability to live 
with multisystem diseases, cope with the ensuing 
problems, and manage their own care was 
diminished and no longer responsive 10 health care 
interventions . .' 
Lachs MS etal 46 Frailty Staging System (FSS) was developed as an index of 
1990 severity of functional impairment using a short approach 
focused on selected tests of vision, hearing, arm and leg 
function, urinary incontinence, mental status, 
instrumental and basic activities of daily living, 
environmental hazards and social support systems 
Speechley M, 61 9 variables correlating strongly with frailty; 
Tinetti M.1991 Age>80 yrs, balance and gait abnormalities, infrequent 
walking for exercise, decreased knee strength, lower 
extreme disability, decreased shoulder strength, 
decreased near vision, depreSSion, sedative use. 
Subjects are frail if have at least four frail attributes and 
no more than one vigorous attribute 
Buchner & 70 'A state of reduced physiological reserve associated 
Wagner 1992 with increased susceptibility to disability .... frailty as 
a 'precursor state' to dis abii ity' . 
Bortz 1993 68 'Diminished energy flow Qnteraction) between the 
individual and their environment. .. when an 
organism is uncoupled from their environment. .. ' 
Rockwood 18 'those in whom the assets maintaining health and 
K,1994 the deficits threatening it are in precarious 
balance ... dependence on others for activities of 
daily living . .' 
Kaufman 64 ' socially produced and is a lived 
SR,1994 experience ... refiects a societal view of aging, as a 
battle between independence and dependence .. .' 
Brown I, 1995 9 'A diminished ability to carry out the important 
practical and social activities of daily living'. 
Continued 
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AuthorlYear Reference Theoretical definitions Operational definitions 
Campbell AJ & 69 ' condition/ syndrome resulting from multi-system 
Buchner reduction in reserve capacity to the extent that a 
DM,1997 number of physiological systems are close to, or 
past. the threshold of symptomatic clinical failure' 
Strawbridge WJ 62 ' a syndrome inwlving deficiencies in two or more Classified as frail if problems/difficulties were reported in 
etal,1998 domains involving physical, nutritive, cognitive and two of the following domains( 16 variables): 
sensory capabilities'. Physical function (4 items) 
Nutritive slatus(2 items) 
Cognitive functioning(4 items) 
Sensory functioning (6 items) 
Dayhoff et al 48 Diminished functioning combined with diminished Combined self reports of two measures: 
1998 self-rated health a) VVHO Assessment of Functional Capacity 
(WHOAFC}-14 item measure of self sufficiency 
in perfonnance of basic and instrumental 
activities of daily living. 
b) self report of health as fair or poor. 
Frailty classified by scoring 21 or more on WHOAFC and 
poor self report of health. 
Ranieri P et al 84 Low serum cholesterol as independent single marker of 
1998 frailty; mean cholesterol levels were significantly lower in 
men; persons living with others; older individuals; and 
individuals with co{Jlitive impairment, poorer somatic 
health, higher disability, and a higher level of malnutrition 
Fried LP & 16 'A state of age-related physiological IIUlnerability 
Walston JM.1998 reslAting from impaired homeostatic reserve and a 
reduced capacity of the organism to withstand 
stress' 
Includes indicators such as sarcopenia neulO-
I 
endocrine dysregulation, nutritional and immune 
dysfunction in the' cycle of hilty'. 
Continued 
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Cartson JE et al 49 Quantifies frailty in terms of 'functional homeostasis Good or poor functional homeostasis defined by a 
1998 i.e. the ability of an individual to withstand illness 'Functional Independence Measure(FIM)' which ranges 
without loss of function'. from 'Complete dependence( score 1 & 2) to 
Independence'(score 7). The FIM score is applied to the 
following areas: eating, grooming, bathing, dressing 
(upper body), dressing (lower body), toileting, bladder 
management, bowel management, transferring (to go 
from one place to another) in a bed, chair, and/or 
wheelchair, transferring on and off a toilet, transferring 
into and out of a shower, locomotion (moving) for walking 
or in a wheelchair, and locomotion going up and down 
stairs. It is also used for cognitive areas such as 
comprehension, expression, social interaction, problem 
SOlving, and memory. 
Hamerrnan 28 Described as an evolving geriatric functional 
0,1999 continuum; a midpoint between independence and 
pre-death. 
Rockwood 71 Geriatric status scale(GSS) ,classification of patients at 
K,1999 four levels appropriate for people li"'ng in the community 
representing fitness to frailty: 
(0) those who walk without help, perform basic 
ADLs , are continent and not cognitively 
impaired. 
(1) Bladder incontinence only 
(2) One (two if incontinent) or more of needing 
assistance with mObility or ADLs, had CIND, or 
has bowel or bladder incontinence 
(3)Two or (three if incontinent) of totally 
dependent for transfers or one or more 
ADLs, incontinent of bowel and bladder, 
and a diagnosis of dementia. 
-----------
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ChinAPawMJ 63 Frailty defined as 'Physical inactivity combined with low 
etal,1999 energy intake, 5-yearweight loss, or low BMI (body 
mass index) 
Physical inactivity-<210minlweek 
Low energy intake-<7.6MJ/day 
5 year weight loss->4kg 
Low BMI-<23.5kg/m2 
Brown Metal 47 Frailty defined as scores oblained on a 36-point physical 
2000 performance test (PPT): 
Not frail (32-36 points), mildly frail (25-31 points). or 
moderately frail (17-24 pOints) 
Fried LP et 20 Frailty Phenotype 'a clinical syndrome in which three or 
al,2001 more of the following criteria were present: unintentional 
weight loss (10 Ibs in past year), self-reported 
exhaustion, weakness (grip strength), slow walking 
speed, and low physical activity' 
Minitski AB et al 72 Frailty Index=The proportion of accumulated deficits 
2001 (symptoms, signs. functional impairments and laboratory 
abnormalities) 
Nourhashemi et 45 Frailty identified as having disability with one or more 
al2001 Instrumental Activities of Daily Living (IADLs) as 
measured by the IADL scale 
Saliba 0,2001 43 'vulnerable older persons as age 65 and older who Vulnerable Elders Survey (VES-13), a function based 
are at increased risk of flIlctional decline and death screen. 
over 2 years. 
Gill TM et aI 2001 24 Physical frailty was defined on the basis of slow gait 
speed and inability to stand from a chair with one's arms 
folded 
--_._--
-------
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Steverink N et all 81 
2001 
Bortz WM,2002 I 66 
Lipsitz ,2002 I 67 
Gerdham et I 85 
al.2003 
Klein BEK et al 182 
2003 
Sydall H et al 121 
2003 
Fried LP at 188 
al,2004 
Groningen Frailty IndicatGr short 15 item screening 
instrument to determine level of frailty. 
Screens for loss of function or resources in the 4 
domains of function; physical (mobility functions, mult!ple 
health problems, physical fatigue, vision, hearing), 
social(emotional isolation), cognitive(cognitive 
functioning )and psychological(depressed mood and 
and feelings of anxiety 
'A state of muscular weakness and other secondfry 
widely distributed losses in function and structure 
that are usually initiated by decreased levels of 
physical activit'v 
'Loss of adaptive capacity due to a loss of 
complexity ... during resting conditions impedes a 
individual's ability to mount a focused response 
during stress. 
'A subjective immediate impression of an individual's 
general health and appearance' ... within 15s from firsl 
sight. This definition was transferred to an arbitrary sclale 
(1-100).1=individual is not frail and 100=very frail or aoed 
"index of frailty" consisting of highest quartile ( slow~st) 
gait time, lowest quartile of peak expiratory flow rate, 
lowest quartile of handgrip strength, and inability to st~nd 
from sittina in one try (for those not in a wheelchair) 
Grip strength as a Single marker of frailty in older peoole 
of similar chronological age. 
, an aggregate expression of risk resulting from-ape 
or diseaseassociated physiologic accumulation 0' 
sub threshold decrements affecting multiple I 
physiologic systems ... no single altered sygem 
defines this state, ... multiple systems must be 
involved.' 
so 
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GililM et al 2004 22 Presence of absence of frailty defined on basis of gait 
speed: score of >10 seconds on the rapid gait 
test(walking back and forth over a ten foot course as 
quickly as possible) 
Studenski S et 23 Global frailty includes intrinsic frailty and its Clinical Global Impression of Change in Physical Frailty 
al,2004 consequences indudes 6 intrinsic frailty and 7 consequence domains. 
Intrinsic domains:-mobility, balance, strength, endurance, 
nutrition, neuromotor performance. 
Consequence domains: medical complexity, healthcare 
utilization, appearance, self-perceived health, ADls, 
emotional status, social status) 
Jones OM, Song 19 FI-CGA was calculated as a cooot of the impairments 
X. Rockwood identified at baseline Comprehensive Geriatric 
K,2004 Assessment (CGA) ; scored and summed as a frailty 
index(FI).Consists of 10 standard domains: 
Cognitive status 
Mood 
Motivation 
Communication 
Mobility 
Balance 
Bowel function 
Bladder function 
IADLs 
Nutrition 
Social resources 
Minitski AS et 51 Frailty Index using 40 variables based on Self report 
I al,2004 data, indudes symptoms, health attitudes, illnesses and impaired function I 
----------- ---
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Cariere et al 91 Measures frailty using a fitting method that establishes a 
2005 hierarchy between components of physical frailty. 
-Mobility (gait speed and chair stand) 
-balance (mndem position test) 
-nutrition (BMI) 
-Muscle strength(grip test) 
-physical activity 
Also included is perceived health (self ra1ed health and 
fear of falling) on probability of becoming dependent. 
Provides a predictive score using an integer-based linear 
combination of risk factors; can be used on subjects with 
apparent good health but are at risk of becoming 
disabled. 
Puts MTE et aI 77 Frailty was defined as present when a subject had 
2005 scores above the cut-off on three or more frailty markers, 
as described by Fried et al but was based on 
nine frailty markers. The static definition was based on 
the frailty markers at T2(1 st fo/ION up). The dynamic 
definition was based on the change in the frailty markers 
between T1 (baseline) and T2. 
The nine frailty markers \\ere body weight; peak 
expiratory flow; cognitive functioning (MMSE); vision 
capacity; hearing capacity; incontinence; sense of 
mastery; depressive symptoms; and physical activity. 
-- '--------- ------------- ----- -- --- -
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Scarcela P 2005 95 Identifies frail Italian elderly using Geriatric Functional 
evaluation(GFA)-modified from original version designed 
by Grauer and Bimbom (1975) 
Mental-physical Area (one question in each section with 
three possible an swers with a score 
ranging from a to _20) 
Sight 
Hearing 
Mobility 
Respiratory functions 
Cardiovascular functions 
Diet 
Pathologies present (no scoring here -only the presence 
or absence is recorded) 
Disorientation 
Delirious psychosis 
Memory loss 
Energy and rno tivation 
Reasoning ability 
Hallucinations 
Socio-economical and functional area (each item has a 
score that varies from 0 to a 
maximum which differs according the specific weight 
established when designing the questionnaire) 
Functional status (7 items, tota I score 0-41) 
Community support (12 items, total score between 0 and 
32) 
Housing (1 item, total score between a and 3) 
Relationship (1 item, total score between a and 15) 
Economical situation (1 item, total score between a and 
8) 
The Final Synthetic Score, resulting from the sum of the 
scores in the 32 items, can vary from _118 to +91 
----------
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Rockwood K et 41 CSHA Clinical Frailty Scale: 
al2005 1 Very fit - robust, active, energetic, well motivated and 
fit; these people commonly exercise regularly and are in 
the most fit group for their age 
2 Well - without active disease, but less fit than people 
in category 1 
3 Well, with treated comorbid disease - disease 
symptoms are well controlled compared with those in 
category 4 
4 Apparently vulnerable - although not frankly 
dependent, these people commonly complain of being 
"slowed up" or have disease symptoms 
5 Mildly frail - with limited dependence on others for 
instrumental activities of daily living 
6 Moderately frail - help is needed with both 
instrumental and non-instrumental activities of daily living 
7 Severely frail - completely dependent on others for 
the activities of daily living, or terminally ill 
Note: CSHA = Canadian Study of Health and Aging. 
--
-----_ .. 
------------
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Klein BEK et al 78 A frailty index combining poorer fl6lction for each 
2005 characteristic was devised according to the following 
scheme: 
• highest quartile of gait-time (3.37 s in women, 
3.19 s in men); 
• lowest quartile of peak expiratory flow rate (290 
IImin for women, 440 Ihnin for men); 
• lowest quartile for hand grip strength for the 
dominant hand (18.5 kg forwomen,34.5 kg for 
men); 
• not being able to stand from a sitting position in 
one try (without use of arms) 
• visual impairment (best-corrected visual acuity of 
2G'40 or poorer in the better eye). 
Equal weight was given to each measure, further 
categorized into four levels: none (none of the 
characteristics), mild (1-2 characteristics), moderate (3 
characteristiCS), and severe (4-5 characteristics). 
Rolfson DB et al 87 Edmonton Frail Scale ,samples 10 domains 
2006 -2 perfonnance based;clock test (cognitive performance) 
and 'timed get up and go'for balance and mobility. 
-mood, 
-functional independence, 
-medication use, 
-social support 
-nutrition, 
-health attitudes, 
-continence, 
-burden of medical illness 
-quality of life. 
Continued 
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Car DB et al 2006 90 Frailty defined as at least two out of three criteria: 
a) Score between 18 and 32 on the modified 
Physical Performance Test(PPT); 
b) Report difficulty or need assistance with two or 
more Instrumental Activities of Daily 
Living(IADLs) or one activity of daily living(ADL); 
c) Achieve a peak oxygen uptake (V02) of less 
than 18MI/1(g body weight per minute. 
Schultz-Larsen 86 Conceptualization of frailty based on a 2-dimensional 
K,2007 perspective; 1) quantitative- an objective interpretation of 
frailty by a health profeSSional; 2) a subjectiw perception 
and experiences of health by an older adult. 
'Objective measure of physical frailty 
-
maximal power in sustained work using a bicycle 
ergometer test 
- co morbidity assessed by thorough physician 
examination, ECG, Lab tests and the presence 
of 2 or more pre-defined chronic conditions such 
as diabetes, hypertenSion, bronchitis, 
osteoarthritis in lower limbs, arteriostenosis in 
lower limbs and myocardial infarction. 
Subjective measure of tiredness in daily activities 
measured by validated Mob-T scale. Participants were 
also asked if they felt tired after performing lhe same six 
activities as in lhe Mob-H scale. 1 )transfer 2)walk 
indoors 3) get outdoors 4)walk out of doors in nice 
weather 5) walk out of doors in poor weather 6)manage 
stairs.' 
-
~ ~--. ---- --- --
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Amici Aetal 150 Marigliano-Cacciafesta polypathological sc ale (MCPS): 
2008 Eleven domains of pathology (Neurological, 
cardiopathy, respiratory, locomotor apparatus,sensory 
deprivation, metabolism and nutritional state,cognitive 
state and mood, peripheral vascular system,malignant 
cancerous and gastroenteritic disorders) 
-Slight polypathology <15 scores. 
- Medium polypathology 15-24 scores. 
-Medium-severe polypathology 25-49 scores. 
- Severe polypathology 50-74 scores. 
- Very severe polypathology >75 scores. 
Boxer RS et al 83 A 6 minute walking test ( 6MWT) may be useful to identify 
2008 frailty and those in transition to frailty. 
Ensrud KE et al 79 A simple frailty index with the components of weight loss, 
2008 inability to rise from a chair 5 times without using arms, 
and reduced energy I evel (Study of Osteoporotic 
Fractures [SOF index)) 
Varadhan R et al 65 ' ... frailty .. signifies a loss of resilience in homeostatic 
2008 regulation 
Ravaglia G et al 94 Variables from six domains were considered as potential 
2008 predictors of mortality: socio -demographic, lifestyle, 
medical status, physical function, nutrition, and mood 
and cognitive status' 
GuiJley E et al 151 ' .. expanded working definition of frailty based on 
2008 deficiencies in mobil ity, memory, energy, and 
physical or sensory capacities .. '. 
Buchman AS et 89 A continuous composite measure of frailty based on four 
al2009 frailty components: 
• Grip strength 
• Gait-time to walk 8 feet 
• 8MI 
• Fatigue 
Each of the four compon ents were dichotomized to I 
represent categorical frailty; lowest quintile of >=2 
i L ____ .. _ __ _____ __ _ ____ component defined as frail. 
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The evolution of frailty 
The 60s and 70s 
The concerns regarding the increased number of elderly, bedridden and 
chronically sick patients, can be traced to early literature by Dr Marjory Warren 
who originated her pioneering work in a former Poor Law institution [52] and 
later helped found the British specialty of geriatrics. Following this, geriatric 
medicine had evolved from addressing the problem of 'bed blocking' by 
vulnerable older persons in acute medical wards to the teaching and 
implementation of geriatric assessments in the management and rehabilitation 
of the elderly patient. This greater rise in geriatric medicine during the 1960s 
and 70s could be seen as a response to the needs of the frail elderly. 
In 1960 J.H. Sheldon published in the British Medical Journal the first 
description of the very old, enfeebled person using a special term; the 'frail 
ambulant'[Sl. It was coined in the interest of 'administrative tidiness' in the hope 
of discovering the correct authority to provide custodial care for increasing 
numbers of very old people presenting to acute hospital departments. 
They were described as 'belonging to the later period of old age, beyond 75 
years with 'an increasing amount of breakdown in health ..... imposing a special 
stress on the community'[8] by virtue of its long duration. Problems of physical 
health were seen to emphasize the importance of problems of social health, 
without which the discharge of ... 'these locally cured but constitutionally or 
mentally enfeebled old person may prove exceedingly difficult' [8]. This very first 
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definition of frailty was qualitative and broadly based on physical and 
psychosocial criteria, and also contained an important element of concern about 
the appropriateness or otherwise of frail people occupying acute medical 
resources. 
In 1963,J Agate who based his definition on Sheldon's, described that after the 
age of 80, a state of general frailty was increasingly common. He defined frailty 
as 'a state of semi-dependence ... the patient is not necessarily ill, and may have 
no specific disabilities; yet she cannot sustain an independent life with safety 
and success, even though willing to try and is mentally normal ..... weakness and 
unsteadiness mean that she cannot shop for herself, nor do her own cooking, 
may need help with dressing, toilet and bathing, and someone at her elbow to 
give confidence in walking.'....... 'they do not need regular medical attention or 
nursing care; they do need gentle supervision and much domestic help ..... the 
state of most of such people who live alone at home is precarious.' [50] This 
definition was similarly based on physical, psychological and social criteria. It is 
interesting to note that the 'patient' here was described in decidedly 'feminine' 
terms. In the United States however, early official use of the term 'frail elderly' 
was later introduced in the 1970s through the work of MonSignor Charles F 
Fahey and the Federal Council of Aging. The heterogeneity of this older 
population was acknowledged and this term was selected to focus attention on 
those with 'physical debilities, emotional impairments and debilitating social and 
physical environments'[53]. 
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The 80s 
It was not until the 1980s that researchers began to elaborate on the term. In 
the early phase, the definitions of frailty were theoretical and hence mainly 
qualitative in nature. These definitions were coined for the purpose of identifying 
the characteristics of frail older people and provided the background for future 
description of frailty as having a single or multiple domains. A single domain 
definition by Gadow 1983 gave a psychological description in which frailty was 
seen as a 'devalued phenomenon' particularly identified with aging and 'its 
negative value reflects a rationalist metaphysic in which body and self are 
adversaries'. [54] In this context of frailty, the spirit or self is seen as 
indestructible; the body or flesh is frail. In 1980,another single domain definition 
on a social context by 0' Brien and Wagner described a special population in 
Portland, U.S.A. of frail urban elderly with characteristics of having 'least 
capacity for self maintenance, for whom institutionalization or death are a very 
real potential occurrence'[55]. This study identified the frail as being over 75 
years of age, living alone with sub-poverty levels of income. This early study not 
only stated the importance of the environment in which these older people lived, 
it also emphasized that they were very dependent on social ties (both formal 
and informal) for continued and functional community living. 
In 1988 Woodhouse and associates followed with a social and functional 
definition of frailty defining the frail elderly as individuals over 65 years of age, 
dependent on others for activities of daily living, often in institutional care and 
not independently mobile[3]. Similarly, in 1989, Berkman described this group of 
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older people with the term 'failure to thrive'; having diminished functional ability 
to live with multisystem disease or cope with ensuing problems and manage 
their own care[56]. They were also deemed no longer responsive to health care 
interventions. This sparked the beginning of more functional definitions of frailty 
using measurable parameters of activities of daily living such as the Barthel 
Index and Katz's Instrumental Activities of Daily Living[45]. 
In 1985, Brocklehurst [57] formally described a multi-dimensional definition of 
frailty from a clinical geriatric perspective using his frailty 'Model of breakdown'. 
This model used a balance between biomedical and psychosocial factors which 
were seen as 'assets' or 'deficits' that affect whether a person could live 
independently in the community. On one side of the balance were assets which 
maintained a person's independence in the community: health, functional 
capacity, a positive attitude toward health and other resources. On the other 
were deficits which threatened independence: ill health (particularly chronic 
disease), disability, dependence on others for activities of daily living and 
burden on caregivers [58]. Later in this decade, a consensus mUlti-dimensional 
definition by the National Institute of Health described the frail elderly as 
individuals who 'tend to exhibit great medical complexity and vulnerability; have 
illnesses with atypical and obscure presentations; suffer major cognitive, 
affective and functional problems; are especially vulnerable to iatrogenesis; are 
often socially isolated and economically deprived; and are at high risk for 
premature or inappropriate institutionalization. '[59] 
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A step towards more operational definitions was the construct of a frailty index 
by Wan et al in 1986 where frailty was described as a 'measure of need for care' 
and conceptualized as 'a first order factor of four unobservable health related 
constructs, including self assessed health status, objectively evaluated 
functional status, perceived service needs and instrumental social support 
available among the elderly' [60].This study proposed that the degree of frailty 
among elderly Bostonians can be explained by their use of formal health 
services. Other frailty indices that followed however focused primarily on self 
reports of health and functional status [19, 51]. 
The 90s 
Combinations of single and multiple domains used to define frailty persisted into 
the nineties. These frailty measures were focused on combining domains of 
mainly physical frailty with other domains of nutrition, psychological (cognitive) 
and sensory functioning included [46, 61-63]. In 1994, Rockwood et al 
introduced a dynamiC model of frailty in older people based on Brocklehurst's 
'model of breakdown'. This model referred to frailty as a balance between 
biomedical and psychosocial domains and included those who were dependent 
on others for activities of daily living or those at risk of dependency[18]. Frailty 
was also described as a diminished ability to carry out important practical and 
social activities of daily living[9]. Purely socially based definitions elaborated 
further on how frailty is defined, framed and understood by older persons, their 
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family members, and their health care providers within the context of a 
multidisciplinary geriatric assessment service[64]. 
In this decade, the questions asked were purposely aimed at understanding the 
underlying pathways and mechanisms of frailty and its association with the 
aging process. This began the era of more physiologically based definitions 
which began to dominate the frailty scene and still do so today [65-67]. In 1993, 
Bortz proposed that a loss of cellular energy production was the key to 
underlying biological processes that led to the altered physiology of frail older 
adults. Using the concept of 'synmorphosis', he suggested that frailty was a 
result of 'early disease in multiple systems leading to impaired muscle strength, 
mobility, balance and endurance'[68]. He also stated that frailty was largely 
separable from the process of aging and should therefore be susceptible to 
active intervention and reversal. Similarly, Campbell and Buchner defined frailty 
as a 'condition or syndrome which results from a multi-system reduction in 
reserve capacity to the extent that a number of phYSiological systems are close 
to, or past, the threshold of symptomatic clinical failure'[69]. This set the stage 
for further physiological definitions of frailty by Fried and Walston with their 
'cycle of frailty' which moved future research towards the identification of the 
aetiologies of frailty. They hypothesized that multiple interrelated physiological 
systems such as inflammatory, skeletal muscle, endocrine, clotting and 
haematological changes that might underlie frailty [16, 23] were altered in the 
frail older person. These systems interact with one another and have the 
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influence on overall health and well being. Although no unifying causal 
mechanism has yet been established, current research is focused on outlining 
the various components of frailty through these physiological and biological 
means. 
Another question posed in this decade was whether frail older people were also 
disabled. In 1991, Buchner and Wagner reviewed the concept of frailty as 
'losses of physiologic reserve that increase the risk of disability.' They regarded 
frailty as a pre-disability state which 'represents a loss of physiologic capacity 
that is either not severe enough to interfere with major activities of daily living' 
[70]. However, other research at this time defined frailty through use of physical 
performance measures to determine severity of functional disability in the older 
person [43, 46-49, 71] and therefore did not fully distinguish frailty from 
disability. Another operational definition was the Geriatric Status Scale (GSS) 
which combined a self reported measure of disability and test performance 
measures of cognitive impairment[71]. Frailty was defined here as a 
dependence on others for activities of daily living, and therefore suggested that 
those who were disabled could also be included in its definition. 
By the end of this decade, there were several different opinions on frailty which 
continue on into the 21 st century. Whilst most researchers agree that frailty was 
a process independent of aging, there is some confusion amongst those who 
emphasize on frailty as a pre-disability state and others who make it a state of 
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disability by including physical performance measures. Furthermore, there are 
also those who believe that frailty is best explained as a complex multi-
dimensional state and others who feel a single domain would suffice. These 
differing opinions are illustrated in Figure 2.3. 
Figure 2.3: Questions arising from the various definitions of frailty 
FRAILTY 
The 21 st century 
Two main frailty definitions formed the background for a considerable amount of 
research at the start of the twenty first century; Fried's phenotype of frailty[20] 
and Canadian Study of Health and Aging (CSHA) frailty index [72]. They were 
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developed as clinical tools used to identify frail older people in the clinical setting 
who were at increased at risk of adverse events. Both measures represent 
extreme ends of the various views on the frailty concept; one interprets frailty as 
a form of accelerated aging[72], the other as an entity with a distinct 
pathophysiological basis[20, 73]. In 2001, Fried et al proposed a phenotype of 
frailty which included key components of the hypothesized 'cycle of frailty'. This 
was based on five domains; (unintentional) weight loss , weakness, poor 
endurance and energy, slowness and low physical activity120]. As a screening 
criterion for frailty; this definition required the presence of more than 3 of these 
clinical manifestations and was found to predict various poor clinical outcomes 
such as falls, development of disability, hospitalization and mortality. Other 
researchers have also validated this phenotype and added to the growing body 
of knowledge that focused solely on physical/physiological measures of frailty 
[1,74-77]. 
Fried also proposed that although frailty frequently existed concurrently with co-
morbid disease and disability, it was independent and distinct from these 
characteristics. This view of frailty was debated by experts from a European, 
Canadian and American Geriatric Advisory Panel at a recent International 
Academy on Nutrition and Aging task force meeting who agreed to consider 
frailty to be a pre-disability state. Although there was no consensus on a 
definition or assessment tool for frailty, they decided that as disability was not a 
cause but rather a consequence of frailty, it should not be included in a frailty 
definition or measure[26). 
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The second most frequently validated definition of frailty was the Canadian 
Study of Health and Aging (CSHA) frailty index (FI). Initially developed for 
elderly Canadians, was based on deficit accumulation which was counted using 
self reports or clinically designated symptoms, signs, disease and disabilities. 
This approach paid less attention to which variables were present, but rather 
assumed that the more people had wrong with them, the frailer they would be. 
The rationale behind this was that it made the assessment of frailty widely 
available without special instrumentation, while adhering to the standard view 
that frailty was multiply determined [40). Different FI's have also been 
constructed under a similar assumption, with differing variables included in them 
[19, 40, 78-82]. 
Further measures developed in the past 10 years can be divided into single/dual 
domain or multidimensional measures. Single measures of frailty were purely 
physical/physiological ones such as slow gait speed[22] and/or inability to stand 
up from a chair[24], grip strength[21], six minute walk test[83], low serum 
cholesterol[84] or was simply a score based on a subjective evaluation of an 
individual's general health appearance[85). Multi-dimensional measures 
included self report instruments such as the Vulnerable Elders Survey(VES-13) 
[43] and tiredness in activities of daily living (Mob T scale)[86] as well as the 
Edmonton Frail Scale which included domain of social support[87]. These 
measures provided subjective measures that identify vulnerable frail elderly 
requiring targeted strategies for prevention. These strategies for frailty 
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prevention also arise from more objective measures of frailty which have 
included other domains such as balance, motor processing (speed of 
movement, coordination), and cognition[23, 88]. 
A step towards translating the concept of frailty into a clinical entity was 
introduced in the Clinical Global Impression of Change in Physical Frailty [23]. 
This measure deliberately restricted itself to physical frailty and emphasized the 
concept of structured clinical judgment as a foundation for the measurement of 
frailty. Another frailty measure which attempted to translate the measurement of 
frailty into a clinically sensible tool was the CSHA's 7- point Clinical Frailty Scale 
which classified older persons from very fit to severely frail. This scale mixed 
items such as co-morbidity, cognitive impairment, dependency on ADLs and 
IADLs as well as disability [15]. 
In summary my main findings on this systematic literature review were as 
follows: 
• The last decade had mainly focused on efforts to quantify frailty resulting 
in mainly physical/physiological definitions of frailty [20-22,47,83,89-92]. 
• There was general agreement with the idea that an identifying feature of 
frailty is increased vulnerability to stressors due to impairments in 
multiple, inter-related systems that lead to decline in homeostatic reserve 
and resilience[66, 67, 88]. 
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Standardization of a frailty definition across populations is not, as yet, 
possible as present validated measures were based on different criteria 
and operationalized in different older populations. 
• The measures that provide single domains or combine several different 
variables from self reports of health status, signs, symptoms of disease, 
to functional, sensory and cognitive impairments as well as poor social 
status into the same measure [71, 72] could introduce misclassification 
as they may not be measuring frailty itself but rather co-morbidity or even 
disability. 
• Despite general agreement that frailty and disability were related but 
distinct concepts [26, 74, 88], there were still measures used today that 
include basic activities of daily living in their measurement of frailty [40, 
43,51,93,94]. 
• Despite the controversies and different viewpoints surrounding the 
literature on frailty, the unifying goal appears to be the identification of 
vulnerable older people so as to delay or prevent the onset of serious 
adverse events such as falls, institutionalization, hospitalization and 
death [20, 40, 41, 76, 95, 96]. 
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Discussion 
This systematic search of the various definitions of frailty provided me with an 
insight into how this concept was born and has now evolved into the more 
operational measures we see today. The numerous measures over the past few 
decades were a testament to the fact that clinicians and researchers did 
generally agree that frailty was a useful concept[73]. However, this in-depth 
review of the extensive literature revealed that there was little coherence in the 
many frailty studies conducted over the whole search period. Early theoretical 
definitions were multidimensional encompassing physical/functional, 
psychological and social criteria but were not operationalized to enable robust 
measurement. These operational approaches varied in the critical domains that 
made up the concept of frailty. The impact of the environmental in which old 
people live on frailty, which was initially deemed an important domain in the 
theoretical definitions[9, 55, 68, 69], alongside psychological and social domains 
dropped out of sight. Instead, the physical/physiological domains were the 
primary focus of operationalized definitions. The original concept of frailty as a 
mUlti-dimensional syndrome had been transposed to a focus on 
physical/physiological function and biomarkers of frailty reflecting the move 
away from holistic geriatric medicine practice and a patient-centred approach. 
This move may have arisen in response to more technological approaches and 
a need to be more objective in applying the science of measurement. This 
evolution of frailty concepts could be due to the phYSicians' desire for more 
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tangible and objectively confirmed evidence of patients' needs, which were 
more likely to be treatable by medical means.[97] 
Whilst there are valid reasons to measure frailty (see Chapter 1), until a 
consensus on a standardized definition is reached, we may be missing or 
denying the truly vulnerable in the community benefits of cost-effective 
prevention measures, acute treatment or rehabilitation. Currently although 
single measures may provide useful associations with frailty [21, 22, 84] 
focusing on one component of frailty alone (such as grip strength or gait speed) 
may result in a misclassification of those who are truly frail. On the other hand, 
they may turn out to be 'an adequate, practical screen for assessing 
vulnerability in non-disabled older people, and that the complexity of diagnosing 
frailty may be unnecessary' [73]. To confirm this, more research is needed to 
further our understanding of underlying biological processes and 
pathophysiology of frailty. Until then, we may rely on classifications that are 
already in operation ,such as the ICIDH1 (International Classification of 
Impairments, Disabilities and Handicap 1980, and the current ICF (International 
Classification of Functioning, Disability and Health)[98] . The ICF is a 
classification of health and health related domains that describe body functions 
and structures, activities and participation. The domains are classified from 
body, individual and societal perspectives. Since an individual's functioning and 
disability occurs in a context, ICF also includes a list of environmental factors. 
This provides a scientific basis and a common language for describing, 
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understanding and studying health and health-related states, outcomes and 
determinants. According to the ICF, an individual's functioning in a specific 
domain is an interaction between the health condition and contextual factors 
(i.e. environment and personal factors) Disability (now classified as activity 
limitation), impairment, participation, handicap (participation restriction) are key 
entities that form these associations. The full health experience is described 
using all these components. This would indeed be a useful guide/template for 
defining frailty or serve as a good alternative as it is already in existence. 
However the ICF concept did not 'catch on' as the obvious approach to defining 
frailty. This is perhaps due to the surge in operational definitions which sought 
more tangible means of measuring frailty leading to a greater focus on physical 
domains. 
In my opinion as a practicing geriatrician and student of epidemiology, a 
successful operational definition is one that is multi-dimensional, encompassing 
all the domains which constitute the whole patient. This would include all 
elements that represent the frail older person in terms of body (structure and 
function), person and societal levels. This includes not only the 
physical/physiological domains but also contributions from psychological, social 
and environmental domains. Frailty in the older person is also subject to time 
variations and is reversible, possessing the quality of changing status over time 
(dynamic) for example in acute illness and recovery[77]. An ideal concept of 
frailty should also translate as a multipurpose classification system designed to 
serve various disciplines and sectors across different countries and cultures. 
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However, we must recognize that as the experience of frailty is an individual and 
qualitative one, there may be latent qualities that may not be derived from 
directly observed or measured frailty indicators. This brings my concept of frailty 
closer to it being a 'latent vulnerability' in older people. This phenomenon is 
subtle, often asymptomatic and 'only evident over time when excess 
vulnerability to stressors reduces the older person's ability to maintain or regain 
their homeostasis12]. This concept of frailty will be presented as a measurement 
model of frailty in Chapter 3 of my thesis. 
73 
Chapter 2.2: Measures of frailty and their prognostic 
value in large study populations: a systematic review 
Introduction 
The search for a unifying definition of frailty in older persons is driven by the 
knowledge that they are a special group of individuals at high risk of adverse 
health outcomes such as falls, hospitalization, institutionalization, morbidity and 
death [62, 71, 99]. Improving and maintaining health care services for the 
growing frail elderly population whilst limiting the economic burden that it entails 
is indeed a challenge for all involved in their care as well as policy makers. A 
major obstacle though to impede targeted care and improvement of health 
outcomes of the older population has been the absence of a standardized 
method for screening those who are at risk in the community. 
Frailty, a concept still yet to be defined, has evolved over the past few decades 
as the answer. Although consensus groups [2, 4] have called for a multi-
dimensional definition of frailty, the focus has mainly been on the 
physical/physiological measures and biomarkers of frailty. This quantitative view 
of frailty in the older population was seen to provide tangible means of 
measurement and has been the focus of much literature on the subject [20, 30, 
31,33,63]. 
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The first part of this literature review revealed that the development of the 
existing measures of frailty had been affected by the definition used. The 
diverse views of clinicians and other health care professionals on the nature of 
frailty resulted in the current situation where "frailty" is used without definition, 
measured in a variety of ways and for a range of purposes [9]. Henceforth , 
developers of these measures should make clear underlying assumptions 
regarding the meaning of frailty for the study population being assessed. As a 
'gold standard' definition does not yet exist, predictive validity provides a means 
of evaluating the ability of a frailty measure to demonstrate susceptibility to 
adverse outcomes. The predictive value of the measure is of course dependent 
on the incidence of the adverse outcomes of interest. Many studies have 
attempted to individually validate the various concepts of frailty; none have 
compared all the different frailty measures in large populations. In this section of 
the systematic literature review I examined all the different measures of frailty 
used in study populations of over 1000 persons. My aim was to determine the 
accuracy of the various frailty measures and their prognostic value in 
determining adverse outcomes such as death, institutionalization, 
hospitalization, disability or falls. 
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Method 
Search strategy and data extraction 
Following the same search employed in Chapter 2.1, from the 219 articles 
screened for eligibility, selected studies which presented the 
prognostic/predictive value of their operational frailty measure. These 
operational measures were classified according to Rockwood et ai's description 
of three types of frailty measure[35]: 
• A rules-based/phenotype of frailty, for example, a person may be defined 
as frail if 3 or more symptoms are present[20] 
• The summing up of accumulated deficits (frailty index),a proportion of all 
potential deficits considered for a given person[100] 
• The reliance on clinical judgment, to interpret the results of history taking 
and clinical examination[41]. 
Articles were limited to the English language and community dwelling older 
persons aged over 65 years. Additional inclusion criteria for this part of the 
search were: 
• studies with populations greater than 1000 were selected so as to 
provide greater likelihood of statistical power to the findings 
• a fully defined description of the prognostic variable, in this case, frailty, 
which was available for all or a high proportion of the study population 
• each study population included was followed up for longer than one year. 
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• the outcomes for each study were objective and fully defined with a 
status which was known for all or a high proportion of the subjects. 
• the predictive value of the frailty measure was dependent on the 
incidence of the adverse outcome and the studies selected had clear 
estimates of the effect of frailty on the outcome of interest. 
The exclusion criteria include: 
• study population less than 65 years of age 
• small study populations of less than 1000 people 3) duplicate measures 
on the same population 
• cross sectional studies. 
Of the 219 articles screened, 22 studies were based on operational definitions 
that fulfilled the inclusion criteria of age over 65 years and study population of 
over 1000. From these, 12 articles were validation studies and 10 were from 
operational definitions actually developed in their respective population (see 
Figure 2.4). 
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Figure 2.4: Flow diagram of search strategy on the prognostic value of 
frailty measures in large study populations 
Num ber of full text articles assessed for 
eligibility: 219 
Number of articles on 
frailty definition only: 47 
Num ber of articles on definition 
and validation of frailty: 10 
Articles included in prognostic 
review of large (>1000) study 
populations: 
22 
Articles included for meta-
analysis: 18 
43 excluded 
reasons: 
Intervention studies: 
4 
Reviews: 39 
Other validation 
studies: 119 
107 excluded 
reasons: Small 
populations 
« 1000). age<65 
years. cross 
sectional 
studies. 
duplicate 
measures on 
sam e population 
4 excluded: 
Non -
mortality 
p outcome: 2 
Lack of raw 
data: 2 
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Table 2.4: Measures of Frailty in 22 large study populations according to predicted adverse outcomes. 
Author(reference) Frailty measure Population Type of Frailty outcomes 
Measure (frail vs. non frail) 
Fried LP et al Phenotype of frailty - Presence Cardiovascular Health Rules- Predictive over 3 years: 
2001(20) of 3/>: Study (CHS) based • Falls -(28%v 15%) 
• Unintentional weight (longitudinal) • Hospitalization-(59% v 33%) 
loss N=5317 community • Worsening mobility and ADL 
• Self-reported dwellers aged >65 disability-(39% v 8%) 
exhaustion Prevalence of frailty • Mortality-{18% v 3%) 
• Weakness (grip (overall) 6.9% 
strength) 
• Slow walking speed 
• Low Physical activity 
Saliba et al Vulnerable Elders Survey N=6205 Medicare Rules- The vulnerable group has 4.2 times risk of 
2001(43) (VES-13) beneficiaries aged>65 based death or functional dedine over 2 years: 
-a survey tool which includes Cohort study • Mortality - 10% 
age, SRH and function Prevalence of frailty • Decline in ADUIADL-14% 
32% 
Rockwood K et al Geriatric Status Scale (GSS) Canadian Study of Rules- Death RRisk- adjusted (95%CI) 
2004(100) Mild, moderate or severe frailty Health and Aging based • Mild frailty- 2.54 (1.92,3.37) 
(CSHA) • Mod/severe frailty- 3.69 (2.26,6.02) 
N=9008 community Institutionalization RRisk-adjusted (95%CI) 
dwellers aged >65 
• Mild frailty- 2.54 (1.67,3.86) 
Cohort study Mod/severe frailty-2.60(1.36,4.96) 
(72% response rate) 
Prevalence of frailty: 
7% age 65-74 
17.5% age 75-84 
- --
_ ..1...6.6% age>85 
Continued 
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Author(reference) Frailty measure Population Type of Frailty outcomes 
Measure (frail vs. non frail) 
Puts et ai, 2005(77) Presence of 3/> frailty Longitudinal Study Rules- Predictive of Mortality: 
markers: Amsterdam(LASA) based (frail vs non frail) 
• Body weight N=2257 (72.6% 
• Peak expiratory flow response rate) Static Frailty-
• Cognition Prevalence of frailty 50% v 15% men 
• Vision Problems men vs. women: 27% v 6% women 
• Hearing problems Static frailty (17 vs18%) 
• Incontinence Dynamic frailty (18 Dynamic frailty-
• Sense of mastery 
vs14%) 34% v 17% men 
25% v 7% women 
• Depressive symptoms 
• Phvsical activity 
Woods et al. Phenotype of frailty: The Women's Health Rules- Baseline frailty predicted risk using HR, 
2005[1] Presence of 3/>: Initiative based 95% C.1. 
• Unintentional weight (WHI)Observational • Death 1.71 
loss study (1.48,1.97) 
• Self-reported N= 40657 aged 65-79 • Hip fractures 1.57 (1.11,2.20) 
exhaustion Prevalence of frailty • ADL disability OR=3.15 
• Weakness (grip 16.3% (2.47,4.02) 
strength) Incident frailty 14.8% Hospitalization OR=1.95 (1.72,2.22) 
• Slow walking speed 
• Low-' 
. _. 
. : ... 
Scarcella Final SynthetiC Score(FSS) Sample of 3060 over Rules Predicted 5 year mortality: 
2005(95) originated from answers to a 65 year old citizens of based HR 2.91 (2.25,3.77) 
Geriatric Functional Evaluation Ragusa(ltaly) who lived Use of public care services: 
questionnaire. in their own home. 1.39(1.09,1.77) 
Folsom AR Phenotype of frailty(as above) Four U.S. communities Rules- Predictive of Venous 
2007(34) involving 4859 based Thromboembolism(VTE) 
participants 65 years RR:1.31 (95% CI:0.93-1.84). The 
old and older. comparably adjusted RR for idiopathic 
VTE: 1.79 (95% CI, 1.02-3.13). 
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Author(reference) Frailty measure Population Type of Frailty outcomes 
Measure (frail vs. non frail) 
Bandeen-Roche K et al Phenotype of frailty-presence Women's Health and Rules- Predictive over 3 years: 
2006(74) of 3/>: aging studies(WHAS) based 
• weight loss (>10% of 1&11 Falls:adjusted HR 1.18 
weight at age 60 or >65 years, 
BMI<18.5kg) N=1438 women Severe IADL disability: adjusted 
• self report exhaustion HR 15.79 
• slowness 
• weakness(grip Hospitalization:adjusted HR 0.67 
strength) 
Permanent nursing home entry: 
adjusted HR 23.98 
Death:adjusted HR 6.03 
Cawthorn 2007(75) Phenotype of frailty: Presence Osteoporotic Fractures Rules- Age adjusted HR for mortality-
of 3/> in Men (MrOS) study. based Frail men 4.41 (95%CI=3.43,5.67) 
• Sarcopenia N=5993 community Prefrail men 1.74 (1.47,2.07) 
• Weakness dwellers aged >65 compared with robust men. 
• Self report years 
exhaustion Prevalence of frailty 4% 
• Low activity level 
• Slow walking 
speed 
Similar but not identical 
measurements to CHS study 
Ensrud 2007(76) Based on Fried's phenotype of Study of Osteoporotic Rules- Recurrent Falls -MOR=1.38( 1.02-
frailty (as above) Fractures (SOF) based 1.88) 
N=6724 Caucasian 
community dwelling Death- 1.B2MHR=1.B2(1.56,2.13) 
women aged >69 
Prevalence of frailty 
16.3% 
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Author(reference) Frailty measure Population Type of Frailty outcomes 
Measure (frail vs. non frail) 
Avila-Funes JA et al Phenotype of frailty - Presence Three City Study (3-C) Rules- Predictive over 4 years of: 
2009(104) of 3/>: French community based 
• Shrinking:weight loss> dwelling older people Incident disability 
3kg >65 years. (mobility,IADL,ADL): 
• Self-reported N=6078 adjusted OR 1.58 (2.10,3.20) 
exhaustion 
• Slow walking speed Hospitalization: 
• Weakness( difficulty adjusted OR 1.36 
rising from chair) 
Death: adjusted HR 1.21 
• Low Physical activity 
Ravaglia 2008(94) Frailty score includes nine Conselice Study of Rules- Predicted 4 year risk of Mortality: 
independent predictors of Brain ageing(CSBA) based HR1.99 (1.82,2.18) 
mortality N=1007 Italian subjects Fractures: 
aged >65 years. OR 1.40(1.12,1.73) 
Hospitalisation: 
OR 1.48 (1.26, 1.77) 
New disability: 
OR 2.21(1.73,2.83) 
Worsening disability: 
OR 1.84(1.57, 2.16) 
------
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Author(reference) Frailty measure Population Type of Frailty outcomes 
Measure (frail vs. non frail) 
I Ensrud 200819 Study of Osteoporotic Fracture Study of Osteoporotic Rules-based Predictive of: 
; (79,103) (SOF) index- Presence of 2/>: Fracture 
• Weight loss(>5% between Falls: OR 3.03(men) 2.38(women) 
examinations) N=6701 women aged>69 
• Reduced energy level years Fractures: HR 2.15(men, non-
• Inability to rise from a chair N=3132 men >67 years spine); 1. 79(women~ip/non-spine) 
5 times without using arms 
Disability: OR 5.28(men); 2.17(women) 
Death: HR 2.53(men);2.37 (women) I 
Minitski et a' Frailty Index calculated from 40 self CSHA-wave1 cohort FI FI corresponding to a person's PBA 
2004(51) 
-reported variables study (personal biological age) is predictive of 
N= 8457 complete death within 6 years.(p=0.017) as well as 
information on all 40 survival time 
variables 
Goggins Frailty Index-62 measures Hong Kong cohort of FI Predictive of death with age adjusted RR 
2005(105) comprised of physical, 2032 persons> 70 years (based on 10 year increments: 2.04 
psychological and socioeconomic (999 men and 1033 
variables. women) 
- ---
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Author(reference) Frailty measure Population Type of Frailty outcomes 
Measure (frail vs. non frail) 
Klein et al Frailty index Beaver Dam Eye FI Morbidity: 
2005(78) calculated from cohort study Increase in age-adjusted odds ratio -35% for 
markers: N= 2962 community Cardiovascular disease 
• Gait time dwellers aged 43-86 20% for hypertension 
• Peak expiratory flow 15-20% of cancer (excl.skin)-not significant. 
rate 
• Hand grip strength HR 1.69 (1.38-2.08) with Survival analysis 
• Inability to stand from 
sitting in one chair 
• Visual impairment 
Index range O(no frailty) to 5 
(max frailty) 
Cacciatore F Frailty Staging System(FSS) 'Osservatorio FI Predictive of mortality (over 12 year follow up): fully 
2005(93) consists of geriatrico regione adjusted HR 1.62(with heart failure) and HR 1.24 
7 domains of functioning: Campania' study (without heart failure) 
disability mobility, subjects N=1332 
cognitive, visual and hearing subjects aged >65 
function,urinary continence years. 
and social support. 
Kulminski Frailty Index of 32 measures National Long Term FI Predictive of death at 1 & 21 years of follow up(men 
2007(102) self-rated health, disease, Care Survey(NL rCS) vs. women): 
cognitive and functional 1 year mortality 
impairments(BADL&IADL) Men:RR4.23 
Women:RR 4.99 
21 year mortality: 
Men:RR2.53 
Women:RR 2.24 
Gu 2009(42) Frailty Index of 39 measures Chinese Longitudinal FI Predictive of 3 year mortality at advanced ages. 
from self reports of health Healthy Longevity Mortality was significantly higher in the 3'd and 4th 
status, cognitive functioning, Survey N=13861 (7929 quartile and higher in men at all age groups. 
disability, auditory and visual women,5932 men) 
ability,depression, heart aged 65-109 years. 
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Author(reference) Frailty measure Population Type of Frailty outcomes 
I Measure (frail vs. non frail) 
Hastings 2009(101) Deficit Accumulation 1851 community- FI Any adverse event (repeat 
Index{DAI) dwelling Medicare fee- outpatient ED visit, hospital 
for-service enrollees, admission, nursing home 
aged 65 and older who admission, or death): 27.4 
were discharged from vs.16.2% 
the emergency Risk of adverse 
department (ED) outcome after ED discharge: 
between January 2000 HR 1.44, 95% 
and September 2002. CI: 1.06-1.96. 
Rockwood et al 200S( 7 -point Clinical Frailty CSHA{wave 2) cohort Clinical Predictive validity for 
(41) Scale: study judgement Death (HR=1.30, 1.27-1.33) 
• categorizes the very fit N=230S community based Institutionalization 
to severely frail dwellers aged >65 HR=1.46,1.39-1.53) 
ROC analyses for adverse 
L-_. ____ outcomes within 70 months 
85 
Table 2.4 summarizes the 22 studies according to type of measure and their 
outcome of interest. These 22 studies were selected by virtue of their respective 
adverse outcomes which varied across the different frailty measures, with the 
majority focusing on outcomes such as death and ADL disability and 
institutionalization. Of these, the common adverse outcome measured was 
risk of death and/or survival which formed the only basis of comparison of the 
prognostic value of the frailty measures reviewed here. Four studies were 
excluded ,two of which had non mortality outcomes[34, 101] one longitudinal 
survey lacked the raw data to enable calculation of a hazard ratio and 
confidence intervals[43] and the other study design was a mixture of a 
longitudinal and cross sectional survey. [102]. 
The final eighteen studies selected were all prospective cohort studies [1, 20, 
41, 42, 51, 74-79, 93-95, 100, 103-105]. Twelve studies used a rules based 
definition offrailty [1, 20, 74-76, 79, 94-96, 100, 103, 104], six of which formed a 
phenotype of frailty. Although similar in theory to Fried's phenotype of physical 
frailty, some rules- based measures used different frailty markers to determine 
the criteria for frailty [74, 77, 79] whilst other rules- based measures included 
markers based on self reported health, instrumental activities of daily living 
(IADL) as well as social and psychological domains. Summing up of deficits 
using the frailty index was reported in five studies. The frailty index initially 
validated by Minitski in 2004 from the CSHA cohorts used only self reported 
variables. Later studies included other domains[42, 93, 105] whilst one 
calculated a frailty index only from accepted physical frailty markers[78]. Only 
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one study employed clinical judgment as a measure of frailty[41]. The CSHA 
population studies developed three frailty measures published in three separate 
studies which were derived from the same population of older Canadians [19, 
41, 51]. The other fifteen measures were derived from different study 
populations. 
Statistical analyses 
A meta-analysis was carried out for each measure of frailty where data was 
available according to the criteria above. For each frailty measure, a pooled 
estimate (hazard ratio and relative risk) was calculated using the random effects 
model, along with a 95% confidence interval to measure the strength of the 
association between each measure of frailty and all cause mortality. The 
random effects model incorporates an estimate of between study variations 
(heterogeneity) into the calculation of the common effect, hence taking into 
account smaller studies[106]. Heterogeneity of effect or similarities between the 
studies was evaluated by the I-square statistic. Further exploration of 
heterogeneity among the studies was conducted by examining effect sizes by 
different subgroups. These subgroups include type of measure (rules-based or 
frailty index), age group (over or under 75 years), sex, number of variables 
included in each frailty measure (5 or less, 6 to 20 or more than 20 variables) as 
well as duration of follow up (more than or less than 5 years). 
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As with all meta-analyses, this review has the potential for publication bias. The 
Begg and Egger test [106] was conducted including all 18 studies to assess for 
evidence of publication bias. Data was analyzed using Stata version 10. 
Results 
The study populations mainly consisted of community dwelling older adults aged 
65 years and older, from the Northern hemisphere with the exception of two 
Chinese population studies [42, 105]. Most of the populations were age stratified 
however one study[100] had over sampling of the two older cohorts 
respectively. Only one study population [76, 79] clearly excluded ethnic 
minorities in their sample population because of their low incidence of hip 
fractures. The ethnic groups were found to be frailer in these populations [1, 20). 
Both sexes were included in the study populations with a majority of women in 
each population, except for four female [1, 74, 76, 79).and two male [75, 103] 
study populations. 
Prevalence of frailty in the different populations varied greatly and ranged 
anywhere from 4 to 32%. Whether the measures were rules-based, clinical 
judgment based or a sum of deficits index, frailty was greater with increasing 
age in all the studies and was found to be higher in women compared to men 
except for one study population[78]. However, it was unclear whether frailty 
predicted a higher predicted mortality in men when compared with women, as 
this differed even when using the same type of measure [20, 79, 103). All the 
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studies addressed appropriate and clearly focused questions which were mainly 
to measure or identify the frail elderly in their individual populations in relation to 
their risk for adverse outcomes which were also clearly defined. The selection of 
subjects was clearly stated as random in only 6 studies [42, 43, 51, 78, 96, 104]. 
All studies addressed the number of subjects studied at baseline and follow up 
but not all provided information on subjects who dropped out or were lost to 
follow up. Accuracy of performance of the individual frailty measures in 
predicting death using receiver operating curves (ROC) and area under the 
curve (AUC) was calculated in only six of the nineteen frailty measures[41, 43, 
79, 103]. Three of these measures were developed in the same population of 
the Canadian Health and Aging study (the CSHA frailty index, the CSHA rules-
based definition and the CSHA Clinical Frailty Scale) [41].AII these measures 
reported an AUC ranging from 0.68 to 0.78 which show a moderately good 
performance in the prediction of all cause mortality. 
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Table 2.5: Frailty measures in eighteen large study populations with estimated risk of death (95% confidence 
interval) according to type of measure, gender and years of follow up. 
Author Type of Frailty Total N Gender (%) Adjusted Hazard (95% Col) Follow up(years) 
Measure Ratio (HR) 
Fried2oo1 Rules 5317 57.9<j? 2.24 (1.51, 3.33) 3 
1.63 (1.27, 2.08) 7 
Rockwood2004:j: Rules 9008 59.5~ 1.17 (1.13,1.20) 5 
Puts2oo5 Rules 2257 52.9~ (1.8,3.8) 3 
(1.7,3.2)t 
Woods2005** Rules 40657 100~ 1.71 (1.48,1.97) 5.9 
Scarcella 2005 Rules 3060 57~ 2.91 (2.25, 3.77) 5 
Sandeen-Roche Rules 1438 1OO~ 6.03 (3.00, 12.08) 3 
2006 
Cawthon2oo7** Rules 5993 100<:3' 2.05 (1.55, 2.~ 4.7 
Ensrud2oo7** Rules 6724 100~ 1.82 (1.56, 2.1:) 9 
Ravaglia 2008 Rules 1007 1.99 (1.82,2.18) 4 
--_.-
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Author Type of Frailty Total N Gender(%) Adjusted Hazard Follow up (years) 
Measure Ratio (HR)* (95% Col) 
Avila-Funes 2008 Rules 6078 61.3~ 1.21 (0.78,1.87) 4 
Ensrud 2008** Rules 6701? 100~ Women: 2.37 (2.14,2.61) 9 
Ensrud 2009** Rules 3132? 1003 Men: 2.53 (1.75,3.66) 3 
Cacciotore 2005 FI 1139 56.4~ 1.24 1.04,1.57 12 
Minitski2004* FI 8457 59.5~ 1.26 (1.24, 1.29) 12 
Klein2005 FI 2515 56.7~ 1.69 (1.38, 2.08) 4.5 
Goggins 2005 FI 2032 50.8~ 2.04 (1.88,2.22) 10 
Gu2009 FI 7901? 57.2~ Men: 3.86 (1.62, 6.09) 3 
5960? 42.83 Women: 2.94 (1.84, 4.04) 
Rockwood2005* Clinical Judgment 2305 62.1~ 1.3 (1.27,1.33) 5 
* RR, HR based on adjusted rates on various confounders e.g.: age (all), sex, ethnicity, education, co morbid disease, self rated health, living alone, 
unmarried, cognitive impairment, smoking, functional status, socioeconomic status and disability, body mass index, estrogen use, femoral neck bone 
mineral density. -Single gender studies tRR based on static frailty :t CSHA studies 
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The risk of death between the frail versus non frail in their sample population 
was mainly calculated using the Cox proportional hazards method as shown in 
Table 2.5, and based on a follow-up times between one to 12 years. These 
were grouped into rules based, FI and clinical judgment based definitions. 80th 
adjusted and unadjusted rates for death were associated with frailty in all the 
study populations. Adjusted hazard ratios for death Isurvival ranged from 1.17 to 
6.03 and 95% confidence intervals that did not include 1. All these studies 
typically adjusted for age and sex but differed with respect to the other 
covariates which were up to 25 in number. These include education, co morbid 
disease, socioeconomic status, smoking, ethnicity, self reported health status, 
living alone, being unmarried, functional status and disability. Single gender 
studies also included other confounders such as body mass index (8MI), 
femoral neck bone mineral density and oestrogen use.[1, 75, 76] 
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Meta-analysis 
Figure 2.5: Forest plot comparing the risk of all cause mortality (Hazard 
ratios and 95% Col.) between different frailty measures in large study 
populations 
Study % 
ID ES (95% el) Weight 
... I 
Avila-Funes et al 2008 
I 
1.21 (0.78, 1.88) 2.86 
8andeen-Roche et al 2006 I 6.03 (3.00, 12.12) 1.52 I 
Cacciotore et al 2005 I 1.24 (1 .04, 1.48) 5.60 I 
Cawthome et al 2007 (Male) 
-f+!- 2.05 (1 .55, 2.71) 4.38 
Ensrud et al 2007 (Female) 1.82 (1 .56 , 2.12) 5.85 
Ensrud et al 2008 (Female) :- 2.37 (2.14, 2.62) 6.37 
Ensrud et al 2009 (Male) J.-..!+-I 2.53 (1.75, 3.66) 3.46 
Fried et al 2001 (a) 
-ti£- 2.24 (1 .51, 3.32) 3.23 
Fried et al 2001 (b) ~ 1.63 (1 .27, 2.09) 4.73 
Goggins et al 2005 ... 2.04 (1 .86, 2.21) 6.54 
Gu et al 2009 (Female) 
" 
2.94 (1 .84, 4.70) 2.65 
Gu et al 2009 (Male) ,. 3.86 (1 .62, 9.20) 1.06 
Klein et al 2005 1.69 (1 .38, 2.07) 5.28 
Minitski et al 2004 1.26 (1 .24, 1.28) 6.84 
Puts et al 2005 (Female) 2.60 (1 .80, 3.76) 3.47 
Puts et al 2005 (Male) 2.30 (1 .70, 3.11) 4.13 
Ravaglia et al 2008 1.99 (1 .82,2.18) 6.48 
Rockwood et al 2004 1.17 (1.13, 1.21) 6.79 
Rockwood et al 2005 1.30 (1 .27, 1.33) 6.62 
Scarcella et al 2005 2.91 (2.53, 3.35) 6.00 
Woods et al 2005 (Female) 1.71 (1 .46, 1.96) 5.95 
Overall (I-squared = 96.9% , P = 0.000) 1.85 (1 .66, 2.04) 100.00 
NOTE: Weights are from random effects analysis 
.5 2 5 10 
Hazard Ratio 
Figure 2.5 displays the results for the effect of each frailty measure as 
estimated by each of the 18 study populations_ The results of each prognostic 
study are shown as hazard ratios with 95% confidence intervals, with a hazard 
ratio of more than 1 representing a risk of all cause mortality_ Overall, the 
combined hazard ratio for the comparison of the estimated risk of death by the 
individual frailty measures was 1_85, 95%C_L: 1.68, 2,04, p<0_001.There was 
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extensive evidence of heterogeneity between the hazard ratios in these study 
populations (l-squared=96.9%, p<O.001). The possible reasons for the 
heterogeneity was explored by examining the effect sizes in subgroups by type 
of frailty measure (rules-based or index), age, sex, length of follow up, the 
number of variables included in each measure and number of covariates 
adjusted for. Although the results of this sensitivity analyses were still very 
heterogeneous, there were specific differences in the degree of heterogeneity in 
the subgroups. The frailty measures which were made up of less than five 
variables demonstrated a lower I-square statistic (76.5%, p<0.001), compared 
with measures which had up to 20 or more variables. Lower 1- square statistics 
were also demonstrated in subjects who were under 75 years of age (1-
square=87.9%, p<O.001), shorter duration of follow up of less than five years (1-
square=62.3%, p<0.001). There was considerably less heterogeneity among 
male participants and when 10 or more covariates were adjusted for in the Cox 
regression analysis of the different frailty measures (see Figures 2.6-2.9). 
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Figure 2.6: Forest plot comparing the risk of all cause 
mortality (hazard ratios and 95% C.I.) between different 
frailty measures in large study populations stratified by 
the number of covariates adjusted for. 
Sludy % 
ID ES (95% CI) Weighl 
-- , 
o to 5 I 
Ensrud el al 2008 (Female) 
.t 2.37 (2.14, 2.62) 6.37 Ensnud el al 2009 (Male) 2.53 (1.75, 3.66) 3.46 Goggins el al 2005 2.04 (1 .88, 2.21) 6.54 Klein el al 2005 1.69 (1.38, 2.07) 5.28 Min~ski el al 2004 1.26 (1 .24, 1.28) 6.84 
PuIs el a12005 (F emale) , 2.60 (1 .80, 3.76) 3.47 PuIs el a12005 (Male) 2.30 (1 .70, 3.11) 4.13 
Ravagl ia el al 2008 1.99 (1 .82, 2.18) 6.48 
Rockwood el al 2005 
-:. 1.30 (1 .27, 1.33) 6.82 Scarcella el al 2005 2.91 (2.53, 3.35) 6.00 
Subtotal (I-squared = 98.3%, P = 0 .000) <> 1.96 (1 .71 , 2.25) 55.38 I 
I 
6 to 10 I 
Avila-Funes el al2008 I 1.21 (0.78, 1.88) 2.86 
Bandeen-Roche el al 2006 • 6.03 (3.00, 12.12) 1.52 Cacciolore el al 2005 1.24 (1.04, 1.48) 5.60 
Gu el al 2009 (Female) 2.84 (1.84, 4.70) 2.65 
Gu el al 2009 (Male) 3.86 (1.62, 9.20) 1.06 
Rockwood el al 2004 1.17 (1 .13, 1.21) 6.79 
Subtotal (I-squared = 88.4%, p = 0 .000) 1.86 (1.34, 2.57) 20.48 
>10 
I 
I 
Cawthorne el al 2007 (Male) f 2.05 (1.55, 2.71 ) 4.38 Ensrud el al 2007 (Female) 1.82 (1.56, 2.12) 5.85 Fried el al 2001 (a) 2.24 (1 .51 , 3.32) 3.23 Fried el al 2001 (b) 1.63 (1 .27, 2.09) 4.73 Woods el al 2005 (Female) 1.71 (1.48, 1.98) 5.95 Subtotal (I-squared = 0 .0%, p = 0 .539) 1.79 (1 .64, 1.96) 24.13 
I 
Overall (I-squared = 96.9 %, p = 0 .000) ~ 1.85 (1.68, 2.04) 100.00 
NOTE: WeiQhls are from random effects analvsis 
~ 5 10 
Hazard Ratio 
Figure 2.7: Forest plot comparing the risk of all cause 
mortality (hazard ratios and 95% C.I.) between different 
frailty measures in large study populations, stratified by 
sex. 
% Sludy 
10 ES (95% CI) Weight 
Both sex 
Avila-Funes el al 2008 
Cacciatore et al 2005 
Fried el al 2001 (a) 
Fried el aI2001 (b) 
Goggins el al 2005 
Klein et al 2005 
Minilski el al 2004 
Ravaglia el al 2008 
Rockwood el al 2004 
Rockwood et al 2005 
Scarcella el al 2005 
Subtotal (I-squared = 97.5%, P = 0 .000) 
Male 
Cawthorne el a12007 (Male) 
Ensnud el al 2009 (Male) 
Gu el al 2009 (M ale) 
Puts et al 2005 (Male) 
Subtotal (I-squared = 0.0%, p = 0.518) 
Female 
Bandeen-Roche el al 2006 
Ensnud el al2OO7 (Female) 
Ensrud el al2008 (Female) 
Gu el al 2009 (Female) 
Puts el al 2005 (Female) 
Woods e\ al 2005 (Female) 
Subtotal (I-squared = 82 .5% , P = 0 .000) 
Overall (I-squared = 96.9%, P = O.oqo) 
NOTE: WeiQhls are from random effecls analvsis 
.5 
,. 
I 
I 
I 
I :. 0: 
I 
I 
~ 
~-
I 
I 
I , 
~ 
.--P 
I 
~ 
2 
Hazard Ratio 
10 
1.21 (0.78, 1.88) 2.86 
1.24 (1.04, 1.48) 5.60 
2.24 (1.51 , 3.32) 3.23 
1.63 (1.27, 2.09) 4.73 
2.04 (1.88, 2.21) 6.54 
1.69 (1.38, 2.07) 5.28 
1.26 (1.24, 1.28) 6.84 
1.99 (1.82, 2.18) 6.48 
1.17 (1.13, 1.21) 6.79 
1.30 (1.27, 1.33) 6.82 
2.91 (2.53, 3.35) 6.00 
1.61 (1.45, 1.79) 61 .17 
2.05 (1 .55, 2.71 ) 4.38 
2.53 (1.75, 3.66) 3.46 
3.86 (1 .62, 9.20) 1.06 
2.30 (1.70, 3.11 ) 4.13 
2.29 (1.92, 2.73) 13.03 
6.03 (3.00, 12.12) 1.52 
1.82 (1.56, 2.12) 5.85 
2.37 (2.14, 2.62) 6.37 
2.84 (1.84, 4.70) 2.65 
2.60 (1.80, 3.76) 3.47 
1.71 (1.48, 1.98) 5.95 
2.30 (1.86, 2.83) 25.80 
1.85 (1.88, 2.04) 100.00 
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Figure 2.8: Forest plot comparing the risk of all cause 
mortality (hazard ratios and 95% Col.) between 
different frailty measures in large study populations 
stratified by number of variables in each measure 
Study 
ID 
5 or less variables 
Avila-Funes et al2008 
Sandeen-Roche et al 2006 
Ca'Mhome et 012007 (Male) 
Ensrud et a12007 (Female) 
Ensrud et al 2008 (Female) 
Ensrud et al 2009 (Male) 
Fried et al2001 (a) 
Fried et al2001 (b) 
Klein et al 2005 
Woods et al 2005 (Female) 
Subtotal (I-squared = 76.5% , P" 0.000) 
6 to 20 variables 
Cacciatore et al 2005 
Puts el 012005 (Female) 
Puts et 012005 (Male) 
Ravaglla ot al 2008 
Rod<wood ot al 2004 
Rockwood et al2oo5 
Subtotal (I-squared = 96.7% , P " 0.000) 
more than 20 variables 
Goggins ot al 2005 
Gu et a12009 (Fomale) 
Gu et al 2009 (Male) 
Minitsld et al 2004 
Scarcella et al 2005 
Subtotal (I-squared = 98.6%, P = 0.000) 
Overall (I-squared" 96.9%, p = 0.000) 
NOTE: Weiahts are from random effects anatvsis 
.5 
, . 
, 
, 
, 
\-
t , 
, 
, 
~ 
!---4 
.i. 
<:> , 
, 
~ 
Hazard Ratio 
I 
10 
ES (95% CI) 
% 
Weight 
1.21 (0.78, 1.88) 2.86 
6.03 (3.00, 12.12) 1.52 
2.05 (1.55, 2.71) 4.38 
1.82 (1.56, 2. (2) 5.85 
2.37 (2.14, 2.62) 6.37 
2.53 (1.75, 3.66) 3.46 
2.24 (1 .51 , 3.32) 3.23 
1.63 (1 .27, 2.09) 4.73 
1.69 (1.38, 2.07) 5.28 
1.71 (1.48, 1.98) 5.95 
1.97 (1.69, 2.28) 43.63 
1.24 (1 .04, 1.48) 5.60 
2.60 (1 .80, 3.76) 3.47 
2.30(1.70, 3.11) 4.13 
1.99 (1 .82, 2.(8) 6.48 
1.17 (1 .13, 1.21) 6.79 
1.30 (1.27, 1.33) 6.82 
1.56 (1 .35, 1.81) 33.29 
2.04 (1.88, 2.21 ) 6.54 
2.94 (1 .84, 4.70) 2.65 
3.86 (1.62, 9.20) 1.06 
1.26 (1.24, 1.28) 684 
2.91 (2.53, 3.35) 6.00 
2.27 (1 .51 , 3.40) 23.09 
1.85 (1.68, 2.04) 100.00 
Figure 2.9: Forest plot comparing the risk of all cause 
mortality (hazard ratios and 95% C.I.) between 
different frailty measures in large study 
populations,stratified by duration of follow up period. 
Study 
ID 
Less than 5 years 
Avila-Funes et al 2008 
Sandeen-Roche et al 2006 
Cawthorne et al 2007 (Male) 
Ensrud et al 2009 (Male) 
Fried at al2oo1 (a) 
Gu at aI 2009 (Female) 
Gu at al 2009 (Male) 
Klein et al 2005 
Puts et al 2005 (Female) 
Puts et aI 2005 (Male) 
Ravaglia et al 2008 
Subtotal (I-squared = 62.3%, P = 0.003) 
More than 5 years 
Cacciatore et al 2005 
Ensrud et al 2007 (Female) 
Ensrud et al 2008 (Female) 
Fried et a12001 (b) 
Goggins et aI 2005 
Minrtski et al 2004 
Rod<wood et al 2004 
Rod<wood et al 2005 
Scarcella et al 2005 
Woads et al 2005 (Female) 
Subtotal (I-squared = 98.1 %, P = 0.000) 
Overall (I-squared = 96.9·~, P" 0.000) 
NOTE: Weiahts are from random effects analvs is 
.5 
ES (95% CI) 
% 
Weight 
, 1.21 (0.78, 1.88) 2.88 
, • 6 .03 (3.00, 12.12) 1.52 
___ 2.05 (1 .55, 2.71) 4.38 
~ 2.53 (1.75, 3.66) 3.46 
2.24 ( lSI , 3.32) 3.23 
r---.-- 2.94 (1 .64, 4.70) 2.65 
•
1 . 3.86 (1 .62, 9.20) 1.06 
1.69 (1 .38, 2.07) 5.28 
~ 2.60 (1 .80,3.76) 3.47 
~ 2.30(1 .70, 3.11) 4.13 1.99 (1 .82, 2. (8) 6.48 2.20 (1.89, 2.57) 38.51 , 
, 
, 
, 
, 
, 
~ 
, 
~ , 
, 
I 
2 
• 
I 
5 
I 
10 
1.24 (1 .04, 1.48) 5.60 
1.82 (1 .56, 2. (2) 5.85 
2.37 (2.14, 2.62) 6.37 
1.63 (1 .27, 2.09) 4.73 
2.04 (1.88, 2.21) 6.54 
1.26 (1 .24, 1.28) 6.64 
1.17(1 .13, 1.21) 6.79 
1.30 (1.27, 1.33) 6.82 
2.91 (2.53, 3.35) 6.00 
1.71 (1.48, 1.98) 5.95 
1.66 (1.48, 1.85) 61.49 
1.85 (1 .68, 2.04) 100.00 
Hazard Ratio 
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Figure 2.10 shows a Begg's funnel plot which is asymmetrical indicating a 
strong evidence of publication Ismail study bias(Egger's test's<O.001) . 
Figure 2.10: 8egg's funnel plot with pseudo 95% confidence limits 
2 
o 
o 
logHR 
o 
-1 
o .2 .4 
s.e. of: 10gHR 
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Discussion 
The prognostic value of various frailty measures were evaluated in 18 large 
study populations. A meta-analysis was conducted to enable a more reliable 
overall assessment of the validity of these measures in predicting all cause 
mortality. A direct comparison of all the different frailty measures showed 
extensive evidence of heterogeneity (I-squared 97%, p<0.001) (see Figure 
2.5), in that the prediction of all cause mortality differed greatly between the 
study populations. When a sensitivity analysis was conducted to evaluate 
reasons for this heterogeneity (see Figures 2.6·2.9), there remained 
considerable evidence of heterogeneity. However, this was less extreme than 
the original heterogeneity evident before when considering age (under 75 
years), male sex, number of variables used in frailty measure (5 or less), a 
shorter duration of follow up (less than 5 years), a higher number of covariates 
adjusted for (more than 10) in the association between frailty and mortality. To 
date, there has been no published meta-analysis comparing all the different 
types of frailty measures and their prognostic value. This may be due to the 
difficulty in identifying all the prognostic studies, the variations in study design, 
methods of analysis and measurement of frailty (using different cut-points) as 
well as differing statistical methods of adjustments for a wide range of 
covariates[1061 
So far, comparisons made on different measures of frailty in large populations 
have been carried out by the CSHA group who had developed three types of 
measures [41, 51, 71 J. They found that in a sample population of older 
Canadians, the predictive validity of the Frailty index and Clinical Frailty Scale 
(clinical judgment based) were indistinguishable, performing better than the 
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rules based definition, the Geriatric Status Scale (41). Another article by the 
same group used the frailty index based on accumulation of health problems 
and their relationship with mortality in fourteen sample populations (N=36424) 
of four developed countries(Canada, Australia, United States of America and 
Sweden) [15].The findings were that women were frailer than men, and for both 
sexes, the mortality rate increased significantly (p<0.001) with increases in the 
frailty index. However, this should be interpreted with caution as some samples 
were cross sectional and not able to measure outcomes prospectively. This 
particular study was not included in this meta-analysis as it included clinical and 
institutional samples as well as cross sectional ones. Other comparisons 
studies have been based on two approaches to measuring frailty in the elderly 
[74,79, 107]. This in effect tells us that any further comparisons should perhaps 
be saved for a time iflwhen a consensus is reached on the whole concept of 
frailty. 
My decision to limit the studies to those with large populations of greater than 
1000 narrowed the search to community dwelling older populations. Selection of 
large population studies should, to a certain extent, enable generalization of one 
set of findings to another. However, relating frailty to the community dwellers 
may only provide conservative estimates of the true population prevalence of 
frailty as those groups who are at greatest risk of being frail, such as the 
institutionalized elderly, those unable to walk, the oldest old as well as those 
with dementia will be excluded (or may be non-responders) in these study 
populations. 
A limitation with meta-analysis is the combining of results of all the studies into 
one overall estimate is not recommended as a prominent component of 
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systematic reviews of observational studies as it could be misleading and lead 
to bias[106]. However, it does allow for a thorough investigation into all possible 
sources of heterogeneity (via sensitivity analysis) which could provide more 
insight into the reasons for this. 
The 8egg's funnel plot which is based on the precision of the effect of mortality 
will increase as the sample size of the component studies increases[106]. The 
asymmetrical plot produced in this meta-analysis may indicate small study or 
publication bias. This is in keeping with the very nature of prognostic studies 
which are more prone to publication bias than randomized trials[108] as their 
positive findings are more likely to be published. Another limitation was the lack 
of information on the percentage of ethnic minorities in the target population 
from which the study populations arise from. In this study, only two study 
populations presented separate results for differences of frailty with ethnicity, 
where ethnic minorities were found to be frailer than other Caucasian groups [1, 
20].Inclusion of this information could provide a clearer picture of the 
generalisability of the results in this respect. 
Conclusion and recommendations 
Translating the existing frailty measures into a standard, clinically practical tool 
to precisely measure frailty has been a challenge for researchers working in the 
care of older persons. If a consensus definition is to be reached, more 
collaborative work is certainly required on what factors constitute frailty, its 
causes and associations and pathophysiology. However, a standard measure of 
frailty requires that it is actually measuring frailty as an entity on its own, rather 
than other factors such as co morbidity, disability or even proximity to death. I 
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will address this in Chapter 3 in the development of an internally reliable 
measure of frailty. 
This review highlights that there must be common ground in terms of types of 
population; numbers, study design, confounding factors and the adverse 
outcome studied. Although previous studies have revealed important 
information on frailty, new prospective cohorts created for the sole purpose of 
frailty research may enable a meta-analysis to be conducted in the future. The 
studies in this review were mainly cohort which offered a wealth of demographic 
and health characteristics useful for understanding the pathway to frailty but 
relied on baseline data which may have been collected for other purposes. 
Therefore, they were not designed to answer specific questions on frailty but a 
bigger research question. This indicates that perhaps the time had come to 
'design new cohort studies that put frailty at the centre of their scientific 
paradigm'[73]. A recommendation for the future may be to conduct a 
randomized controlled trial for frailty where the hypothesis is that screening for 
frailty will result in a better clinical outcome. This method would be used to 
compare different frailty measures with the number of adverse events (for 
example death) avoided as the outcome. 
Until then, future studies could focus on detecting frailty in much larger 
populations, making comparisons between men and women, ethnic and socio-
economic groups as well as on estimating the economic burden of frailty in 
older populations. Unless a consensus definition is reached, targeting 
preventative measures or care interventions in the pre-frail population using 
current non standardized measures may not be particularly useful for the older 
person or cost effective to health care systems. A novel approach would be to 
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channel our resources towards the identification of the very frail that are at 
greater risk of adverse outcomes so as to decide on the correct pathway of care 
needed; for example, palliative or rehabilitative care. 
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Summary: 
• The systematic literature review identified studies that used various 
terms apart from 'frailty' to describe and predict adverse outcomes in the 
same population of frail older people at risk. 
• Although the purposes behind identifying frailty in older people remains 
the same, its evolution from concept to measure has translated a holistic 
geriatric approach to a more tangible measurement which focus greatly 
on physical frailty. 
• Two main types of operational frailty measures (rules based or deficit 
accumulation index) dominate the research publications on frailty with 
variations in the frailty indicators included in them. 
• A formal meta-analysis on observational studies to assess the 
prognostic value of various frailty measures revealed extensive 
heterogeneity in the prediction of all cause mortality even after 
considering age, sex, number of variables used in frailty measure, 
duration of follow up, number of covariates adjusted for in the association 
between frailty and mortality. 
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Chapter 3: Development of a model based measure of 
frailty. 
Introduction 
Identifying frail elderly people in clinical practice or in the wider population 
through various aspects of their health and social status is a challenge worth 
attempting as it would enable pre-emptive action to be taken that might avoid 
serious sequelae at individual and population levels. Frailty has been measured 
using markers such as physical ability, self reported health indicators and well 
being, co-morbidity, physiological markers as well as psychosocial factors. 
Despite the efforts to quantify this experience, frailty in older adults remains 
undefined with no consensus about how it should be measured. This is evident 
from the numerous existing frailty measures presented in chapter 2, which were 
driven by a common goal of reducing the burden of suffering that frailty entails -
hospitalisation[20, 94, 101, 104, 109] , falls [20, 45, 74, 75], institutionalisation 
[15,19,74] and death [1,15,19,20,43,51,74,75,93,95,96,102,104,105]. 
A standardized definition and method of measurement could target health and 
social care for elderly people by enabling early detection and thereby reduce 
adverse outcomes and costs of care. Understanding the pathways that lead to 
frailty [31, 33, 95] is also valuable as it may lead to discovery of ways to prevent 
or delay the onset of frailty through interventions that target the 'pre-frail elderly' 
or those at high risk of becoming frail. 
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The current situation has evolved where "frailty" is used without a standardized 
definition, measured in a variety of ways and for a range of purposes [9]. This 
had resulted in three types of measures that exist in literature - rules based, 
clinical judgement and indexes [35].The first determined that frailty was made 
up of a set number of criteria. Fried's rules-based frailty criteria, as validated by 
other studies [1,74-76,104], gave primacy to physical measures of frailty. Other 
measures assume a mUlti-dimensional form [17, 23, 62] or, at the other 
extreme, a single component physical/physiological measure such as grip 
strength[21 ],walking speed[22, 83], functional reach[11 0] and blood markers[32, 
84, 111].Frailty measures relying on clinical judgement to interpret results of 
history taking and clinical examination are unlikely to be repeatable and will vary 
from clinician to clinician making them of little value for research or audit 
purposes[15]. The frailty index approach was based on a proportion of deficits 
accumulated in an individual in relation to age [40, 51]. The problem with this 
measure was the use of 'unweighted' variables which assumed that deficits 
such as 'cancer' and 'arthritis' were of equal importance to one another in 
indexing frailty. Also, in large indexes (40 or more variables) a smaller subset of 
items, selected at random, were similarly associated with the risk of adverse 
outcomes as the whole set of items[40] .The more variables considered, the 
greater the problems of measurement error and miSSing data. Despite its 
reproducibility, [78, 105] and high correlation with mortality [40, 51], the index 
measure is time consuming and not widely used clinically. Additionally, all three 
types of measures may not be measuring frailty alone but also comprise other 
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entities that overlap with frailty such as morbidity or disability. Despite defining 
apparently useful frailty markers from clinical and physiological characteristics 
and showing strong correlation with the risk of adverse outcomes, none of these 
frailty measures have provided adequate evidence to inform policy and clinical 
practice. 
To date, no model of frailty based on defining and quantifying frailty on a purely 
data driven approach has been produced. Thus, I propose a frailty model 
developed from factor analysis (FA), a robust analytical technique which uses 
latent variables as a means of data reduction to represent a wide range of 
attributes/variability among observed variables on a smaller number of 
dimensions or factors[112]. These latent variables are not directly observed 
but rather inferred (through a statistical model) from directly observed or 
measured variables[113]. This mirrors the concept of frailty as a 'latent 
vulnerability' in older adults, subtle, often asymptomatic and only evident over 
time when excess vulnerability to stressors(e.g. acute illness) reduces the older 
person's ability to maintain or regain their homeostasis[2]. This model's 
advantage over previous frailty measures is that it corrects for measurement 
error and assigns relative weights in the association of each indicator with frailty. 
In this chapter I present a model- based measure of frailty and examine its 
reliability for use in a community dwelling elderly population. This new model of 
frailty was developed using the British Women's Heart and Health Study 
(BWHHS) population and was replicated using data from the "usual care" arm of 
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a large randomised trial of health care in general practice for people aged 75 
and over. 
Description of the British Women's Heart and Health Study 
(BWHHS) population 
The British Women's Heart and Health Study (BWHHS) cohort of women 
provide the dataset for the construct of frailty. This study was based on the 
British Regional Heart Study which recruited men aged 40-59 years in 1978-80 
from 24 towns throughout Britain. The British regional heart study framework 
was used to randomly select women aged 60-79 from general practice lists in 
23 towns in England, Scotland, and Wales. No women were excluded from the 
study, and all 7166 women in the age range, regardless of whether they 
normally lived in private accommodation, a residential home, or a nursing home, 
and irrespective of medical conditions, were invited to participate. Transport to 
examination centres was offered to immobile and frail women. Invitations were 
sent to the women, and two reminders were sent to non-responders. A total of 
4286 women (60% of those invited) participated. Baseline data (from a self 
completed questionnaire, interviews by a research nurse, physical examination, 
and review of primary care medical records) were collected between April 1999 
and March 2001 [114]. At the interview participants were asked about diagnosed 
diseases and underwent a medical examination which recorded blood pressure, 
waist and hip circumference, height and weight. The women completed a 
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questionnaire collecting behavioural and lifestyle data, including smoking habit, 
alcohol consumption and indicators of socio-economic position. The indicators 
used in my secondary analysis of this dataset were based on those collected at 
baseline. 
Description of the MRC trial of assessment and management of 
older people in the community. 
This study was a cluster-randomised factorial trial in 106 general practices 
(43219 eligible patients aged 75 years and older, 78% participation), comparing 
(1) universal versus targeted assessment and (2) subsequent management by 
hospital outpatient geriatric team versus the primary-care team[115]. General 
practices from the MRC General Practice Research Framework were recruited 
to the trial. The sampling of practices was stratified by tertiles of the 
standardized mortality ratio (mortality experience of a local area relative to the 
national mortality) and the Jarman score [116] (a measure of area deprivation) 
to ensure a representative sample of the mortality experience and deprivation 
levels of general practices in the United Kingdom. Practices were randomly 
assigned to two groups receiving targeted or universal screening. All 
participants received a brief multidimensional assessment followed, in the 
universal arm by a nurse led in-depth assessment while in the targeted arm the 
in-depth assessment was offered only to partiCipants with pre-determined 
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problems at the brief assessment. The in depth assessment included a wide 
range of health related, social and psychological factors while in the targeted 
arm only elected patients had a full assessment. The baseline assessments 
were performed between 1995 and 1999. Referrals to the randomised team 
(geriatric management or primary care), other medical or social services, health-
care workers, or agencies, and emergency referrals to the general practitioner 
were based on a standard protocol at the in-depth assessment. In this analysis 
I used data only from participants in the universal arm (53 practices) as they 
were considered a representative sample of community dwelling older people 
receiving "usual" care. People living in nursing homes were not eligible for the 
trial. The frailty indicators extracted from this dataset was matched closely to the 
ones extracted from the BWHHS dataset. Table 3.1 summarizes the frailty 
indicators extracted from both datasets. 
Construct of frailty using the BWHHS indicators 
A multidimensional view of frailty incorporating its physical, physiological, 
psychological and social aspects was represented by the frailty indicators listed 
in Table 3.1. These frailty indicators included those in existing literature [17, 35, 
51,62,74,77,88, 107] that was also available in the dataset. These included 
variables derived from self reports of health status, diseases, symptoms and 
signs, physical activity, activities of daily living, social as well as lifestyle 
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indicators. Blood investigations were deliberately excluded to create a measure 
which was non- invasive and practical to identify older people at risk in a primary 
care setting. These were extracted from the BWHHS database and recoded into 
binary categorical variables, coded as '1' if the indicator was present and '0' of it 
was absent. The indicators chosen in this dataset were limited to those available 
to the MRC Assessment study so that a comparable measure could be 
replicated. The development and testing of my hypothesis on frailty was 
conducted with factor analysis (MPlus version 4.21 software appropriate for 
binary data) using these chosen indicators from which 35 indicators were 
derived and confirmed by the data. This method is explained in detail in the 
following sections. 
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Table 3.1: A summary of the questions representing indicators chosen from 
both the BWHHS and MRC Assessment study datasets. 
BWHHS frailty indicators MRC Assessment of Older People Study frailty 
indicators 
Living with someone else? Does someone else live at home with you? 
Any contact with others i.e. relatives, Do you see relative, friend or neighbour (other than 
friends, siblings, children, neighbours? those you live with)? (daily- rarely) 
How would you describe your health at Compared with other people your age would you say 
present? your health is generally: excellent, good, fair or poor? 
Have you had a fall in past year? In last 6months, how many falls have you had at 
home? (NoneO,1,2,3,4,>4) 
Compared with your activity level 3 Compared with other people your age, would you 
years ago, are you doing more, same describe yourself as .... (v physically active not at all) 
or less? 
Do you have problems washing or Wash all over, include bath and shower. 
dressing? (no problem, some problem Dress yourself including. zips Ibuttons 
,unable to wash and dress) (no difficulty, some, unable but help available, unable 
and no help) 
Is your present state of health causing Do light housework or simple repairs? (no difficulty, 
you problems with household chores? some, unable but help available, unable and no help) 
YIN 
Difficulty in carrying out activity on their Go up and down stairs(if necessary using frame, 
own: going up and downstairs tripod or stick) (no diff, some, unable but help available, unable and 
no help) 
Difficulty in carrying out activity on their Walk 50yrds down the road(if necessary using frame, 
own: walking about/going out of tripod or stick) 
houselwalking 400 yards? (no difficulty, some, unable but help available, unable 
and no help) 
Do you have trouble with your hearing? Do you have difficulty hearing & understanding what a 
person says to you in quiet room, even with hearing 
aid? (no difficulty, a little, a lot) 
Continued 
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BWHHS frailty indicators MRC Assessment of Older People Study 
frailty Indicators 
Do you have trouble with your eyesight?(not Do you have difficulty in seeing newsprint, 
simply needing specs) even when wearing glasses? (no difficulty, a 
little, a lot) 
Compared to five years ago, is your memory: Do you have problems with your everyday 
improved, same, almost as good, worse, much memory?(never, occasional, often, always) 
worse? Dementia on medical exam. 
Your health over all: are you anxious or Do you feel sad depressed or 
depressed, not, moderately, extremely. miserable?(never, occasional, often, always) 
Do you smoke cigarettes currentlyl if so how Do you smoke cigarettes? YIN If yes, how 
many? many do you smoke a day? 
Would you describe your intake During the last year, have you taken an 
as:(1.dailymostdays2.weekends alcoholic drink? YIN 
only3.one/twice a mnth,4.special occasions) During past week (include 0, how many 
drinks have you had of each of the following? 
Spirits(number of singles),wine, sherry or 
port, beers(number of half pints) 
Type of accommodation? (owner occupier, What kind of accommodation do you live 
renting from local authority, renting privately, in?(Council-+ private nursing home) 
other) 
Do your ankles swell up regularly? nla 
Do you ever have any pain or discomfort in your Have you ever had any pain or discomfort in 
chest? your chest? YIN 
Have you ever had a severe pain across the Have you ever had severe pain across front 
front of your chest lasting for half an hour or of your chest lasting >1 hour? YIN 
more? 
When you walk at an ordinary pace on the level Do you get it on walking at an ordinary pace 
does this produce the pain? on the level? YIN 
When you walk uphill or hurry does this produce Do you get this pain when walking uphill? YIN 
the pain? 
Do you usually bring up phlegm (spit) from your Do you usually bring up phlegm first thing in 
chest first thing in the morning in the winter? the morning in the winter? YIN 
Do you bring up phlegm on most days as much Do you bring up phlegm like this on most 
as 3 months in the winter each year? days for as much as 3 months each year? 
YIN 
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BWHHS frailty indicators MRC Assessment of Older People Study 
frailty indicators 
In the past four years, have you ever had a In the past 3 years, have you had a period of 
period of increased cough and phlegm lasting increased cough and phlegm lasting 3wks or 
for 3 weeks or more? more? YIN 
Does your chest often sound wheezy (on Does your chest sound wheezy or whistling on 
most days or nights?) most days (or nights)? YIN 
Do you get short of breath with other people Do you get short of breath walking with people 
of your own age on level ground? of your own age on level ground? Y /N 
Have you ever been told by a doctor that you Has your doctor ever told you that you had any 
have or have had asthma? of the following? 
Asthma? 
Have you ever been told by a doctor that you Bronchitis or emphysema? 
have or have had bronchitis or emphysema? 
Have you ever been told by a doctor that you Arthritis/Rheumatism? 
have or have had arthritis? 
Have you ever been told by a doctor that you High blood pressure? 
have or have had high blood pressure? 
Have you ever been told by a doctor that you Thyroid trouble? 
have or have had thyroid disease? 
Have you ever been told by a doctor that you Cataract? 
have or have had a cataract? 
Have you ever been told by a doctor that you Glaucoma? 
have or have had glaucoma? 
Have you ever been told by a doctor that you Gout? 
have or have had gout? 
Have you ever been told by a doctor that you Depression? 
have or have had depression? 
Have you ever been told by a doctor that you Diabetes? 
have or have had diabetes? 
Continued 
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BWHHS frailty indicators MRC Assessment of Older People Study 
frailty Indicators 
Have you ever been told by a doctor that you Stomach ulcer or other digestive ulcer? 
have or have had gastric or peptic ulcer? 
Have you ever been told by a doctor that you Heart attack? 
have or have had heart attack (MI)? 
Have you ever been told by a doctor that you Angina? 
have or have had angina? 
Have you ever been told by a doctor that you Stroke? 
have or have had a stroke? 
Have you ever been told by a doctor that you Cancer? 
have or have had cancer? 
Have you ever fractured your hip? Fractured hip? 
Have you ever been told by a doctor that you nla 
have or have had Cardiovascular disease 
(diagnosed angina, mi, stroke) 
Body mass index: high or low Body mass index: high or low 
Postural hypotension: according to 1996 Postural hypotension: according to 1996 
consensus definition consensus definition 
Hypertensive (>140/90) Hypertensive (>140/90) 
Waist hip ratio (>/<0.85 Waist hip ratio (>/<0.85 
Sinus tachycardia (>100 bpm) Sinus tachycardia (>100 bpm) 
.. 
*Alllndicators listed were ones originally Included In the factor analysIs (exploratory 
factor analysis) from which 35 indicators were derived and confirmed by the data. 
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Missing data 
Table 3.2 lists the BWHHS frailty indicators included in the measurement model 
with the percentage of missing data present for each indicator. All the BWHHS 
indicators were included in the exploratory part of developing the hypothesis for 
frailty. In the BWHHS cohort, 80% of the indicators had less than 10% missing 
data whereas in the MRC Assessment study, all of the indicators had less than 
5% missing data (see Table 3.3). This analyses were conducted under the 
assumption that the data was misSing at random (MAR)[117]. 
In both cohorts, a complete case was defined as those respondents with 
complete data on all 35 frailty indicators. There were 4286 women respondents 
from the BWHHS database of whom 1568 had complete data. People in the 
MRC replication data set comprised 9032 women (6709 complete data) and 
5622 men (4486 complete data). 
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Table 3.2: BWHHS frailty indicators included in exploratory factor analysis 
with percentage of missing data. 
BWHHS Indicators Present Absent Missing Percentage Total 
missing (%) 
Arthritis 1832 1962 492 11.48 4286 
Asthma 474 3406 406 9.47 4286 
Anxiety/depression 992 2879 415 9.68 4286 
Angina 642 3644 0 0 4286 
Ankle oedema 1730 2102 454 10.59 4286 
Bronchitis 738 3145 403 9.40 4286 
Cancer 556 3730 0 0 4286 
Cataract 527 3304 455 10.62 4286 
Depression 678 3169 439 10.24 4286 
Diabetes 220 4066 0 0 4286 
Hypertension 1572 2411 303 7.07 4286 
Dementia 59 3919 308 7.19 4286 
Heart attack (MI) 199 4087 0 0 4286 
Glaucoma 144 3639 503 11.74 4286 
Stroke 125 4161 0 0 4286 
Cerebrovascular disease 763 3523 0 0 4286 
Thyroid disease 457 3383 446 10.41 4286 
Ulcer 299 3546 441 10.29 4286 
Falls 676 3371 239 5.58 4286 
Hip fracture 59 3576 651 15.19 4286 
Memory 784 3215 287 6.70 4286 
Continued 
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BWHHS Indicators Present Absent Missing Percentage Total 
missing (%) 
Chest discomfort 1233 2736 317 7.4 4286 
Ever had chest pain 205 3764 317 7.4 4286 
On level pain 145 3767 374 8.73 4286 
On uphill pain 494 3417 375 8.75 4286 
Short of breath 754 3192 340 7.93 4286 
Morning phlegm 626 3313 347 8.1 4286 
Most days phlegm 399 3475 412 9.61 4286 
Increased cough 1569 2377 340 7.93 4286 
Often wheeze 353 3399 534 12.46 4286 
Eyesight trouble 746 3077 463 10.8 4286 
Hearing trouble 879 3105 302 7.05 4286 
Postural hypotension 647 3132 507 11.83 4286 
Waist hip ratio 1225 2721 340 7.93 4286 
LowBMI 112 3845 329 7.68 4286 
High BMI 1378 2908 0 0 4286 
Sinus tachycardia 122 3831 333 7.77 4286 
High blood pressure 2329 1635 322 7.51 4286 
Difficulty going out 205 3245 836 19.51 4286 
Walkabout 987 2966 333 7.77 4286 
Difficulty walking 400 517 2990 779 18.18 4286 
yards 
Go up down stairs 848 2784 654 15.26 4286 
Household chores 850 3044 392 9.15 4286 
Wash & dress 375 3582 329 7.68 4286 
Continued 
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BWHHS Indicators Present Absent Missing Percentage Total 
mlsslng(%) 
Status activity 2395 1351 540 12.6 4286 
Present health 127 3924 235 5.48 4286 
Lives alone 1341 2750 195 4.55 4286 
No contact others 956 2108 1222 28.51 4286 
Accommodation 92 3990 204 4.76 4286 
Current smoker 444 3516 326 7.61 4286 
Alcohol 647 3261 378 8.82 4286 
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Table 3.3: MRC Assessment Study frailty indicators showing percentage 
of missing data. 
MRC Assessment Present Absent Missing Percentage Total 
Study Indicators missing (%) 
Arthritis 8167 6338 149 1.02 14654 
Asthma 1484 13046 124 0.85 14654 
Anxiety/depression 1251 13167 236 1.61 14654 
Cancer 1480 13008 166 1.13 14654 
Cataract 4316 10207 131 0.89 14654 
Depression 1608 12887 159 1.09 14654 
Diabetes 1146 13508 0 0.00 14654 
Hypertension 4887 9612 155 1.06 14654 
Emphysema 314 14214 126 0.86 14654 
Heart attack (MI) 1561 12962 131 0.89 14654 
Glaucoma 941 13561 152 1.04 14654 
Stroke 1300 13242 112 0.76 14654 
Thyroid disease 1335 13185 134 0.91 14654 
Ulcer 1758 12747 149 1.02 14654 
Falls 3044 11530 80 0.55 14654 
Hip fracture 548 13962 144 0.98 14654 
Memory 1358 13132 164 1.12 14654 
Chest discomfort 2495 12114 45 0.31 14654 
Ever had chest 1076 13263 315 2.15 14654 
pain 
On level pain 425 13267 962 6.56 14654 
On uphill pain 1328 12466 860 5.67 14654 
Continued 
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MRC Present Absent Missing Percentage Total 
Assessment missing (%) 
Study indicators 
Short of breath 3089 11062 503 3.43 14654 
Morning phlegm 3706 10753 195 1.33 14654 
Most days phlegm 2234 11918 502 3.43 14654 
Increased cough 2036 12378 240 1.64 14654 
Often wheeze 1936 12598 120 0.82 14654 
Eyesight trouble 4776 9699 179 1.22 14654 
Hearing trouble 6304 8183 167 1.14 14654 
Postural 3105 10244 1305 8.91 14654 
hypotension 
Waist hip ratio 9593 5061 0 0.00 14654 
Low BMI 830 12489 1335 9.11 14654 
High BMI 3535 11119 0 0.00 14654 
Sinus tachycardia 451 14071 132 0.90 14654 
High blood 9236 5239 179 1.22 14654 
pressure 
Walk 50 yards 4299 10070 285 1.94 14654 
Go up down stairs 6021 8188 445 3.04 14654 
Household chores 4124 10330 200 1.36 14654 
Wash & dress 4757 9763 134 0.91 14654 
Status activity 3414 11099 141 0.96 14654 
Present health 312 14201 141 0.96 14654 
Lives alone 7741 6758 155 1.06 14654 
No contact others 657 13769 228 1.56 14654 
Accommodation 1285 13237 132 0.90 14654 
Current smoker 1431 13153 70 0.48 14654 
Alcohol 11013 3457 184 1.26 14654 
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Methods 
Statistical analysis: Factor analysis with Exploratory Factor Analysis 
(EFA) and Confirmatory Factor Analysis (CFA) 
In order to better define frailty, factor analysis (FA) appropriate for binary data 
was conducted using the Mp/us software (version 4.2). FA is a statistical 
technique used to analyze correlations among a wide range of observed 
variables to explain these variables, largely or entirely, in terms of their common 
underlying (latent) dimensions called factors, in this case, frailty[112]. EFA was 
used to explore the underlying factor structure of the frailty indicators and 
develop the construct/hypothesis of frailty. The resulting EFA model was 
subjected to CFA to further test this latent structure. We proceeded by testing 
the higher order dimensionality of the EFA driven 1st order solution by estimating 
a 2nd order and a general specific model. In EFA as well as the three CFA 
models (1 st order, 2nd order and General Specific Models), Mplus initially 
estimated the factor loadings and item thresholds. Standardised factor loadings 
can be thought of as the correlation of the original/manifest variable (frailty 
indicator) with a latent factor and are useful in determining the importance of the 
original variable to the factor. Item threshold refers to the level of the latent 
factor (Le. frailty) that needs to be attained for a response shift in the observed 
variables. Although the response scale for each frailty indicator is binary 
(1 "present" or 0 "absent") , the underlying factor model assumes that each 
indicator varies on an underlying continuous scale and each person can be 
located on that continuum[118]. Persons located above a certain threshold on 
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that continuum will endorse that the frailty indicator was present. Each of these 
possible measurement models were analyzed to see which best fit the data as 
well as the concept of frailty. Figure 3.1 gives an overview of the steps taken in 
factor analysis. 
Figure 3.1: Overview of steps in factor analysis using BWHHS frailty 
indicators 
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Factor analysis was carried out on respondents with complete data on all 35 
frailty indicators, which resulted in a study population of 1568 complete cases, 
as well as the total study population of 4286 women which included those with 
partial data (Le. those with at least one frailty indicator missing). In addressing 
the problem of missing data in the frailty indicators used in the analysis, the 
model was estimated with the WLSMV (Weighted Least Squares, Mean and 
Variance adjusted) which applies pair wise missing data analysis using all 
individuals with observations for all possible pairs of variables in the data. 
Individuals with partial data are therefore retained in the analyses and their 
information was used for all further analyses. In our case, the pairs are made 
from frailty items. 
A sensitivity analysis using an unpaired t-test was carried out to compare the 
mean difference between the complete case frailty score of 1568 women and 
the frailty scores of the total population of 4286 women with missing frailty 
indicators included (see Table 3.4). 
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Table 3.4: Sensitivity analysis to compare the mean difference between 
frailty scores in complete dataset to frailty scores in dataset which 
includes missing variables 
Frailty scores Number of Mean Standard 95%C.I. 
observations deviation 
Complete 1568 0.146 0.727 0.110 to 
cases 0.182 
Cases 4286 0.159 0.721 0.138 to 
including at 0.181 
least one 
missing 
indicators 
Mean 0.013 0.023 -0.028 to 
difference* 0.055 
*Degrees of freedom=5852, p value 0.536 
At a 5% level, the difference in means was not significant with a p value of 
0.536, showing no difference in mean scores derived from both groups. 
Goodness of fit tests 
The Scree plot approach, the Kaiser-Guttman rule (for EFA only) and indices of 
fit such as the Comparative Fit Index (CFI), the Tucker Lewis Index (TU) and 
the Root Mean Square Error of Approximation (RMSEA) (for both EFA and 
CFA) were used as a means of evaluating results of the FA. Both the Scree plot 
and Kaiser-Guttman rule was used to decide on the number of 
factors/dimensions to be retained for further analysis[119]. The Scree plot is a 
graph of each Eigen value, which represents the total variance of each 
factor,(Y-axis) against the factor with which it is associated(X-axis).The Kaiser 
Guttman rule retains only factors with Eigen value larger than 1 [119]. 
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The CFI refers to the discrepancy function adjusted for sample size. TLI was 
used to assess the incremental fit of a model compared to a null model. Both 
range from 0 to 1 with a larger value indicating better model fit. Acceptable 
model fit is indicated by a CFI and TLI value of 0.95 or greater. RMSEA is 
related to residual in the model. RMSEA values range from 0 to 1 where an 
acceptable model fit is indicated by an RMSEA value of 0.06 or less. The chi-
squared goodness of fit test and these indices of fit were used to assess model 
fit as suggested by guidelines proposed by Hu and Bentler [120]. These three 
goodness of fit indices were emphasized since the chi-squared test was 
deemed highly sensitive to sample size, leading to rejection of well-fitting 
models. 
Results 
Exploratory factor analysis (EFA) 
Seven factors were needed to adequately explain the common variance 
between the frailty indicators and were labelled as: physical ability, cardiac 
disease or symptoms, respiratory disease or symptoms, physiological 
measures, psychological problems, co morbidity and visual impairment. As 
stated earlier each of these identified latent factors were derived from subsets of 
indicators that correlated strongly with each other and weakly with other 
indicators in the dataset. They provided meaningful theoretical 'explanations' or 
'interpretations' linking them to the overall construct of frailty. 'Physical ability' 
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comprised of highly correlated indicators such as level of activity, ability to do 
household chores, go up and downstairs, walk out and about wash, dress or 
groom oneself. 'Cardiac and respiratory disease or symptoms' included self 
report or doctor diagnosis of myocardial infarction, angina, asthma, chronic 
obstructive airways disease or emphysema and their associated symptoms of 
chest pain or discomfort, pain on uphill or level walking, shortness of breath, 
increase cough or frequent wheeze. The 'physiological measures' included body 
mass index(BMI), waist hip ratio(WHR), pulse rate, blood pressure as well as 
evidence of orthostatic hypotension. Markers such as subjective feelings of 
anxiety or depression, self reports and diagnosis of memory problems and 
depression were meaningfully explained by 'psychological problems'. Other 
indicators such as stroke, diabetes, hypertension, peptic ulcers, thyroid disease 
and cancer were also explained by 'co-morbidity'. Lastly, 'visual impairment' 
explained the correlations between indicators of diagnosed cataract or 
glaucoma as well as a self report of visual problems. 
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Table 3.5: Summary of results from confirmatory factor analysis of the BWHHS and MRC Assessment study 
(complete and missing data) 
CFA 1 Order model CFA2 Order model General Specific model 
BWHHS BWHHS MRC MRC BWHHS BWHHS MRC MRC BWHHS BWHHS MRC 
Indices of complete missing female female complete Missing female female complete missing female 
model fit cases complete missing cases complete missing cases complete 
cases cases cases 
X2 6404.29 22275 42380 76468 6404 22275 42380 76468 6404 22275 42380 
Of 195 251 292 290 195 251 292 290 195 251 292 
P 0.000 0 .000 0.000 0.000 0.000 0 .000 0 .000 0.000 0.000 0 .000 0.000 
CFI 0.938 0.932 0.962 0.968 0.931 0.925 0.954 0 .960 0.957 0.948 0.967 
TLI 0.949 0 .950 0.970 0.976 0.944 0 .946 0 .965 0 .970 0.964 0.962 0.974 
RMSEA 0.032 0.032 0.025 0.027 0.034 0.033 0.027 0.029 0.027 0.028 0.024 
MRC MRC MRC MRC MRC 
male male male male male 
complete misSing complete missing complete 
cases cases cases 
X2 23473 39003 1820 39003 23473 
Of 266 264 355 264 266 
CFI 0 .941 0.962 0.937 0 .957 0.954 
TLI 0 .955 0.972 0.953 0 .969 0.964 
RMSEA 0.029 0.027 0.030 0 .028 0.026 
Cut off criteria for good fit- CFI&TLI >0.95, RMSEA <0.06- Hu and Bentler 1990 
MRC 
female 
missing 
76468 
290 
0.000 
0.969 
0.976 
0.026 
MRC 
male 
missing 
39003 
264 
0.970 
0.978 
0.024 
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Confirmatory Factor Analysis (CFA) 
We empirically compared three latent structures based on the EFA seven factor 
model: 1 st order, 2nd order and General specific models. Model fit statistics for 
each of the models tested in both BWHHS and MRC datasets are shown in 
Table 3.5. These results support the contention that the frailty model of choice 
for both BWHHS women and the MRC Assessment study (both men and 
women) was the General Specific model (See Figure 3.2). 
Figure 3.2: General Specific Model 
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General refers to frailty, the general factor that is loaded (explained by) all the 
indicators. Specific refer to the 7 latent factors that account for the association 
between the frailty indicators and the specific dimensions/factors. The fit of the 
General Specific frailty model was better than each of the other two models 
(Figures 3.6 and 3.7 are described in the Discussion section) in both 
datasets. This was true for participants with complete data as well as those with 
missing data, with very little difference between them. In the BWHHS complete 
data, standardized factor loadings of the frailty indicators by the overall Frailty 
factor (Le. correlations of the observed frailty indicators with Frailty) revealed 
highest loadings (0.60-0.77) on indicators such as being 'short of breath on level 
walking', the inability to do 'household chores', 'walking up and down stairs', 
'walking about', 'wash and dress',' having a low 'status activity level' as well as 
'difficulty going out'. This is followed by midrange loadings (0.3-0.55) of having 
symptoms of 'angina', 'chest discomfort' or 'ever having chest pain', 'arthritis',' 
feeling 'anxious or depressed', 'memory problems', having a 'high body mass 
index ( BMI)' or 'waist hip ratio', 'eyesight trouble', 'hearing trouble' as well as 
having specific diseases(see Table 3.6). These 'weighted' loadings form the 
basis of an idea for which indicator would be useful to include in a frailty 
measure. 
When replicated in the MRC complete dataset of women, these factor loadings 
were similar to the BWHHS dataset. Factor loadings for 'hypertension' and 
'waist hip ratio' by overall frailty, were lower in men compared to women in the 
MRC dataset. 
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Table 3.6: Standardized Factor loadings of the general/overall Frailty factor derived from the General 
Specific model in both the BWHHS and the MRC Assessment study. 
Variable factor BWHHS BWHHS MRC MRC MRC MRC 
Loadings: complete MiSSing female Female Male Male 
cases Complete missing Complete missing 
Cases Cases 
Household chores 0.736 0.759 0.632 0.722 0.718 0.765 
Uo and downstairs 0.725 0.748 0.739 0.800 0.791 0.808 
Walkabout/walkout 0.685 0.673 0.745 0.821 0.865 0.878 
Difficulty going out 0.601 0.635 
Wash and/or dress 0.612 0.594 0.59210.521 0.68310.620 0.657/0.604 0.712/0.685 
Status activitY level 0.616 0.585 0.655 0.731 0.746 0.785 
Arthritis 0.421 0.434 0.324 0.322 0.176 0.206 
Falls 0.261 0.390 0.342 0.389 0.387 0.444 
Eye sight trouble 0.410 0.385 0.485 0.486 0.438 0.467 
Cataract 0.325 0.305 0.229 0.201 0.180 0.186 
Glaucoma 0.195 0.158 0.054 0.063 0.065 0.031 
Angina 0.550 0.587 
Ever had chest pain 0.401 0.413 0.287 0.254 0.274 0.250 
Chest discomfort 0.405 0.482 0.331 0.279 0.341 0.297 
Myocardial Infarction 0.344 0.433 0.303 0.281 0.310 0.273 
Asthma 0.263 0.347 0.196 0.154 0.224 0.201 
Bronchitis/emphysema 0.260 0.320 0.336 0.284 0.369 0.311 
Short of breath on 0.770 0.815 0.676 0.624 0.699 0.683 
level walking 
Increased cough/phlegm 0.247 0.303 0.193 0.150 0.220 0.220 
Morning phlegm 0.305 0.394 0.267 0.231 0.281 0.278 
Deoression 0.300 0.390 0.172 0.150 0.214 0.195 
Anxious or deoressed/sad 0.418 0.462 0.426 0.405 0.367 0.404 
Memory oroblems 0.365 0.399 0.34~ __ 0.354 ___ ~ 0.396 
--
_ 0.447 
Continued 
I 
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Variable factor BWHHS BWHHS MRC MRC MRC MRC I 
Loadings: complete Missing female Female Male Male 
cases Complete missing Complete missing 
Cases Cases 
Hypertensive 0.036 -0.009 -0.054 -0.076 -0.110 -0.116 
(baseline> 140/90) 
Waist Hip Ratio 0.362 0.262 0.228 0.278 0.034 0.040 
(>1<0.85) 
8MI (high) 0.412 0.346 0.342 0.420 0.232 0.348 
Postural hypotension 0.114 0.048 -0.020 -0.009 0.046 0.060 
Sinus tachycardia 0.111 0.058 -0.030 -0.028 0.120 0.102 
Diabetes 0.305 0.244 0.196 0.196 0.178 0.205 
Hypertension 0.340 0.304 0.110 0.060 0.090 0.064 
Stroke 0.412 0.403 0.372 0.411 0.402 0.432 
Stomachl~ptic ulcers 0.241 0.340 0.258 0.196 0.120 0.103 
Th~oid disease 0.191 0.250 0.143 0.104 -0.090 0.095 
Cancer 0.150 0.072 0.033 0.014 0.042 0.018 
Hearing trouble 0.310 0.344 0.357 0.337 0.265 0.290 
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Table 3.7: Standardized factor loadings of the specific factors derived 
from the General Specific model 
Specific Factors BWHHS BWHHS MRC MRC MRC MRC 
complete Missing female Female Male Male 
cases Complete missing Complete Missing 
Cases Cases 
Physical Ability 
Household chores 0.533 0.524 0.624 0.561 0.500 0.477 
Up and downstairs 0.557 0.532 0.483 0.414 0.399 0.378 
Walkabout/walkout 0.622 0.627 0.562 0.459 0.366 0.343 
Difficulty going out 0.622 0.581 
Wash and/or dress 0.635 0.627 0.641/0.632 0.577/0.602 0.657/0.604 0.605/0.540 
Status activity level 0.217 0.263 0.470 0.411 0.746 0.274 
Arthritis 0.372 0.356 0.106 0.043 0.176 0.115 
Falls 0.104 0.097 0.179 0.138 0.387 0.183 
Visual Impairment 
Eye sight trouble 0.792 0.792 0.488 0.467 0.470 0.448 
Cataract 0.678 0.706 0.612 0.636 0.649 0.626 
Glaucoma 0.668 0.673 0.523 0.515 0.566 0.567 
Cardiac symptoms/disease 
Angina 0.619 0.602 
Ever had chest pain 0.674 0.674 0.835 0.829 0.838 0.866 
Chest discomfort 0.411 0.387 0.466 0.476 0.344 0.393 
Myocardial Infarction 0.885 0.797 0.680 0.702 0.737 0.733 
Respiratory 
symptoms/disease 
Asthma 0.659 0.650 Bronchitis/emphysema 0.607 0.601 0.480 0.501 
Short of breath on 0.653 0.674 0.471 0.478 0.440 0.497 
level walking 0.245 0.236 0.317 0.372 0.304 0.354 
Increased cough/phlegm 0.582 0.546 0.491 0.533 0.550 0.546 
Morning phlegm 0.621 0.596 0.509 0.538 0.540 0.525 
Psychological problems 
Depression 0.583 0.524 0.156 0.228 0.365 0.335 
Anxious or depressed/sad 0.773 0.800 2.174 1.501 0.721 0.792 
Memory problems 0.208 0.207 0.107 0.174 0.367 0.346 
PhYsiological markers 
Hypertensive 0.754 0.258 1.853 0.084 1.282 1.063 
(baseline> 140/90) 0.147 0.540 0.018 0.338 0.089 0.086 
Waist Hip Ratio (>/<0.85) 0.149 0.464 0.045 0.722 0.039 0.068 
BMI (high) 0.339 0.111 0.120 -0.040 0.181 0.222 
Postural hypotenSion 0.319 0.235 0.008 -0.060 0.058 0.016 
Sinus tachycardia 
other co-morbidities 
Diabetes 0.353 0.382 0.305 0.267 0.253 0.188 
Hypertension 0.567 0.467 0.542 0.647 0.507 0.591 
Stroke 0.576 0.490 0.380 0.318 0.386 0.340 
Stomach/peptic ulcers -0.090 -0.077 -0.111 -0.073 -0.154 -0.092 
Thyroid disease -0.077 0.095 0.045 0.042 0.036 -0.059 
Cancer -0.144 -0.062 -0.011 0.009 -0.018 -0.005 
Hearing trouble -0.075 -0.208 -0.130 -0.095 -0.012 -0.044 
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In the General Specific model, the standardized factor loadings of frailty 
indicators on the seven specific latent factors (correlation of individual frailty 
indicators with each specific factor), are shown in Table 3.7. These loadings 
show how differently the frailty indicators correlate with frailty, compared to their 
specific factors. We derived individual frailty scores for all subjects in each 
dataset based on the selected model. The distribution of frailty in BWHHS 
women and both men and women of the MRC assessment study, by age group 
and sex are shown in Figures 3.3-3.5. The BWHHS women (ages ranged from 
60 to 79 years) in the older age group (over 75 years) had higher frailty scores 
i.e. were more frail compared to the younger age group (median scores 0.015 
vs. 0.276). They also appeared to be more frail when compared to the MRC 
women, all of whom were over 75 years old (median scores 0.276 vs. 0.132) .. 
In the MRC women, the median frailty scores increased with age and when 
stratified, were higher in those in the older age groups of 80-84 years and 85 
years and above, with scores of 0.213 and 0.578 respectively. The MRC men, 
whose scores also increased with age, were less frail compared to the women 
(median scores -0.811 vs. 0.132) (see Figure 3.5). 
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Figure3.3: Histogram showing the distribution of frailty scores in 1568 
BWHHS women according to age. 
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Figure 3.4: Histogram showing the distribution of frailty scores according 
to sex in the MRC Assessment study. 
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Figure 3.5: Histogram showing the distribution of frailty scores according 
to age in men and women of the MRC Assessment study 
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Discussion 
In order to better define the concept of frailty in older adults, a measurement 
model which was based on theoretical underpinnings of the concept of frailty, 
derived from an 'a priori' knowledge and research from existing literature [35, 
62, 74, 88, 121] as well as statistical criteria has been developed. Factor 
analysis (FA) was used in order to develop and test the hypothesis of frailty as a 
'latent vulnerability' in older adults by incorporating all possible frailty indicators 
available to both datasets based on these criteria. This differed from existing 
measures of frailty by controlling for measurement error with weighted frailty 
indicators giving way to a more internally reliable measure than previously 
developed. EFA provided an initial latent structure of seven first order latent 
factors and CFA tested the hypothesis and confirmed the General Specific 
model as the best choice to form the conceptual basis for frailty in older adults. 
It best reflects the association between frailty, its indicators and its underlying 
factors, in that particular indicators are explained by both a dominant general 
factor, (Le. frailty),as well as seven specific factors, and these factors are 
mutually uncorrelated (see Figure 3.2). The implication is that frailty serves as 
the underlying factor that contributes to different forms of frailty indicators, and 
in addition, there are processes separate from this that contribute to the 
development of specific factors of visual impairment, respiratory 
disease/symptoms, cardiac disease/symptoms, phYSical ability, physiological 
markers, psychological problems and co-morbid disease, which vary 
independently of frailty. By contrast, in the 2nd order model, frailty was seen to 
drive/subsume all the factors/dimensions acting as a single broad, coherent 
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construct broken down into increasingly specific factors and indicators (see 
Figure 3.6 below). 
Figure 3.6: Second order model 
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In the 1 st order model, frailty was represented by each of the seven specific 
factors which were correlated to each other (see Figure 3.7). 
Figure 3.7: First order model 
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On a conceptual level, these models (1 st and 2nd order) do not fit in with the idea 
of frailty. Not all the specific factors need to be present for an individual to be 
considered frail , as implied by the second order model. For example, an elderly 
person with 'eyesight trouble' with 'difficulty with going out' may still be 
considered frail despite not having other co-morbidities, cardio-respiratory 
disease or symptoms. The problem with the 1 st order model was that the factors 
need not necessari ly be correlated to one another for frailty to occur (see 
Figures 3.2, 3.6 and 3.7 to compare the models). 
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External to this measurement model were socioeconomic status (SES) 
indicators such as income, education, social class, marital status, lifestyle 
indicators as well as social contact. As frailty is likely to be socially patterned 
[74], SES was expected to have a causally influence on frailty [122]. Hence 
frailty can be thought of as a mixed (reflective and formative) construct, that is 
reflected in the binary frailty indicators, but also driven by SES status [123] 
among other external forces (e.g. built environment). 
Other population studies have developed frailty measures using principal 
component analysis (PCA)[ 17, 61, 124]. Unlike one particular study that looked 
for sub dimensions of a pre-existing physical phenotype of frailty[124],our 
measure used all known and easily available frailty indicators in the datasets so 
as to fulfil its mUlti-dimensional concept. FA is used to identify the structure 
underlying all the frailty indicators and provides more internal reliability to the 
measure by controlling for measurement error, as it analyzes only the variability 
in an indicator that is shared among the other indicators (common variance 
without error or unique variance) while PCA assumes that all variability in an 
indicator should be used in the analysis. 
In both datasets, a majority of indicators represented by physical ability were 
ones that best explained frailty. This supports the theory that frailty is identified 
through characteristics directly related to physical function [74]. The analYSis 
also highlighted the importance of 'shortness of breath on level walking' as a 
more important frailty indicator than diagnosed respiratory diseases. Similarly, 
reports of symptoms such as 'ever having chest pain /chest discomfort' had 
higher factor loadings than having had a myocardial infarction. These higher 
loadings of self reported symptoms compared to diagnosed conditions may 
reflect that the diagnosed diseases were already under control/treated in our 
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respondents. Although co-morbidities featured strongly in some existing 
measures[17, 40], our model focused specifically on diseases such as 
myocardial infarction, angina, stroke, diabetes, peptic ulcers and hypertension. 
Strengths of this study include the construction of a measurement model of 
frailty in a large representative cohort of British women and replication in a 
further large cohort representative of the British community-dwelling older 
population of men and women, using variables that were direct inputs from the 
respondents, including both objective and subjective attributes. FA enabled the 
identification of latent dimensions of frailty that may not have been apparent 
from direct observation of the data. This also enabled us to develop a reliable 
measure that translates into a frailty score for use in future analyses. 
Initial assessments of the distribution of frailty in both the BWHHS and MRC 
datasets showed that frailty increased with age in both men and women and 
was also higher in women than in men. The higher median frailty scores in the 
older BWHHS women aged 75-79 years may reflect the frailest in this study 
population as their scores were comparable to the scores of MRC women aged 
80 years and above. 
Limitations of this study lie in the fact that the frailty indicators used were 
derived from self reports of symptomsl disease at baseline only; hence it is not 
a dynamiC measure of frailty. We concentrated on only complete cases but 
found similar findings for those with missing data. Although indicators used 
were based on known indicators from existing measures, we were limited to 
those available in both datasets. 
The following chapter will focus on testing the construct and external criterion 
validity of this new measurement model of frailty which will now be called the 
British Frailty Index (BFI). Its performance in predicting survival, 
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hospitalisation and institutionalisation will be tested in Chapter 5. This new 
measure should lead to more valid and reliable answers to the ultimate question 
of whether frailty is indeed a useful measure in predicting adverse outcomes in 
older populations. 
Summary: 
• The British FI translates the concept of frailty as a latent vulnerability in 
older people through the use of factor analysis (FA), a robust analytical 
technique which uses latent variables as a means of data reduction to 
represent a wide range of attributes/variability among observed variables 
on a smaller number of dimensions or factors. 
• Its advantage over previous frailty measures is that it corrects for 
measurement error and assigns relative weights in the association of 
each indicator with frailty. 
• Seven subsets or factors explained the association between frailty 
indicators: visual impairment, respiratory disease/symptoms, cardiac 
disease/symptoms, physical ability, physiological markers, psychological 
problems and co-morbid disease. 
• The reliability or internal consistency of the 'General Specific' model was 
shown by the goodness of fit of the confirmatory factor analysis. The 
validation of the model as a measurement of frailty was reaffirmed it was 
tested in a larger independent cohort of the MRC assessment study 
whose respondents were older of both sexes. 
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Chapter 4: Determinants of frailty 
Background 
In the earlier chapters the heterogeneous nature of the frailty concept was 
reaffirmed by its historical background and evolution as well as the predictive 
validity of existing measures. With the British FI, I developed a measure which 
considers the inter-correlation of various frailty markers through the statistical 
method of factor analysis. Through factor analysis (FA), a robust measurement 
model of frailty was obtained and that included a latent frailty index that will be 
used in all further analyses. 
In this chapter I examined the validity of the British FI in both the BWHHS older 
women population and in the MRC Assessment Study. Construct validity 
assesses whether the measure provides information on expected associations 
between frailty and criterion variables such as age, being more common in 
women than men, related to socioeconomic status, co-morbidity or self rated 
health (38). Furthermore an assessment of evidence for criterion validity was 
made. This involved the correlation between the measure and a criterion 
variable (or variables) taken as representative of the frailty construct. 
Frailty and its associated factors have been described widely in literature 
through other measures [1, 20, 78, 100). A useful way of describing the 
experience of frailty would be by creating a theoretical causal path-diagram of 
frailty and its association with an adverse event. As mentioned in Chapter 1, 
frailty can be described from an individual and societal perspective, within the 
context of the International Classification of Functioning, Disability and Health 
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(ICF) framework, a classification of health and its domains that describe body 
functions and structures, activities and participation[98]. When incorporated into 
this framework, frailty can be translated as the interaction between the health 
condition (disease) and contextual factors (environmental including physical, 
social and attitudinal environment and personal factors), as illustrated in Figure 
4.1. These interacting factors affect a person's bodily functions and their degree 
of activity and participation. These in turn determine his degree of frailty and 
indirectly, the risk of an adverse event which can be precipitated by certain 
stressors such as an acute infection or surgery. Personal factors on this causal 
pathway can include expected associations with frailty such as age, sex, marital 
status, living alone, smoking and alcohol intake. Environmental factors include 
those that constitute the physical environment such as type of accommodation 
(housing tenure); interaction of the individual to their social environment in 
terms of social contact or participation, as well as socioeconomic position 
status. A case study illustrating a clinical scenario using this pathway is 
presented in Chapter 7. 
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Figure 4.1: Theoretical Causal path-diagram of frailty 
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The choice of covariates examined for its expected association with frailty did 
however depend on whether the variables were already included in the 
measure itself. Hence, the association of the British FI with basic activities of 
daily living or co-morbidity was not assessed because it had already been 
incorporated into the measure. Previous frailty measures have found significant 
associations with age[20, 100],female sex[20, 96],being unmarried[75] ,ethnic 
minority groups[20], poor self rated health[1, 100],low education[75, 77], low 
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income[1], poor cognitive function[41, 93], depression[20] and number of 
chronic diseases[20, 1 04],falls[1 , 76], hip fractures [76]and disability[94]. The 
frail were also found to be current smokers[1, 75] but less likely to live alone[1] 
or drink alcohol[75]. 
I attempted to examine the construct validity of the British FI with factors which 
were external to my concept of frailty such as age, sex, housing tenure, living 
alone, marital status, social contact, self rated health as well as socioeconomic 
position. The association of each of these external factors with frailty was then 
examined in both the BWHHS and MRC Assessment study datasets. 
Methods 
Subjects 
In both the BWHHS study and MRC assessment study cohort, a complete case 
was defined as those respondents with complete data on all 35 frailty indicators. 
Although only 1568 women in the BWHHS dataset had complete data, all 4286 
women respondents were included here as a sensitivity analysis showed that at 
a 5% level, there was no significant difference in means of frailty scores, p value 
of 0.54) between the two groups. In the larger MRC Assessment study dataset 
only respondents with complete data (N=11195) were included in the analysis. 
They comprised of 6079 women and 4486 men. 
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Measurements 
As detailed in Chapter 3, the British FI was developed using factor analysis 
using the BWHHS study and this process was replicated in the MRC 
Assessment study. In both datasets, each respondent was assigned a frailty 
score developed from baseline observed variables -frailty indicators- using the 
selected General Specific model. This continuous frailty score was divided into 
quartiles and each ascending quartile classified as 'low or not frail', 'mild', 
'moderate' and 'severe' frailty, so as to assess the degree of frailty when 
adjusted for sociodemographic and lifestyle variables. These variables were 
similarly collected in both datasets from self completed questionnaires and 
research nurse interviews at baseline (at entry into study) which dealt with 
social, demographic and lifestyle data. In the BWHHS dataset, a multiple 
imputation procedure was conducted on these variables using Stata version10 
so as to enable inclusion of all 4286 respondents in this analysis. This was 
carried out because as the missing values were scattered throughout these 
variables, a substantial amount of power would be lost if the analysis were 
restricted to those with only complete data. Multiple imputations replace all the 
missing values with multiple versions (five in this case) of imputed ones. The 
BWHHS socio-demographic and lifestyle variables with miSSing data were 
imputed with the assumption that these were missing at random, where the 
'missing ness mechanism' does not depend on the unobserved data, i.e. there is 
no relationship between whether or not the covariate is miSSing and the value 
of the respondent's response variable[117). This imputation procedure was not 
conducted with the sociodemographic and lifestyle variables in the MRC dataset 
as there were only a small numbers of respondents with missing data on each 
of these variables i.e. less than 2% missing data ranging from 0.1 % to 1.8%. 
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These variables with the percentage of data missing in both datasets are 
presented in Table 4.1. 
Table 4.1: List of sociodemographic and lifestyle variables with 
percentage of missing data in the BWHHS and MRC Assessment study. 
Sociodemographic and lifestyle BWHHS MRC Assessment 
variables Study 
Number Missing data Number Missing data 
(%) (%) 
Age 4286 0 11195 0 
Sex - - 11195 0 
Current smoker 3960 326 (7.6) 11176 17 (0.2) 
Alcohol intake 3908 378 (8.8) 11190 85 (0.8) 
Living arrangement 4091 195 (4.6) 11115 80 (0.7) 
Marital status 4106 180 (4.2) 11195 207 (1.8) 
Housing tenure 4082 276 (4.8) 11138 57 (0.51) 
Social contact 3064 1222(28.5) 111064 131 (1.2) 
Socioeconomic position scores 3186 1100(25.7) - -
Self rated health 4052 234 (5.5) 11181 14 (0.1) 
The sociodemographic and lifestyle variables included were age in years, sex 
(only for the MRC dataset which included men), living arrangements (living 
alone or with others), marital status (married/living with partner, single, divorced 
or separated or widowed). In the BWHHS dataset, good or poor social contact 
was derived from a combination of variables which assessed the frequency of 
contact the respondents had with their children, siblings, relatives or friends. In 
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the MRC dataset, this was defined as the frequency of contact the respondent 
had with any other people (daily, 2 to 3 times per week, less than twice a week 
or rarely). Housing tenure in the BWHHS dataset included whether the 
respondent lived in their own home, rented privately, rented from local authority 
or lived in other type of accommodation. In the MRC dataset, the 'other type of 
accommodation' was specified as council housing, sheltered accommodation, 
local authority or private residential home. In both datasets, 'self rated health' 
was rated as excellent, very good, good, fair and poor. Smoking habit in both 
datasets was similarly categorized as 'Never smoked', 1-9, 10-19, >20 
cigarettes per day with the addition of 'ex-smokers' in the BWHHS dataset. In 
the BWHHS dataset, regular alcohol intake was categorized as 'yes' if intake 
was daily, most days or every weekend and 'no' if intake was once or twice a 
month, only on special occasions or not at all. In the MRC dataset, regular 
alcohol intake in the last year was categorized as 'yes' or 'no' but was further 
assessed by the amount of alcohol consumed, in those who drank more or less 
than either 10 single shots of spirits, 1 0 glasses of wine or 10 half pints of beer a 
week. 
Information on socioeconomic position was also only available in the BWHHS 
dataset. This was presented as a life-course socioeconomic position (SEP) 
score generated from 10 indicators [125). These indicators included adult and 
childhood social class which were based on the register general's classification 
of occupation (a hierarchical classification: I, II, III non-manual, III manual, IV, 
V-with I (highest SEP) being professional occupations and V (lowest SEP) 
being manual unskilled occupations).Other indicators were pension 
arrangements, adult housing tenure, age at leaving full time education, the 
longest held occupation of the participant's father during her childhood, 
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childhood household amenities (bathroom, hot water, bedroom sharing, and car 
access), the longest held occupation of the participant and her spouse and car 
access. Childhood occupational social class of the women was based on their 
fathers' longest held occupation and adult (head of household) occupational 
social class was based on their husbands' longest held occupation, or their own 
for single women and for women whose occupation was of a higher social class 
than their husbands. Age at leaving full time education was classified into four 
categories: <15 years (lowest SEP), 15-17 years, 18-21 years, >21 years 
(highest SEP) [125]. Non binary indicators were recoded as follows: adult and 
childhood social class into non manual (I, II, III non-manual) and manual (III 
manual, IV, V); pension arrangements into state only or state plus other 
(employment or private pension); adult housing tenure into local authority 
(social housing) or other (owner occupied, private rental, living with a relative); 
and age at leaving full-time education into those leaving school at or younger 
than 15 years, or above that age. The score ranged from 0 (most advantaged 
position across the life course) to 10 (most disadvantaged position across the 
life course). However, as there were small numbers in the 0 category and in the 
10 category, the 0 category was combined with the 1 category and the 10 
category with the 9 category. Both weighted and unweighted scores were 
generated for adult and childhood socioeconomic position. Weighted scores 
gave greatest weight to adverse indicators that were least prevalent and as 
such may be thought of as being more severe indicators of adverse 
socioeconomic position. However, the analyses by unweighted score did not 
differ substantively from those using the weighted score and therefore the main 
analyses presented here the unweighted SEP scores was used. 
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Statistical analysis 
A descriptive estimation was carried out using a two way scatter plot of the 
frailty score with each of the external factors such as age, sex, lifestyle factors 
such as smoking and alcohol, socioeconomic position, social contact, marital 
status, housing tenure, own age activity, living status as well as self rated 
health. As these independent variables were not normally distributed, median 
frailty scores with their respective inter-quartile range was calculated for each 
variable. The odds ratio with 95% confidence interval of each quartile of frailty 
from 'low or not frail', 'mild', 'moderate' to 'severe' frailty, by each 
sociodemographic and lifestyle variable was assessed using ordered logistic 
regression. This statistical technique used an ordered (from low to high 
dependent variable), in this instance, each ascending quartile of frailty 
corresponded to a higher level of frailty. These analyses were carried out in 
both datasets for comparison. 
Results 
Median and inter-quartile range (IQR) of frailty scores by the independent 
sociodemographic variables used for this analysis are shown in Table 4.2 and 
Table 4.3 for the BWHHS and MRC Assessment study respectively. In the 
BWHHS women, these median scores were shown to increase with age and in 
those who were current smokers. Women who lived alone had higher median 
frailty scores than those who did not (Le. those who lived with their husbands, 
partners or relatives), as were those who were single compared to those who 
were married. Socioeconomic position scores calculated from the BWHHS 
dataset ranged from 1 to 9 (from advantaged to disadvantaged). Median frailty 
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scores by socioeconomic position scores for the BWHHS women increased 
almost linearly from the lower 'advantaged' group (Le. lower SEP scores) to 
those who were more disadvantaged (i.e. higher SEP scores). Women who 
owned their own home had lower median scores compared those who rented 
privately or lived in local authority or other types of accommodation. Those who 
rated their health as poor had the highest median frailty scores compared to 
those who rated it as fair, good or excellent. There was very little difference in 
the median scores of those who reported good or poor social contact. Also, 
women who reported regular alcohol intake had lower median frailty scores 
compared to those who did not. 
Similar results were found in both men and women of the MRC assessment 
study with the exception of the variable living alone, where those who lived 
alone had lower scores compared to those who did not. Also, frailty increased 
with age in this older cohort but women had higher median frailty scores when 
compared to men. Two way scatter plots showing median frailty scores by each 
independent variable provide further graphical description of these results. (see 
Figures 4.2- 4.12) 
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Table 4.2: Median frailty scores and inter-quartile range according to 
independent sociodemographic and lifestyle variables in the BWHHS 
study population 
Variables Median Inter-quartlle range(IQR) 
Age group: 
60-64 
65-70 
71-74 
75-79 
Socioeconomic position 
scores: 
1 
2 
3 
4 
5 
6 
7 
8 
9 
Smoking. cigarettes per day: 
Never 
Ex smoker 
1-9 
10-19 
>20 
Alcohol Intake: 
No 
Yes 
Lives alone: 
No 
Yes 
Marital status: 
Married 
Single 
Divorced/separated 
Widowed 
Social Contact: 
Every day/week 
Every few months 
Every year 
Rarely/never 
Housing tenure: 
Own home 
Private rental 
Local authority rental 
Other 
Self rated health: 
Excellent 
Good 
Fair 
Poor 
-0.07 
0.04 
0.13 
0.32 
-0.15 
-0.15 
0.01 
0.06 
0.19 
0.25 
0.32 
0.46 
0.36 
-0.01 
0.21 
-0.07 
0.19 
0.50 
0.18 
-0.05 
0.02 
0.24 
0.03 
-0.08 
0.32 
0.22 
0.08 
0.07 
0.02 
0.08 
0.02 
0.29 
0.46 
0.18 
-0.51 
-0.07 
0.76 
1.37 
-0.47-0.46 
-0.04-0.60 
-0.33-0.68 
-0.18-0.85 
-0.55-0.30 
-0.52-0.36 
-0.40-0.52 
-0.33-0.61 
-0.31-0.74 
-0.23-0.84 
-0.24-0.99 
-0.08-1.00 
-0.01-0.91 
-0.44-0.53 
-0.27-0.77 
-0.34-0.61 
-0.32-0.69 
0.03-1.05 
-0.32-0.44 
-0.47-0.44 
-0.42-0.56 
-0.25-0.80 
-0.42-0.56 
-0.42-0.37 
-0.11-0.85 
-0.27-0.82 
-0.38-0.64 
-0.37-0.63 
-0.38-0.67 
-0.38-0.67 
-0.42-0.55 
-0.22-0.85 
-0.11-1.037 
-0.31-0.77 
-0.84--0.22 
-0.44-0.34 
0.32-1.14 
0.88-1.80 
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Table 4.3: Median frailty scores and interquartile(lQR) range according to 
independent sociodemographic and lifestyle variables in the MRC 
assessment study population. 
Variable 
Age in years: 
75-79 
80-84 
>85 
Sex: 
Male 
Female 
Current Smoker: 
No 
Yes 
Alcohol Intake: 
No 
Yes 
Lives alone: 
No 
Yes 
Marital status: 
Married 
Single 
Divorced/Separated 
Widowed 
Social contact: 
Daily 
2-3x/week 
<2x1week 
Rarely 
Housing tenure: 
Own home 
Private rental 
Local Authority/Housing association 
Council/sheltered/Private residential 
Self rated health: 
Excellent 
Very good/good 
Fair/poor 
Interquartlle 
Median range(IQR) 
-0.139 -0.54-0.39 
0.123 -0.36-0.71 
0.446 -0.11-0.92 
-0.081 -0.50-0.46 
0.132 -0.39-0.71 
0.03 -0.44-0.62 
0.12 -0.42-0.66 
0.26 -0.31-0.81 
-0.01 -0.47-0.55 
-0.03 -0.49-0.55 
0.12 -0.37-0.68 
-0.09 -0.52-0.46 
-0.02 -0.45-0.53 
0.06 -0.42-0.59 
0.19 -0.34-0.75 
-0.02 -0.49-0.57 
0.03 -0.43-0.60 
0.21 -0.34-0.77 
0.28 -0.24-0.80 
-0.07 -0.50-0.48 
0.11 -0.38-0.67 
0.22 -0.32-0.79 
0.54 -0.04-0.99 
-0.25 -0.59-0.20 
0.20 -0.28-0.70 
0.89 0.42-1.31 
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Frailty and Age/Sex 
Figure 4.2: The association between frailty and age in the 
British Women's Heart and Health Study. 
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Figure 4.3: The association between frailty and age in 
men and women of the MRC Assessment study of older 
people. 
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Frailty and marital status 
Figure4.4: The association between frailty and marital 
status in the BWHHS study 
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Figure 4.5: The association between frailty and marital 
status in the MRC assessment study 
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Frailty and housing tenure 
Figure 4.6: The association between frailty and housing 
tenure in the BWHHS 
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Figure 4.7: The association between frailty and housing 
tenure in the MRC Assessment study 
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Frailty and self rated health 
Figure 4.8: The association between frailty and self rated 
health in the BWHHS 
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Figure 4.9: The association between frailty and self rated 
health in the MRC assessment study 
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Frailty and social contact 
Figure 4.10: The association between frailty and social 
contact in the BWHHS 
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Figure 4.11 The association between frailty and social 
contact in the MRC assessment study 
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Figure 4.12: The association between frailty and socioeconomic position 
(SEP) scores in the BWHHS 
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The odds ratio calculated here was the effect of each independent 
socioeconomic and lifestyle variable on the odds of being in a higher category 
of frailty versus a low or not frail category. Adjustments were made for a) age 
and additionally for b) other sociodemographic and lifestyle variables in the 
model to examine the independent effects of each one. The association of 
these variables with the frailty categories is shown in Tables 4.4 and 4.5 for the 
BWHHS and MRC assessment study cohorts respectively. In both cohorts, age 
was associated with being in a higher category of frailty (p for trend <0.001).ln 
the BWHHS cohort, women aged 75 years or older had almost twice these odds 
than those aged 60-64 years. In the MRC assessment study the odds were 
almost three times as high in those aged over 85 years and above than in those 
aged 75-79 years. In the MRC dataset, the proportion of women was higher 
than in men (60 vs. 40 %). Women were associated with a nearly 30% increase 
in odds of being in a higher frailty category than men even after fully adjusting 
for all other sociodemographic and lifestyle variables. 
These odds were also increased in those respondents who currently smoked (in 
addition to number of cigarettes smoked). The odds of being frail was highest 
among those who smoked > 20 cigarettes per day (fully adjusted OR 
3.22,95%C.I.:2.20,4.72,p<0.01) and ex-smokers(fully adjusted OR 
1.63,95%C.I.:1.46, 1.82,p<0.001).ln the MRC respondents, the odds of being in 
a higher frailty category increased significantly when assessed by the number of 
cigarettes smoked especially in those who smoked more than 20 Cigarettes a 
day (fully adjusted OR 1.27, 95% C.I.:1.02, 1.58,p<0.05). 
BWHHS respondents who reported regular and increased amount of alcohol 
intake had significantly lower odds of frailty (fully adjusted OR 0.69, 95% 
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C.I.:0.61, 0.77,p<0.001. This association was similar but more significant in the 
MRC cohort (fully adjusted OR 0.72,95% C.I.:0.65, 0.79,p<0.001). 
For this part of the analysis, socioeconomic position (SEP) scores (only 
available in BWHHS dataset) were recoded as binary; 0 represented the less 
disadvantaged group with lower scores of one to four, whereas 1 represented 
the disadvantaged group with higher scores of five to nine. Women with higher 
SEP scores (more disadvantaged) had an increased odds of being in a higher 
frailty category than women who had lower SEP scores (more advantaged), 
(fully adjusted OR1.55, 95% C.I.:1.35, 1.77, p<O.001). 
In the BWHHS respondents, living alone was associated with an increased 
odds of being in a higher category of frailty (fully adjusted OR1.22, 95% 
C.I.:1.02, 1.46, p<O.05). In the MRC cohort, the age adjusted odds were 
significantly increased when adjusting for age (OR 1.13, 95% C.I.:1.04, 1.21, 
p<0.01) but were attenuated when fully adjusted (OR 0.75, 95% C.I.:0.6, 0.83, 
p<0.001). 
Among the BWHHS women, being single, significantly reduced the odds of 
being in a higher category of frailty (fully adjusted OR 0.59,95% C.I.:0.46, 0.77, 
p<0.001) than those who were married. These odds were similarly reduced 
among MRC respondents who were single but this was not significant when 
fully adjusted, OR 0.94, 95% C.I.:0.78, 1.13, p=0.48. BWHHS and MRC 
respondents who were widowed had a higher age adjusted odds of being frail 
than those who were married. However, this remained significantly increased 
only among the MRC when fully adjusted (OR 1.45, 95%C.I.:1.31, 
1.61,p<0.001 ) 
The effect of having poor social contact compared to good was not associated 
with increasing levels of frailty in the BWHHS respondents. This association 
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however, was very significant in the respondents of the MRC assessment study 
(fully adjusted OR 1.80, 95%C.1.:1.00, 2.17, p<0.01). 
Not living in or owning their own home also increased the odds of being in a 
higher frailty category in all respondents in both datasets These odds were 
especially high in the MRC respondents who lived in sheltered, local authority or 
private residential homes (fully adjusted OR 2.42,95%C.1.:2.11 ,2.78,p<0.001). 
Lastly, self reports of fair or poor health compared to excellent health, greatly 
increased the odds of being in a higher category of frailty in the respondents of 
both datasets. 
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Table 4.4: Association of sociodemographic and lifestyle characteristics by frailty categories in the British Women's Heart and Health Study. 
Variable Frailty scores per quartile (%) Age adjusted Fully adjusted -I 
Low or not frail Mild frailty Moderate frailty Severe frailty Odds Ratio odds ratio odds ratio 
n=1072 n=1072 n=1073 n=1069 95%C.I 95"1.C.I. 95% C.I. 
Age in years 
60-64 371(34.6) 315(29.4) 276(25.7) 218(20.4) 1.00 - 1.00 
65-69 300(28.0) 292(27.2) 272(25.4) 270(25.3) 1.30(1.11,1.51) 1.22(1.03,1.45) 
70-74 245(22.8) 286(26.7) 282(26.3) 298(27.8) 1.57(1.32,1.88) 1.45(1.20,1.77) 
>75 156(14.6) 179(16.7) 243(22.6) 283(26.5) 2.14(1.83,2.49) 1.88(1.59,2.22) 
Smoker,cigarettes per day 
Never smoked 686(64.0) 623(58.3) 575(53.6) 494(46.3) 1.00 1.00 1.00 
Ex-smoker 281(26.2) 336(31.4) 363(33.9) 426(39.9) 1.61(1.45,1.79) 1.58(1.41,1.78) 1.63(1.46,1.82) 
1-9 46(4.3) 52(4.9) 49(4.6) 47(4.4) 1.23(0.91,1.68) 1.25(0.91,1.71) 1.20(0.88,1.64) 
10-19 46(4.3) 44(4.1) 56(5.2) 55(5.1) 1.44(1.08,1.93) 1.56(1.14,2.13) 1.49(1.11,2.01 ) 
>20 13(1.2) 14(1.3) 29(2.7) 45(4.2) 3.1012·15,4.4~ 3.57(2.44,5.24 3.22(2.20,4.72) 
Regular alcohol intaket 
No 615(57.4) 649(60.7) 710(66.2) 794(74.4) 1.00 1.00 1.00 
Yes 457(42.6) 420(39.3) 362(33.8) 273(25.6) 0.61 (0.54,0.68) 0.64(0.56,0.72) 0.69 (0.61,0.77) I 
SocioeconomiC Position Score: I 
low (advantaged) 694(64.7) 680(63.6) 589(54.9) 449(42.1) 1.00 1.00 1.00 
High(disadvantaged) 378(35.3) 389(36.4) 483(45.1) 618(57.9) 1.88(1.63,2.18) 1.81(1.57,2.10) 1.55(1.35,1.77) 
Lives alone: 
No 797(74.3) 757(70.8) 718(67.0) 638(59.8) 1.00 1.00 1.00 
Yes 275(26.7) 312(29.2) 354(33.0) 429(40.2) 1.55(1.38,1.74) 1.39(1.24,1.55) 1.22(1.02,1.46) 
Marital Status: 
Married 717(66.9) 683(63.9) 656(61.2) 564(52.9) 1.00 1.00 1.00 
Single 56(5.2) 63(5.9) 44(4.1) 30(2.8) 0.79(0.64,0.97) 0.75(0.60,0.92) 0.59(0.46,0.77) 
Divorced/separated 47(4.4) 50(4.7) 79(7.4) 93(8.7) 1.92(1.53,2.41 ) 2.04(1.62,2.56) 1.28(1.01,1.62) 
Widowed 252(23.5) 273(25.5) 293(27.3) 380(35.6) 1.53(1.35,1.73) 1.30(1.15,1.46) 0.88(0.75,1.04) 
Social Contact: 
Good 730(68.1) 737(68.9) 753(70.2) 718(67.3) 1.00 1.00 1.00 
Poor 342(31.9) 332{31.1) 319(29.8) 349/32.7) 1.01(0.91,1.12) 0.97(0.87,1.08) 1.04(0.92,1.18) 
Housing tenure: 
OWn home 921(85.9) 901(84.3) 869(81.1) 730(68.4) 1.00 1.00 1.00 
Renting privately 104(9.7) 105(9.8) 141(13.1) 257(24.1) 1.74(1.37,2.15) 1.62(1.2,2.04) 1.35(1.10,1.66) 
Renting local authority 29(2.7) 36(3.4) 42(3.9) 53(5.0) 2.33(1.95,2.79) 2.23(1.83,2.72) 1.59(1.29,1.96) I Other 18(1. 7) 27{2.5) 20(1.9) 27(2.5) 1.37(0.91,2.0]1 1.33(0.87,2.05) 1.25(0.78,2.00) 
Present health: 
I Excellent/Good 1016(94.8) 942(88.1) 753(70.2) 
312(29.2) 1.00 1.00 1.00 
Fair 55(5.1) 121(11.5) 305(28.4) 645(60.5) 10.8(9.0,12.9) 10.5(8.7,12.6) 9.65(8.12,11.46) 
Poor 1(0.1) 4(0.4) 14(1.3) 110(10.3) 47.9(31.0,74.1} 45.7(29.5,70.9) 37.8Oc24.31 ,58.78) 
*Fully adjusted p for trend <0.001 for all except variable 'social contact' p=O.6 and lives alone p<O.05, t Regular alcohol intake was also assessed by amount of alcohol consumed per wee 
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Table 4.5: Baseline association of demographic and health characteristics with each quartile of frailty with percentages and odds ratio in the MRC 
assessment study of older people. 
Variable Frailty scores per c uartile(%) Odds Age adjusted Fully adjusted 
Low or not frail Mild frailty Moderate frailty Severe frailty Ratio odds ratio odds ratio 95%C.I. 
n=3022 n=2697 n=2740 n=2736 95%C.I. 95%C.I* 
Age in years: 
75-79 1923(63.6) 1495(55.4) 1277(46.6) 941(34.4) 1.00 
-
1.00 
80-84 814(26.9) 822(30.5) 903(33.0) 964(35.2) 1.78(1.63.1.93) 1.62(1.50,1.76) 
>85 285(9.3) 380(14.1) 560(20.4) 831(30.4) 3.26(2.90,3.65) 2.76(2.46,3.09) 
Sex: 
Male 1393(31.0) 1191(26.6) 1045(23.3) 857(19.1 ) 1.00 1.00 1.00 
Female 1629(24.3i 1506(22.4) 1695(25.3) 1879(28.0) 1.52(1.42,1.63) 1.43{1.34,1.53) 1.27(1.06,1.53) 
Smoking, Cigarettes per day: 
None 2750(91.1) 2453(91.1) 2452(89.5) 2453(89.9) 1.00 1.00 1.00 
1-9 101 (3.4) 81(3.0) 107(3.9) 107(3.9) 1.17(0.98,1.40) 1.30(1.1 0,1.54) 1.27 (1.05,1.53) 
10-19 91(3.0) 86(3.2) 95(3.5) 90(3.3) 1.08(0.92,1.28) 1.31(1.10,1.55) 1.25(1.05,1.48) 
>20 75(2.5i 7212·71 84(3.1) 79(2.9) 1.14(0.91,1.42) 1.25(0.99,1.57) 1.27{1.021.58) 
Regular alcohol intaket: 
No 524(17.5) 510(19.1) 647(23.7) 810(29.9) 1.00 1.00 1.00 
Yes 2473(82.5) 2163(80.9) 2079(76.3) 1904(70.1) 0.61 (0.56,0.68) 0.68(0.61,0.75) 0.72(0.65,0.79)t 
Lives alone*: 
No 1784(59.3) 1466(54.7) 1371(50.3) 1330(49.2) 1.00 1.00 1.00 
Yes 1223(40.7) 1213(45.3) 1356(49.7) 1372(50.8) 1.33(1.23,1.44) 1.13(1.04,1.21 ) 0.75(0.67,0.83) 
Marital Status: 
Married 1548(52.1) 1224(46.4) 1076(39.9) 918(34.2) 1.00 1.00 1.00 
Single 188(6.3) 180(6.8) 173(6.4) 135(5.0) 1.16(1.00,1.35) 0.95(0.82,1.10) 0.94(0.78,1.13) 
Divorced/Separated 52(21.8) 45(1.7) 51(1.9) 46(1.7) 1.34(1.09,1.64) 1.32(1.05,1.67) 1.39(1.06,1.82) 
Widowed 1181(39.8) 1190(45.1) 1394(51.7) 1587(59.1) 1.74(1.61,1.88) 1.38(1.28,1.48) 1.45(1.31,1.61) 
Social Contact: 
Daily 1516(30.1) 1214(24.1) 1176(23.4) 1130(22.4) 1.00 1.00 1.00 
2-3x1week 1084(26.4) 1031(25.0) 1043(25.4) 955(23.2) 1.13(1.03,1.23) 1.12(1.02,1.22) 1.14(1.04,1.25) 
<2xlweek 314(21.4) 322(21.9) 384(26.1) 450(30.6) 1.56(1.34,1.82) 1.48(1.28,1.71) 1.53(1.32,1.77) 
Rarely 77(17.3) 103(23.1) 113(25.4) 152(34.2 1.84(1.55,2.19) 1.77(1.47,2.12) 1.80{1.oo,2.17) 
Housing tenure: 
Own home 2229(74.0) 1894(70.4) 1695(62.3) 1422(52.3) 1.00 1.00 1.00 
Private rental 110(3.7) 108(4.0) 115(4.3) 122(4.5) 1.44(1.22,1.70) 1.34(1.13,1.59) 1.33(1.12,1.58) 
Councillhousing association rental 560(18.6) 560(20.8) 694(25.5) 809(29.7) 1.75(1.59,1.92) 1.78(1.62,1.95) 1.74(1.58,1.91 ) 
Sheltered,local authority & private res.home 112(3.7) 127(4.7) 215(7.9) 36.6(13.5) 3.18(2.72,3.72) 2.51(2.15,2.92) 2.42(2.11,2.78) 
Present health: 
Excellent 1021(33.8) 646(24.0) 397(14.5) 134(4.9) 1.00 1.00 1.00 
Very good/Good 1930(63.9) 1910(70.9) 2002(73.2) 1595(58.4) 2.74(2.49,3.02) 2.88(2.64,3.15) 2.73(2.49,3.00) 
FairiPoor 69(2.3) 137(5.1) 336(12.3) 1004(36.7) 19.32(15.94,23.43) 22.23(18.41,26.84) 20.59(17.11,24.76) 
*Fully adjusted p for trend <0.001 for all independent variables t Regular alcohol intake was also assessed by amount of alcohol consumed per week. 
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Discussion 
The external criterion validity of the British FI was assessed in two well 
represented British study populations. This measure was able to significantly 
demonstrate the effect of various socioeconomic and lifestyle variable on frailty, 
enabling comparisons to be made of this effect between the younger, female 
cohort of the BWHHS and both men and women of the larger and older MRC 
assessment study .. In both cohorts, older age, smoking, not living in or owning 
one's own home, living alone and having poor self rated health independently 
increased the odds of being in a higher category of frailty. A socioeconomic 
position (SEP) score demonstrated that being disadvantaged (higher SEP 
score) was also strongly associated with higher levels of frailty in women of the 
BWHHS. This SEP score incorporated a more comprehensiv~ range of 
socioeconomic factors, hence it strongly confirms similar associations between 
frailty and socioeconomic markers suc~ as low education[1, 41] and income[20, ~ 
45],non white collar occupations [126]which had been assessed separately in 
other studies. 
The association of all these variables used in this study were highly in keeping 
with the findings of other large population studies which used different frailty 
measures [74-76] [78, 105], thus confirming their important role with increasing 
levels of frailty as well as their role in the causal pathway of frailty. In both 
cohorts, respondents who reported having regular and increased alcohol intake 
had significantly reduced odds of being frail. This was similar to previous study 
findings which reported a negative association with alcohol intake and frailty [1, 
75, 126], hence confirming that those who were frail tended to abstain from 
regular and increased alcohol intake than those who were not frail. The odds of 
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being in a higher frailty category were also reduced in respondents who were 
single when compared to those who were widowed divorced or separated (see 
Table 4.4 and 4.5). 
Additionally, in the MRC cohort, these odds were increased in women 
compared to men. Social contact was found to be more important with 
increasing age as it was shown that poor social contact did not increase the 
odds of being frail among the BWHHS cohort of women but were nearly 
doubled among both men and women of the older MRC respondents. This was 
in line with findings of other large population studies that showed an association 
between poor social contact[126] and social vulnerability [122] with frailty. 
However, these differences could be due to the difference in the way frailty was 
measured in these studies or could more likely indicate that the association with 
frailty was perhaps related to social participation of the frail individual with their 
environment rather than actual contact with relatives, friends or neighbours. 
All these associations showed a significant trend with higher categories of 
frailty, even after adjusting for all the independent variables and thus provide 
evidence that a true relationship may exist between them. The identification of 
the association of these independent variables with increasing frailty would 
make them amenable to intervention. These include improving lifestyle 
modifications such as reduction of alcohol intake and stop smoking campaigns. 
These advertisements and prevention usually focus on younger people and 
could prevent the onset of frailty in later life but more targeted efforts could be 
improved in older people who were already at risk of frailty. At a community or 
primary care level, identification of frail older people who are socially isolated 
and living alone in poor housing could improve the allocation of social services 
to those truly in need and help budget the resources appropriately to the frail 
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who are known to be at increased risk of adverse outcomes. At the level of the 
community, social services with the help of primary care professionals could 
identify those who are socially and physically isolated and improve their social 
participation of older people by promoting activities at a community or day 
centres for older people. These activities could include workshops for the 
promotion of a healthy lifestyle that provide nutritional and dietetic support, 
improve existing skills, group exercise and other efforts that would help maintain 
their independence at home. 
The association with poor self rated health was particularly significant in both 
datasets when using the British FI. This was in keeping with findings of several 
large study populations [1, 20, 76]. This relationship could be explained by the 
fact that poor self rated health itself was a strong predictor of co-morbidity as 
well as mortality. However a more reasonable explanation may be that poor 
health was on the causal pathway between frailty and mortality. 
The BWHHS and the MRC assessment study of older people are large, 
population-based cohorts which are representative of British community 
dwelling older people. It has nurse-verified data on a whole range of 
sociodemographic and lifestyle data; hence these are reflected on a wide range 
of locations in the UK. Other strengths of this part of the thesis include use of 
only complete cases in both cohorts, with imputed independent variables in the 
BWHHS cohort as well as less than 2% missing data in the variables from the 
MRC cohort. The respondents in the BWHHS study consisted of only women 
who were younger «80 years old) compared to the respondents of the MRC 
study. This enabled important comparisons to be made between a younger 
older population with an older and larger population of men and women. The 
cross sectional nature of the data used in this analysis would make causal 
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inference difficult, hence it is possible, but unlikely, that the associations 
observed are susceptible to reverse causality. Also, as the populations were 
largely Caucasian, there was no ethnic minority population used for comparison 
of the association of these independent variables with frailty. 
This part of the analysis has not only showed important expected associations 
with frailty(construct validity) but has replicated the associations that were 
reported in previous studies in the expected directions, hence providing external 
criterion validity to this new measure of frailty. The results also suggest that by 
modifying the factors that were strongly associated with frailty, it may be 
possible to postpone the onset of frailty or ameliorate its further development in 
older people. 
Summary: 
• This newly developed British Frailty Index had expected associations 
with sociodemographic and lifestyle variables and demonstrated both 
construct and external criterion validity. 
• Frailty is associated with increased age, female sex, smoking, living 
alone, poor social contact and not owning one's own home but not with 
being single or taking increased and regular alcohol intake. 
• This study provided greater evidence for the association of frailty with 
socioeconomic position by using the BWHHS SEP score which 
incorporated various markers of socioeconomic position. 
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Chapter 5: Predictive validity of the British Frailty 
Index. 
Introduction 
One of the main reasons for identifying frail elderly people was to devise ways 
to reduce their burden of suffering through the early detection of frailty, its 
prevention and delay of frailty outcomes. However, until a 'gold standard' 
definition of frailty is agreed upon, we can only rely on predictive validity of a 
frailty measure to provide means of choosing between alternative 
measures[127]. In terms of the performance of a measure, its validity relates to 
its ability to predict an external- distal criterion at a future time. 
The identification and measurement of frailty had always been dependent on its 
definition, which varied greatly; and in the way it was measured. Hence, it would 
be expected that different measures would yield different results, especially with 
regards to their predictive performance. However, regardless of how each frailty 
measure was constructed, most have shown the ability to predict adverse 
outcomes, namely death [20, 74, 100], hospitalization [20, 41], 
institutionalization [20, 40]and falls[7S, 79]. This good predictive ability may be 
related to the fact that some of these measures included indicators that were 
already closely correlated with the adverse outcomes. For example, a measure 
that included indicators such as age, multiple co morbidities and poor self rated 
health which are highly correlated with death would certainly have a greater 
ability to predict death than one that did not. 
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Since it is regarded as a latent vulnerability in older people[2],frailty was not 
something which could be observed or measured directly.The British Frailty 
Index, a purely measurement driven model was based on this theoretical 
premise and provided internal reliability in that it measured frailty itself and not 
other external criteria such as death. It did so by considering inter correlations 
of indicators that were associated with frailty as a latent factor and excluding 
those that were not. 
In this chapter, death (all-cause mortality) was chosen as the external criterion 
because of its simplicity as an outcome measure. Furthermore, as frailty is on 
the trajectory between age and death, it can therefore be associated with 
mortality from all causes of death. 
The main aim of this chapter was to assess the long term survival of 
respondents using the British Frailty Index (BFI). As this measure was 
developed from indicators measured at baseline (start of study) an analysis of 
survival over the whole follow up period was conducted to assess its predictive 
ability in both the BWHHS and MRC assessment study cohorts. However to 
understand the time series distribution in the various causes of death 
associated with frailty, a sUb-analysis of cause specific mortality was 
undertaken. I also examined whether frailty was associated with an increased 
risk of first time hospitalization or institutionalization with data that was available 
in the MRC assessment study. 
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Data and Methods 
Study Population 
A detailed description of both datasets is available in Chapter 3. Briefly, all 4286 
respondents (60% response rate) of the BWHHS who entered the study 
between April 1999 and March 2001 were included in this analysis. This was 
based on a sensitivity analysis using an unpaired t-test to account for misSing 
data which did not importantly change any of the results. At this baseline period, 
the women recruited were aged between 60 to 79 years with a mean age of 
68.9 years. All these women were followed up from the date of their entry into 
the study until the 10th of August 2008. This date referred to the censored date 
which indicates the last time their status was known (e.g. the last time they were 
known to be alive). 
In the MRC assessment study, the analyses were carried out on 11195 out of 
14639 respondents as they had complete data on indicators used to derive their 
respective frailty scores. Both the men and women aged between 75 years and 
108 years with a mean age of 80.8 years. The men and women had a mean 
age of 80.4 years and 81.1 years respectively. 
The British Frailty Index (BFI) 
Frailty was represented as a continuous score, as this was estimated by the 
selected measurement model. An assessment was made of the distribution of 
scores in each dataset. These scores were then divided into quartiles, the first 
to fourth quartiles reflecting the lowest to highest levels of frailty. Each 
ascending quartile was labelled as 'not frail/ low, mild, moderate and severe 
frailty. 
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Outcomes 
The principal outcome measures for hypothesis testing were mortality, 
hospital and institutional admissions. In both datasets, mortality follow-up 
was achieved by registering all eligible patients with Office of National Statistics 
(ONS) for notification of death, date and cause of death. In the BWHHS, 633 
out of 4286 respondents have died (14.8%). In the mortality analysis, all the 
BWHHS women were followed up from the date of their entry into the study until 
the censored date of 10th of August 2008, giving a median follow up period of 
8.2 years (range 4 months to 9.3 years).This date referred to the censored date 
which indicates the last time their status was known (e.g. the last time they were 
known to be alive). 
Since their entry into the study until the 4th of October 2007, 7469 out of 11195 
respondents of the MRC Assessment study have died (66.7%). Of the 6709 
women, 4197 had died (62.6%). Of the 4486 men, 3272 had died (72.9%). In 
the mortality analysis, all MRC respondents were followed up for a median time 
of 7.9 years (range 22 days to 12.6 years). Specific cause of death referred to 
cause of death related to a particular system. These deaths occurred in the 
cardiovascular system, circulatory, respiratory, gastrointestinal, renal, 
genitourinary, musculoskeletal, nervous system, in addition to mental health, 
infection or diabetes related deaths as well odd and unknown causes of death. 
The main causes of death focused in this analysis were cardiovascular, cancer, 
respiratory and Circulatory causes. The other causes were combined in view of 
the small number of deaths in each subgroup. 
Information on hospitalization and institutionalization was only available for 
analysis in the MRC assessment study. Data on hospital admissions were 
collected for each respondent for a 2-year period from the time of the study 
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entry by using information from hospital discharge letters in the patients' GP 
records. Information collected included specialty, dates of admission and 
discharge, diagnoses, specialty of consultant. The discharge letter was 
considered to be a reliable source since this was the routine method of 
providing information to general practitioners from hospital services[115]. This 
analysis used 'time to first hospital admission' as the outcome measure. For this 
analysis, the MRC respondents were followed up for a median time of 2 years 
(range 22 days to 2 years) 
Institutional admissions were collected on an ongoing basis for each patient 
from the date of the baseline assessment until a censor date (30th September 
2000). In the analysis using admission into an institution as the outcome 
measure, all MRC respondents were followed up for a median time of 3.9 years 
(range 1.6 to 5.7 years). 
Statistical analysis 
A multivariate Cox proportional hazards model was employed to assess the 
independent contribution of the British FI to predicting adverse events such as 
all cause mortality, cause specific mortality, hospitalization and 
institutionalization. In both datasets 'time to event' was calculated from the 
respondent's date of entry into study to a 'censored' date. This date represented 
the respondent's date of death, first admission to hospital and date of entry into 
an institution. 'Censored' individuals referred to all subjects who had not 
experienced the event at the last date their status was known. They instead 
contribute to the number of respondents 'at risk' of the event up until this point. 
The proportional hazards assumption (PHA) was assessed in both datasets 
based on Schoenfeld residuals prior to the analysis. The assumption was that 
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the hazard ratio (the probability or risk of an event) for each respondent with or 
without the event, remained constant, i.e. did not change over time. 
To further determine the association between frailty and its adverse outcomes, 
potential confounders were introduced into the Cox regression model such as 
age, sex(for the MRC study), marital status, housing tenure, living alone or 
otherwise, smoking, alcohol intake and socioeconomic position(SEP) scores 
(BWHHS only).These covariates were identified to be associated to both frailty 
and its adverse outcomes. They were identified on the basis of 'a priori' 
hypothesis, its association with the frailty (see Chapter 4) and its role as a risk 
factor for the outcome (e.g. death). Furthermore, confounders must not be a 
factor on the causal pathway between frailty and its adverse outcome. Crude, 
partially adjusted (age and/or sex) and fully adjusted models were fitted for 
these outcomes. A test for interaction was performed to assess whether there 
was a difference in the effect of frailty at different ages and by sex. Any 
evidence of interaction in this association was subjected to stratification of the 
Cox models by age and sex. The analysis was adjusted for the sampling design 
of the surveys resulting in robust standard errors clustering on town (BWHHS) 
and general practice (MRC). 
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Results 
To assess the independent predictive validity of the BFI, I evaluated its 
association with three important adverse health outcomes; mortality (all cause 
and cause specific), first hospital admission and institutionalization. This was 
ascertained using Cox proportional hazards models based on these adverse 
events occurring throughout the length of follow-up in each dataset. 
All cause mortality 
In the BWHHS cohort of women whose median follow up period was 7.9 years, 
the cumulative incidence of mortality was 14.8%. This increased from 8.5% in 
the lowest quartile of frailty scores (low/not frail) to 24.9% in the highest quartile 
(severe frailty). In the MRC assessment study in which the respondents had a 
median follow up period of 8.2 years, the cumulative incidence of mortality was 
66.7% and ranged from 53% in the lowest quartile up to 83% in the highest 
quartile of frailty. This incidence also increased similarly with age in both 
cohorts. Figures 5.1 and 5.2 show the distribution of frailty among all 
respondents in both datasets who were still alive and those that had died, 
conducted at the end of the analysis time. These graphs demonstrated 
considerable overlap between the scores in those that were still alive or were 
dead at this time. This enabled cut-off points of varying degrees of frailty to be 
established with respect to all cause mortality; whereby those who were 
severely frail were dead by the end of the analysis. 
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Figure 5.1: Distribution of frailty scores among 4286 women of the 
BWHHS who were alive or dead at the end of the analysis. 
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Figure 5.2: Distribution of frailty scores among 11195 men and women of 
the MRC assessment study who were alive or dead at the end of the 
analysis. 
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As there was no violation of the proportional hazards assumption in the BWHHS 
dataset, the hazard ratio for all cause mortality was displayed in Tables 5.1 and 
5.2 for the whole follow up period ranging from 4 months up to 9.3 years. Frailty 
was estimated to increase a woman's mortality rate by about 1.8(95%C.I.:1.7, 
2.0), per unit score. This remained significant even when fully adjusted, HR 
1.5:95%C.I:1.4, 1.6, p<0.001 (see Table 5.1). There was strong evidence of 
interaction between frailty and age among the BWHHS women, so an age 
stratified hazard ratio was presented showing that frailty estimated a four times 
higher risk of mortality in those over 75 years of age than those aged 60 to 64 
years of age, fully adjusted, HR 4.1,95% C.I:3.1,5.5,p<0.001 (see Table 
5.2).When the scores were divided into quartiles (low/not frail, mild, moderate 
and severe frailty), the HR was calculated for those who were in the second to 
fourth quartiles at baseline (mild, moderate and severe), each relative to those 
with the lowest quartile of frailty (not frail/low frailty) The crude HR for mortality 
was up to 3 times higher per unit frailty score in women with scores in the third 
and fourth quartiles (moderate and severe frailty). The BFI still independently 
predicted mortality in these women (up to 2 times higher risk of mortality per 
unit increase of score), even after full adjustments were made for associated 
covariates (see Table 5.3). 
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Table 5.1: Hazard ratios for mortality per unit increase in frailty scores in 
4286 BWHHS women 
Frailty Total(N) Number of deaths HR 95%C.1 
Crude 4286 633(14.8%) 1.8 1.7-2.0 
Age adjusted 4286 633(14.8%) 1.7 1.6-1.8 
Fully adjusted* 
4280 631(14.7%) 1.5 1.4-1.6 
p-value ** <0.001 <0.001 
*fully adjusted for age, socioeconomic position scores (SEP), smoking, alcohol intake, marital 
status, living alone and housing tenure. 
**p value is for crude, age and fully adjusted HR. 
Table 5.2: Age stratified association between frailty and all cause mortality 
in the BWHHS study 
Age group Number (%) 
60-64 1180(27.5) 
65-70 1134(26.5) 
71-74 1111(25.9) 
75-79 861(20.1) 
Total 4286(100) 
Crude 
1.0 
1.6(1.2,2.2) 
2.5(1.8,3.5) 
3.8(2.9,5.1) 
Fully adjusted 
1. 7(1.3,2.3) 
2.6(1.8,3.80 
4.1 (3.1,5.5) 
p(trend) <0.001 <0.001 
t Fully adjusted refers to adjustments made for socioeconomic position scores (SEP), smoking, 
alcohol intake, marital status, living alone, and housing tenure. 
Table 5.3: Hazard ratios(95%C.I.) for mortality according to frailty category 
in 4286 BWHHS women 
Hazard ratio Frailty category(scores per quartile) 
Low/Not frail Mild (N=1072) Moderate Severe 
(N=1072) (N=1073) (N=1069) 
Crude 1.0 1.4*(1.0,1.9) 1.6**(1.2,2.2) 3.2**(2.5,3.9) 
Age adjusted 1.0 1.3(1.0,1.8) 1.5*(1.1,2.0) 2.7**(2.2,3.2) 
Fully-adjustedt 1.0 1.3(0.9,1.8) 1.4*(1.1,1.8) 2.3**(1.9,2.8) 
P trend <0.001 <0.001 <0.001 
*p<0.05 
**p<0.001 
t Fully adjusted refers to ad~ustments ":l~de for age, socioeconomic position scores (SEP), 
smoking, alcohol intake, mantal status, hVlng alone, and housing tenure. 
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The survival experience of groups within the MRC assessment study was also 
compared with the hazard ratio using the Cox proportional hazards model. 
However, for the whole duration of analysis time (Le. time of entry into study to 
exit date of 4th October 2007), the assumption of non-proportional hazards was 
violated. This violation is presented graphically in Figure 5.3 where groups with 
different quartiles of the frailty score (adjusted for age and sex) were compared 
over the whole analysis time (log transformed). This graph suggests that the 
hazard ratio for each ascending quartile (mild moderate or severe frailty) 
relative to the 1 st quartile of the frailty score (low/not frail) decreases with time, 
i.e. the lines converge over time. However, the plots should be parallel if the 
proportional hazards assumption were true. To fulfill the assumption of 
proportional hazards, the analysis time was split or divided into three shorter 
time periods: 0 to 2.5 years, 2.5 to 5.5 years and 5.5 to 12.6 years (end of follow 
up time). This resulted in three Cox regression models which are jointly 
presented in Table 5.4. 
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Figure 5.3: Log-log plot of frailty survival curves per quartile, adjusted by 
age and sex. 
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In unadjusted analysis of all three Cox models, frailty independently predicted 
all cause mortality in both men and women of the MRC assessment study with 
hazard ratios ranging from 1_5 to 2_2,p<O.001. After adjusting for covariates, 
frailty remained a significant predictor of all cause mortality with hazard ratios 
ranging from 1.3 to 1.8, p<O.001 (see Table 5.4). However, frailty doubled the 
mortality rate per unit score in the first 2.5 years of follow-up in both sexes, but 
this rate was attenuated in later periods of follow up as shown in Figure 5.4. 
When the scores were divided into quartiles, frailty remained the strongest 
predictor of all cause mortality in the highest quartiles of frailty (moderate and 
severe frailty), even after fully adjusting for all covariates (see Table 5.5). 
There was weak evidence of interaction between frailty and different age groups 
as well as sex later in the analysis (after 5.5 years of follow up), p=O.08. Hence 
the third Cox model was stratified by age and sex as shown in Table 5.6. Frailty 
remained a significant predictor of all cause mortality in both men and women 
up to the age of 85 years (p<O.001). In those aged over 85 years, this was only 
significant in men (p<O.05). 
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Table 5.4: Frailty and all-cause mortality: hazard ratios per unit increase in frailty score with 95% confidence intervals for men, 
women and total population in the MRC Assessment study population over three follow up periods:. 
Follow up time (years) 
0-2.5 2.5-5.5 >5.5 
Hazard ratio (95% C.I) Hazard ratio (95% C.I) Hazard ratio (95% C.I) 
Crude Age Full:t: Crude Age Full:t: Crude Age Full:t 
Men 2.1 .... 2.0"· 1.9 .... 1.6·" 1.5 .... 1.5 .... 1.7"· 1.5· " 1.5 .... 
(1 .9-2.4) (1 .8-2.2) (1 .7,2.1) (1 .5-1 .8) (1.4-1 .7) (1.4,1.6) (1 .5,1.8) (1.4,1.7) (1.4,1 .7) 
Women 2.2"· 1.9"· 1.8 .... 1.8** 1.6 .... 1.5** 1.5** 1.3·" 1.3 .... 
(2.0-2.4) (1 .7-2.1) (1 .6,2.0) (1 .7-2.0) (1 .5-1 .7) (1.4,1 .6) (1.4,1.6) (1.2,1.4) (1 .2,1.4) 
Total 2.0"· 1.9 .... t 1.8 .... 1.7·" 1.6· .. t 1.5·" 1.5 .... 1.4"·t 1.4 .... 
(1.9,2.2) (1 .8,2.1 ) (1.7,2.0) (1 .6,1.8) (1 .5,1.6) (1.4,1.6) (1.4,1.6) (1 .3-1.5) (1 .3,1.5) 
** p<0.OO1 
tadjusted by age and sex 
:f;fully adjusted by age, sex, smoking, alcohol intake, social contact, housing tenure, living alone and marital status, 
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Table 5.5: Hazard ratios per unit increase in frailty score in ascending 
quartiles of frailty in 11195 men and women of the MRC Assessment 
study (example of Cox model 1) 
All cause mortality 
Men 
Frailty Total Number of HR (95% Col.) Age adjusted HR Fully adjusted HR 
scores N deaths (95%C.I.) (95% C.I.) 
Quartil (%) 
e 
1 sl 1393 838(25.6) 1.00 1.00 1.00 
2nd 1191 822(25.1 ) 1.5(1 .2,1 .9) ** 1.4(1 .1,1.8)* 1.4(1 .1,1 .7)* 
3rd 1045 835(25.5) 2.6(2.1,3.2) ** 2.3( 1.8,2.8) ** 2.1 (1 .6,2.6) ** 
4tn 857 777(23.8) 4.5(3.6,5.6) ** 3.8(3.0,4.7) ** 3.2(2.5,4.0) ** 
P trend <0.001 <0.001 <0.001 
Women 
1 sl 1629 764(18.2) 1.00 1.00 1.00 
2nd 1506 823(19.6) 1.9(1.5,2.4) ** 1.8(1.4,2.2) ** 1.6(1 .3,2.1) ** 
3rd 1695 1141(27.2) 2.8(2.2,3.7) ** 2.4(1 .8,3.1) ** 2.3(1 .8,3.0) ** 
4th 1879 1469(27.2) 5.0(4.0,6.2) ** 3.7(2.9,4.7) ** 3.3(2.6,4.4) ** 
P trend <0.001 <0.001 <0.001 
Total populationt 
1 sl 3022 1602(21 .4) 1.00 1.00 1.00 
2nd 2697 1645(22.0) 1.6(1.4,1.9)** 1.6(1 .3,1.8) ** 1.5(1.2,1.7) ** 
3rd 2740 1976(26.5) 2.5(2.1,2.9) ** 2.3(2.0,2.7) ** 2.2(1.8,2.6) ** 
4th 2736 2246(30.1) 4.1 (3 .6,4.8) ** 3.7(3.3,4.2) ** 3.3(2.9,3.8) ** 
Total 11195 7469(100) 
P trend <0.001 <0.001 <0.001 
* p<0.05 
**p<0.001 
ttotal population age (and sex) adjusted HR 
*Fully adjusted refers to adjustments made for age, sex, alcohol , smoking, housing tenure, 
social contact, living alone and marital status. 
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Figure 5.4: Hazard ratio for mortality per unit increase in frailty scores 
within each time band in the MRC Assessment study 
I ! 
I I I 
I 
Timeband 1 Timeband 2 Timeband 3 
I t-I ---II Crude !-----il Age_adjusted !-----il Fully_adjusted 
Table 5.6: Frailty and all cause mortality: Hazard ratios per unit increase in 
frailty score stratified by age and sex in 11195 men and women of the 
MRC assessment study, from 5.5 years to end of follow up period. 
All cause mortality 
Frailty Age(year Men Women Total 
s) HR 95%C.1 HR 95%C.1 HR 95% C.1 
75-79 1.6** 1.5-1.8 1.4** 1.3-1.5 1.4** 1.3-1.5 
Crude 80-84 1.6** 1.4-1.8 1.5** 1.3-1 .7 1.5** 1.3-1.6 
85+ 1.4* 1.1-1 .7 1.2* 1.0-1.4 1.2* 1.0-1.3 
Partial 75-79 1.4**t 1.3-1.5 
adjusted 80-84 1.5**t 1.4-1.6 
85+ 1.2**t 1.1-1 .3 
Fullyt 75-79 1.5** 1.4-1.7 1.3** 1.2-1.4 1.4**t 1.3-1.5 
adjusted 80-84 1.5** 1.3-1 .8 1.4** 1.2-1 .6 1.4 **t 1.3-1 .6 
85+ 1.4* 1.1-1 .8 1.1 1.0-1.4 1.2**t 1.1-1.3 
*p<0.05 · ·p<0.001 
t adjusted for age and sex 
tFully adjusted refers to adjustments made for sex, alcohol , smoking, housing tenure, social 
contact, living alone and marital status. 
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Sensitivity and specificity 
As with any continuous scale of measurement, the different cut-off points in the 
British FI result in differing levels of specificity and sensitivity. When the cut-off 
point rises, sensitivity (true positive rate) increases with a corresponding 
decrease in specificity (false positive rate). This relationship can be summarized 
by testing the overall performance of the index which was calculated as the 
area under the receiver operating curve (ROC). 
To evaluate the usefulness of this frailty measure as a screening tool to predict 
future mortality, sensitivity and specificity were calculated for frailty scores at 
different cut-off points. Respondents with scores above the specified cutoff 
point, were deemed to be frail, and below it, not frail. This showed that at lower 
cutoff points the measure was more sensitive but at higher cutoff points the 
measure was more specific.The area under the ROC curve was 0.64 (Figure 
5.5) in the BWHHS population and 0.65, 0.63, 0.62 in Cox model 1, 2 and 3 of 
the MRC assessment study population (Figure 5.6) respectively, showing a 
moderate ability of the British FI in predicting all cause mortality. 
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Figure 5.5: Receiver Operating Curves assessing the ability of the British 
FI in predicting death in the BWHHS study population of 4286 women. 
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Figure 5.6: Receiver Operating Curves assessing the ability of the British 
FI in predicting death in the MRC assessment study. 
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Table 5.7: Frailty score cut-off points in the 4286 women from the BWHHS 
study population 
Frailty score True Positives False positives Sensitivity 1-Speclflclty 
cut-off point (FPR) 
per quartile 
.0.38 542 2673 85.6% 73.2% 
0.08 415 1730 65.6% 47.3% 
0.85 266 806 42.0% 22.1% 
In assessing the British FI, we would ideally want a high success rate of 
detecting 'positives', in other words, a highly sensitive test that was able to 
detect those who are truly frail and at risk of dying. However, death status may 
not be an appropriate 'standard' as not everyone who was frail had died at the 
end of the follow up period, and vice versa. Although predicting death using 
sensitivity and specificity tests would be useful in a clinical setting as a 
screening tool, assessing the measure's ability to predict death using this test 
may not be entirely appropriate diagnostically. For example(see Table 5.7), by 
choosing a cut-off point at the third quartile of frailty (0.08 in BWHHS 
population), we identified 66% of respondents as frail and had died at the end of 
follow up time but 47% of these women had been falsely identified. However, 
choosing a higher cut-off point of 0.65; we identified 42% of the population who 
were frail and had died, at a much lower false positive rate of 22%. Hence, re-
categoriSing the frail as those with the highest quartile of frailty scores, this 
group of women could be reassessed further for their risk of death using more 
specific criteria. 
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Cause specific mortality 
Further analysis into the association between frailty and specific causes of 
death was conducted on the MRC assessment study dataset. The proportional 
hazard assumption was fulfilled in all three Cox models for the periods specified 
in previous mortality analysis. Table 5.8 shows the frequency of deaths from 
causes related to a specific system. The most prevalent cause of death in this 
study population was due to cardiovascular disease (27.8%), cancer (13.3%) 
and respiratory disease (10.7%). 
Table 5.8: Frequency of deaths related to specific causes of 11195 
respondents of the MRC study population with complete data on frailty. 
Deaths Population (N) Percentage J%) 
No deaths 3726 33.3 
Cardiovascular 3111 27.8 
disease(CVD) 
Cancer 1495 13.3 
ResDiratorv disease 1193 10.7 
Circulatory (not CVD) 213 1.9 
Digestive 321 2.9 
Other* 1136 10.1 
Total 11195 100 
.. 
*Other deaths due to diabetes, Infection/parasItic, renal, nervous, mental, genitor-urinary (not 
renal), musculoskeletal system, unknown and odd causes of death. 
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Table 5.9: Frailty and cause specific mortality, hazard ratio per unit 
Increase in frailty score in 11195 men and women of the MRC assessment 
study, in three different time bands. 
cause 
Of 
DNtha 
0-2.5 
Hazard ratio (95"10 Col) 
Crude 
Cardiovascular 2.1** 
dl ..... (1.9,2.2) 
Cancer 1.5** 
(1.4,1.7) 
R .. plratory 2.8** 
(2.5,3.1) 
Circulatory 2.2-
(1.8,2.7) 
Otherst 2.6** 
(2.2,3.1) 
• p value<0.05 
•• p value<0.001 
Partial Full 
2.2** 1.8** 
(2.0,2.3) (1.7,2.0) 
1.6** 1.5** 
(1.4,1.8) (1.3,1.7) 
3.0** 2.3-
(2.7,3.4) (2.0,2.7) 
2.3- 2.1-
(1.8,2.8) (1.7,2.6) 
2.3** 2.2-
(1.9,2.8) (1.7,2.8) 
Follow up time (years) 
2.5-5.5 
Hazard ratio (95% Col) 
Crude Partial Full 
1.8** 1.9** 1.7** 
(1.7,2.0) (1.8,2.0) (1.6,1.8) 
1.0 1.1* 1.0 
(0.9,1.2) (1.0,1.3) (0.9,1.1) 
2.1- 2.2** 1.8-
(1.9,2.3) (1.9,2.5) (1.6,2.1) 
1.4* 1.4* 1.3* 
(1.1,1.8) (1.1,1.8) (1.0,1.6) 
1.9** 1.5** 1.5-
(1.6,2.2) (1.3,1.8) (1.3,1.7) 
t0ther deaths not related to specific systems 
>5.5 
Hazard ratio (95% C.I) 
Crude Partial Full 
1.6** 1.7** 1.5** 
(1.5,1.7) (1.6,1.8) (1.4,1.7) 
1.1 * 1.2* 1.1 
(0.9,1.3) (1.1,1.4) (1.0,1.3) 
1.7** 1.8** 1.5** 
(1.5,1.8) (1.6,1.9) (1.4,1.7) 
1.4** 1.5- 1.4** 
(1.2,1.7) (1.2,1.7) (1.1,1.7) 
1.4- 1.2- 1.2-
(1.3,1.6) (1.1,1.4) (1.1,1.4) 
Fully adjusted refer to adjustments made for age, sex, alcohol, smoking, housing tenure, living 
alone, and marital status social contact and self rated health. 
In the first two years of follow up, frailty doubled the mortality rate per unit 
increase of score in deaths from cardiovascular disease, circulatory and 
respiratory disease, even after fully adjusting for all covariates. This risk was 
attenuated with increasing lengths of follow up (see Table 5.9). 
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First hospital admission 
Frailty was found to be an independent predictor of the risk of first time 
hospitalization in the MRC assessment study population, with 1.5 times 
increase in risk after fully adjusting for all covariates as shown in Table 5.10. 
There was evidence of interaction between frailty and sex (p<O.05) but not with 
age and hence the data was stratified by sex. This showed that frailty predicted 
a slightly higher risk of the first hospital admission in men compared to women 
(HR 1.6 versus HR 1.5). When the scores were divided into quartiles, relative to 
the lowest quartile, frailty doubled the risk of a first hospital admission in the 
highest quartile, even after adjusting fully for all covariates (see Table 5.10) . 
Table 5.10: Frailty and first hospital admission, hazard ratio per unit 
increase in frailty score in 11195 men and women of the MRC assessment 
study. 
Crude 1.7** 
Age 1.6** 
adjusted 
Fully 1.6** 
adjusted 
* p value<O.05 
**p value<O.001 
tadjusted by age and sex 
1.5-1 .8 
1.5-1 .7 
1.5-1.7 
1.6** 1.5-1 .7 1.6** 1.5-1 .6 
1.5** 1.4-1.6 1.6**t 1.5-1.6 
1.5** 1.4-1 .6 1.5** 1.4-1 .6 
*Fully adjusted refer to adjustments made for age, sex, alcohol, smoking, housing tenure, living 
alone, and marital status social contact and self rated health. 
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Table 5.11: Frailty and first hospital admission, hazard ratio per unit 
increase in frailty score by frailty category in 11195 men and women of the 
MRC assessment study. 
Hazard ratio 
Low/Not frail 
Crude 
Partially adjustedt 
Fully-adjusted* 
P trend 
* p value<O.OS 
**p value <0.001 
tadjusted by age and sex 
1.0 
1.0 
1.0 
Frailty scores per quartile 
Mild Moderate Severe 
1.3**(1 .2,1.5) 1.8**(1 .6,1.9) 2.3"(2.1,2.S) 
1.3**(1 .2,1.5) 1.7**(1 .6,1 .9) 2.3**(2.0,2.S) 
1.3**(1 .1,1 .4) 1.7**(1 .S,1.9) 2.2**(2.0,2.4) 
<0.001 <0.001 <0.001 
:a:Fully adjusted refer to adjustments made for age, sex, alcohol, smoking, housing tenure, living 
alone, marital status, social contact and self rated health. 
Institutional admission 
Frailty was found to be an independent predictor of institutionalization in both 
men and women of the MRC assessment study. As shown in Table 5.12, frailty 
doubled the rate of institutionalization in both men and women in this population 
with a slight attenuation in the rate after fully adjusting for all the covariates and 
was higher in men than women. In Table 5.13, frailty increased the rate of 
institutional admission by nearly three times in those with the highest quartile of 
score (severe frailty) even after fully adjusting for all the covariates. 
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Table 5.12: Frailty and risk of institutionalization: hazard ratios with 95% 
confidence intervals for men and women in the MRC Assessment study 
population 
Frailty 
Men 
HR 95%C.I 
Crude 2.2** 1.9-2.5 
Age 1.9** 1.6-2.3 
adjusted 
Fully 1.7** 1.4-2.0 
adjusted* 
**p value<0.001 
tadjusted by age and sex 
Institutionalization 
Women 
HR 95%C.I 
1.9** 1.6-2.2 
1.6** 1.3-1 .8 
1.5** 1.2-1.7 
Total 
HR 
2.0** 
1·7**t 
1.5** 
95%C.1 
1.8-2.2 
1.5-1 .9 
1.3-1 .7 
*Fully adjusted refers to adjustments made for age, sex, alcohol, smoking, housing tenure, 
living alone, marital status, social contact and self rated health. 
Table 5.13: Frailty and institutional admission, hazard ratio per unit 
increase in frailty score by frailty category in 11195 men and women of the 
MRC assessment study. 
Hazard ratio Frailty scores per quartile 
Low/Not frail Mild Moderate Severe 
Crude 1.0 1.7**(1 .3,2.1) 2.1**(1 .7,2.5) 4.2**(3.3,5.3) 
Partially adjustedt 1.0 1.5*(1 .2,1.9) 1.7**(1 .4,2.0) 2.9**(2.3,3.7) 
Fully-adjustedt 1.0 1.4*(1 .1,1.8) 1.5**(1 .3,1.8) 2.5**(1 .9,3.2) 
p trend <0.001 <0.001 <0.001 
• p<0.05 
*1op value <0.001 
t adjusted by age and sex 
:t:Fully adjusted refers to adjustments made for age, sex, alcohol, smoking , housing tenure, 
living alone, marital status and social contact. 
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Discussion 
The predictive validity for adverse outcomes of the British FI was assessed in 
this chapter. Using this measure, frailty was shown to be an independent 
predictor of all cause mortality in these two cohorts of community dwelling older 
people after adjustments were made for age, sex, socioeconomic position, living 
alone, marital status, social contact and housing tenure. In similar large study 
populations [20, 41, 74, 100] there were great variations in the potential 
confounders adjusted for with little attention focused on how they might explain 
the association between frailty and its adverse outcome. Efforts to rigorously 
control for potential confounding may also reduce this association to non 
significance and result in over adjustments due to co-linearity of the covariate 
with the explanatory variable (frailty). In this study, this was seen with the 'self 
rated health' and 'own age activity' covariate which was excluded from the 
analysis. The variations in number and type of potential confounders may often 
reflect the type of frailty measure used for example; a more physiological 
measure such as Fried's frailty phenotype (adjusted with sixteen covariates) 
were additionally adjusted for objective measures of subclinical disease such as 
brachial and tibial systoliC blood pressure, abnormal left ventricular ejection 
fraction, major ECG abnormalities(20). 
Although age was included in the Cox model in both cohorts, there was strong 
evidence of interaction by age in the association between frailty and mortality. 
Hence age stratified hazard ratios were presented where the effect of frailty on 
all cause mortality differs according to different age categories, with an increase 
in frailty estimated mortality in higher age groups seen in both cohorts. A distinct 
finding of this analysis was that frailty was a stronger predictor of all- cause 
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mortality at earlier periods of follow-up (within the first 2.5 years from baseline) 
in the larger and older MRC assessment study population. As those with a 
severe degree of frailty were already dead earlier in the follow up period, this 
analysis identified the more robust in the population but also and more 
importantly, those who were frail but still surviving in the community. It is the 
frail survivors (with mild to moderate frailty) who could be potential targets in the 
longer term for preventive or therapeutic strategies aimed at reducing their risk 
for further adverse outcomes. There were no significant differences in frailty 
related mortality between the sexes at earlier ages (75-79, 80-84 years) but 
frailty predicted a higher mortality rate in men over the age of 85 years which 
was an expected result as men do have a higher mortality than women at 
extremes of age. 
Further analysis on this dataset showed that frailty was a strong independent 
predictor of cardiovascular, circulatory and respiratory related deaths. Frailty 
was also an independent predictor of death from cancer in the MRC 
respondents but only in the first two and a half years of follow up. This suggests 
that this could be related to survival bias associated with the type of cancer 
(whether the cancer was slow growing or rapidly progressive could affect time 
to death). 
Another important finding was that frailty was a strong independent predictor of 
first time hospitalization and institutional admissions in the MRC cohort, 
confirming the findings of other large population studies [1, 20, 40]. Frailty also 
predicted a higher rate of institutionalization in men even after fully adjusting for 
all the covariates. 
All these findings were most significant at the third and fourth quartiles of frailty 
scores where respondents were classified as moderate or severely frail. The 
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decision of which cut-off point to use when determining who was frail or not at 
baseline would highly depend on what this measure was used for. As a 
screening tool it could be used to correctly identify those at highest risk of 
adverse outcome, but at a compromise on its specificity and result in a high 
false positive rate. As this measure was highly sensitive in capturing those who 
were frail but still alive, this measure has the potential to target the severely frail 
survivors in the population (at the highest quartile of score) and enable more 
sensible decisions to be made on which type of service (preventive, 
rehabilitative or even palliative) was to be extended to this highly vulnerable 
group of elderly people. This would help reduce the burden of suffering that they 
endure as well as help reduce the cost on the health service. As mentioned 
earlier, longer term goals of prevention, therapy or intervention could target 
those with mild to moderate degree of frailty to reduce their future risk of 
adverse outcomes. 
A limitation of this analysis was that socioeconomic position was only measured 
and adjusted for in the BWHHS cohort using the SEP score. Also both cohorts 
consisted of a large Caucasian majority, therefore the effect of frailty in 
predicting adverse outcomes could not be inferred to those belonging to an 
ethic minority group. Another limitation is that only the risk for a first or single 
hospitalization was examined in this study. As frailty strongly predicted risk of 
first hospitalization, future work with this new frailty measure should perhaps 
focus on repeated hospital admissions which are a common problem among 
elderly people and drive a large part of the burden and costs associated with 
frailty. 
Lastly, future work will involve refinement of this measure by reducing the 
number of frailty indicators, selecting those indicators with greater weights and 
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rescaling the score so that it is more user friendly, especially for use in a 
primary care setting. 
In conclusion, this study provides good insight into the predictive validity of the 
British Frailty Index and supports its relationship with adverse outcomes that 
occur early as well as those occurring over long follow up periods. Hence, it 
should provide a convenient and cost-effective measure for guiding public 
health efforts in the community dwelling older people. 
Summary 
• Frailty is a strong independent predictor of all cause mortality in both the 
BWHHS and MRC assessment study cohorts, especially in higher age 
groups. 
• The British FI is the first measure to independently predict cause-specific 
mortalities from cardiovascular, respiratory and circulatory causes among 
community dwelling older people in the U. K. 
• Frailty is also a strong independent predictor of time to first 
hospitalization and institutionalization on both men and women. 
• The British FI has potential use in targeting the severely frail survivors in 
the population (at the highest quartile of score) to enable more sensible 
decisions to be made on which type of service (preventive, rehabilitative 
or even palliative) was to be extended to this highly vulnerable group of 
older people. 
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Chapter 6: Comparison between the British frailty 
index with a well known index and other single 
markers of frailty. 
I ntrod uction 
In the previous chapters, I have examined the construct, external criterion 
and predictive validity of the British Frailty Index (FI). The question posed in 
this chapter was whether this newly developed measure was better at 
predicting all cause mortality than another well validated measure, in addition 
to single markers of frailty. 
The measure chosen for comparison with the British FI was the Canadian 
Study of Health and Aging (CSHA) frailty index, which was initially 
developed for elderly Canadians. Apart from being closely related to a more 
multi dimensional concept of frailty, the CSHA index is one of the most 
widely published frailty measures, having been evaluated in many study 
populations [42, 78, 102, 105]. In constructing this index, Rockwood et af 
aimed for a measure that could evaluate impairments in many body systems, 
accommodate change, was graded and conceptually simple. By combining 
items in a single index, frailty was explicitly based on the idea that 'the more 
things individuals had wrong with them, the higher the likelihood that they 
would be frail'.[107] This likelihood of frailty was associated with a greater 
risk of adverse outcomes. With regard to the specific nature of the variables 
that were included in the frailty index, Rockwood et al reported that when a 
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sufficiently large number of variables were considered (whether 40, 70 or 
even 90), the variables could be selected as different combinations yielded 
comparable predictions of the risk of adverse outcomes[40]. The individual 
variables in the CSHA were 'unweighted' as the frailty index treated all the 
problems equally. Other studies have reproduced a high correlation between 
an equal weights deficit count and mortality which indicates this approach to 
frailty measurement is valid [40, 80, 105]. However, the British FI, derived 
using factor analysis, adjusts for measurement error and assigns relative 
weights to each frailty indicator in association with frailty. This provides a 
more refined model which identifies the specific contribution of variables to 
best explain the underlying construct of frailty and distinguish those who are 
frail from those who are not. 
Despite the many different measures used to identify frailty and factors 
associated with its concept, there is general agreement amongst frailty 
researchers that a core feature of frailty is an increased vulnerability to 
stressors due to impairment of multiple inter-related physiological 
systems[73]. This negative interplay involves several key systems, espeCially 
the muscular, neuroendocrine, and immune systems to create a downward 
spiral that we eventually recognize as frailty [29]. On this basis, several 
correlates or markers of frailty have been proposed in order to identify frailty 
more precisely[28]. Although currently, no single marker could fully assess 
the complexity of frailty, there is growing evidence that certain contributing 
factors could facilitate a person's entry into the frailty state, or a define a pre-
frailty state. These include factors that have been implicated in the 
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pathophysiology of frailty such as chronic inflammation, which may be due to 
regulatory failure of the immune system during the aging process[28, 29].The 
inflammatory markers most studied with respect to frailty, aging and survival 
have been interleukin-6 (IL-6)[31 , 32, 128], tumour necrosis factor alpha 
(TNF-a)[129] and C-reactive protein (CRP)[33, 130]. These markers are not 
the only mediators of the adverse outcomes associated with frailty. In 
addition to CRP, markers of coagulation such as fibrinogen and D-dimer are 
also implicated with frailty in view of their role in the generation of 
atherosclerosis and prediction of cardiovascular outcomes [31, 131]. Other 
markers studied in relation to frailty include metabolic markers such serum 
albumin[129], haemoglobin [132], white cell count[32, 133], cholesterol [84, 
134] and glucose[31]. Physical markers such as sarcopenia (degenerative 
muscle loss) which has been indirectly associated with leptin levels in the 
blood through modulations of growth hormone secretion, provide another 
frailty criteria which is included in the widely known phenotype of physical 
frailty by Fried et al [20]. However, further studies have suggested a link 
between frailty and obesity in older people , specifically in relation to body 
mass index(BMI) and central obesity[121, 135].Orthostatic hypotension 
thought to be a normal accompaniment of aging, reflects baroreceptor 
dysfunction and decreased responsiveness to sympathetic stimulation in 
older people[136]. This may also be related to phYSical frailty, which is 
conceptualized as a reduction in physiological reserve capacity. 
Other possible correlates of frailty include self rated health, a subjective 
evaluation by an individual of their overall health status, which is also an 
important predictor of mortality among community living elderly people[16]. 
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With this background in mind, there were two aims in this chapter. The first 
was to assess how the small, weighted British FI compared to a larger, 
unweighted additive type of measure (CSHA frailty index) in predicting 
adverse health outcomes, namely all cause mortality, institutionalization and 
hospitalization. To provide a more balanced comparison, the predictive 
validity of an abridged CSHA FI with an equal number and type of variables 
to the British FI was also compared. The second aim was to assess the 
correlation of the British FI with single markers of frailty and compare its 
predictive ability with these single markers using data from the BWHHS 
cohort. 
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Methods 
Study population 
The study populations used for this analysis was as detailed in Chapter 5. 
Briefly, all 4286 women, aged between 60 to 79 years in the BWHHS dataset 
were included in the first part of the analysis. There were 633 deaths until 
censored date of 10th August 2008 giving a median follow up period of 8.2 
years (range 4 months to 9.3 years). In the MRC assessment study, the 
mortality analysis was carried out on respondents with complete data. Since 
entry into the study until the 4th of October 2007, 7469 out of 11195 
respondents of the MRC Assessment study have died (66.7%). Of the 6709 
women, 4197 had died (62.6%). Of the 4486 men, 3272 had died (72.9%). In 
the mortality analysis, all MRC respondents were followed up for a median 
time of 7.9 years (range 22 days to 12.6 years. When 'time to first hospital 
admission' was used as the outcome measure, the MRC respondents were 
followed up for a median time of 2 years (range 22 days to 2 years).This 
shorter follow up period for hospitalization data was because these data 
were not collected for the full duration of follow up. For similar reasons, in the 
analysis using admission into an institution as the outcome measure, all 
MRC respondents were followed up for a median time of 3.9 years (range 
1.6 to 5.7 years). 
The second part of the analysis which compared the British FI with Single 
measures of frailty was confined to 3331 women who had complete data on 
all the blood markers of frailty including physical measurements of blood 
pressure, height, weight, waist and hip and nurses' estimation of life 
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expectancy. All these were collected at baseline examination and interview 
by a trained nurse. 
Replication of CSHA measure using the BWHHS and MRC assessment 
cohorts 
The CSHA Frailty Index (FI) score was calculated as the proportion (from a 
given set) of deficits present in a given individual, and indicating the 
likelihood that frailty was present. The ranges of deficits were counted from 
variables collected from self reports or clinically designated symptoms, signs, 
disease and disabilities that were readily available in surveyor clinical data. 
The variables for each FI were recoded as binary with value '1' when the 
deficit was present and '0' when absent. For example, if a total of 20 deficits 
were considered, and the individual had 3, then the frailty index value is 
3/20=0.15. 
FI=XIY=Sum of deficits/total number of variables 
Using the equation above, I replicated two versions of the CSHA FI using the 
method above using unweighted variables derived from the BWHHS and 
MRC assessment study datasets. The difference between the two versions 
was that the first version was larger (51 and 44 variables in the BWHHS and 
MRC study dataset respectively) whereas the second was calculated from 
the same type and number of variables as the British FI (36 and 35 variables 
which were identified via factor analysis in the BWHHS and MRC study 
dataset respectively). Details of the variables included in each CSHA FI are 
given in the Appendix. 
201 
Single markers used in this analysis 
At the start of the study, the respondents were assessed by research nurses, 
who apart from completing the survey, were responsible for taking blood 
samples and measurements of height, weight, waist and hip measurements. 
Blood was drawn from the respondents who attended the interview following 
an overnight fast using standardized protocols. Based on the expectation 
that a 65 year old woman would live on average, another 20 years, the 
nurses were asked to provide an estimation of life expectancy in years that 
the respondent might expect. 
The single markers identified were those available mainly to the BWHHS 
dataset. These included blood markers (inflammatory and metabOliC) such as 
IL-6, CRP, D-dimer, white cell count, haemoglobin, albumin, glucose and 
total cholesterol. Unfortunately, TNF-a and leptin levels were excluded as 
they were only measured on small sub-sets of respondents (n=500, for case-
control studies) and therefore demonstrated very limited statistical power to 
this part of the analysis. Other single measures examined include BMI, which 
was calculated by dividing the respondent's weight (kg) by height squared 
{m).Waist hip ratio (WHR) was calculated as the ratio of measured waist 
circumference (side measurements at the waist identified as midpoint 
between the iliac crest below and the lower edge of the ribs above) to hip 
circumference measured around the hips at maximum point of 
circumference. Orthostatic hypotension (OH) was calculated from the 
respondents' blood pressure levels which were measured at the time of the 
interview, with two sitting measurements followed by two standing 
measurements (all at 1-min intervals). OH was defined as a drop of 
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~10mmHg in diastolic blood pressure and/or a drop of ~20mmHg in systolic 
blood pressure on standing (based on the differences between the first sitting 
and fourth standing measurements, within 3min of standing)[137]. The 
respondents' perception of their health status (Le. self rated health ranging 
from excellent to poor) was also included in this analysis. Data was 
presented as a mean ±SD for the variables used here so as to standardize 
the increase in hazard ratio per 1 standard deviation of the continuous 
variables measured. 
Data analysis 
Cox proportional hazards regression analysis was used to compare the 
difference between hazard ratios for adverse outcomes when using the 
British FI and the CSHA frailty index. Hazard ratios for all cause mortality 
were compared in both the BWHHS and MRC assessment study datasets 
and risk of first hospital admission and institutionalization was assessed 
using data which was only available in the MRC assessment study. 
The correlations between frailty (using the British FI) and each of the single 
measures of frailty were calculated using Pearson's correlation. To evaluate 
the relationship between each single measure with frailty level, Pearson H,2 
tests were used for categorical variables and analysis of variance F tests 
were used for continuous variables. Each level of frailty represents 
increasing quartiles of the respondent's score ranging from 'nollow frailty' to 
'mild', 'moderate' and 'severe' frailty. The comparison of hazard ratios for all 
cause mortality between the British FI and single measures of frailty was 
made using the BWHHS dataset. In both datasets, the covariates introduced 
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into the Cox regression model were age, sex(for the MRC study), marital 
status, housing tenure, living alone or otherwise, social contact(good or 
poor),smoking, alcohol intake and socioeconomic position (SEP) scores 
(BWHHS only). Crude, partially adjusted (age and/or sex) and fully adjusted 
models were fitted for these outcomes. Additionally, as a summary index of 
the performance of each measure, the area under the receiver operating 
curve (ROC) was calculated, where the greater the area, the greater the test 
performance. This curve was generated from different cut-off points 
calculated along a continuous scale of measurement, resulting in a graph 
which plots sensitivity (y axis) versus 1-specificity (x axis). 
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Results 
Descriptive statistics are shown in Table 6.1 below comparing the British FI 
and the CSHA FI using both the BWHHS and MRC assessment study 
cohorts. As these measures were not normally distributed in both these 
cohorts, the frailty scores were presented median and inter-quartile range 
(IQR). 
Table 6.1: Median scores with inter-quartile range of the British FI and 
CSHA FI in both the BWHHS and MRC assessment study cohorts. 
Frailty BWHHS MRC Assessment study 
Number Median lOR Number Median lOR 
British FI 4286 .077 (-0.38,0.65 11195 0.04 (-0.44, 0.63) 
CSHA FI* 4286 0.16 (0.10,0.25) 11195 0.23 (0.15,0.44 ) 
CSHA FI** 4286 0.17 (0.11,0.28) 11195 0.18 (0.12,0.28) 
* CSHA FI uSing 51 or 44 variables In the BWHHS and MRC assessment study respectively 
- CSHA FI using 36 or 35 variables in the BWHHS and MRC assessment study 
respectively 
Figures 6.1 and 6.2 demonstrate the spread of frailty scores as measured 
using the British FI, the CSHA FI as well as the abridged version of the 
CSHA Fl. These figures show that in both cohorts, the British FI has greater 
variance, giving a more refined distribution of frailty and serves as a better 
population metric compared to the CSHA Fl. 
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Figure 6.1: Graph box showing median and inter quartile 
ranges of the British FI and the CSHA FI calculated in 
4286 BWHHS cohort. 
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Figure 6.2: Graph box showing median and inter quartile 
ranges of the British FI and the CSHA FI calculated in 
11195 men and women of the MRC assessment study 
cohort. 
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The British FI was a better predictor of all cause mortality in the women of 
the BWHHS cohort as shown in Table 6.2, when compared to both the larger 
and the reduced unweighted CSHA FI (age adjusted HR 1.7(95% C.I:1.6,1.7 
)versus 1.4(95% C.I:1.3,1.4) and 1.3 (95% C.I:1.2,1.4), p<O.001 
respectively). This was also true in both men and women of the MRC 
assessment study cohort (see Table 6.3), with frailty being a stronger 
predictor of mortality earlier on in the follow up period (between 0 to 2.5 
years). The British FI was also a better predictor of the risk of hospital 
admission; age adjusted HR 1.5(95% C.I:1.4,1.6) vs. 1.3 (95% C.I:1.2,1.4) as 
well as institutionalization ( age adjusted HR 1.7 (95% C.I:1.5,1.9)vs. 1.4 
(95% C.I:1.2,1.5) in the MRC assessment study cohort (see Table 
6.4}.These predictions were independent of covariates such as age, sex, 
socioeconomic position scores, smoking, alcohol intake, living alone, marital 
status, housing tenure and social contact. When the covariate 'self rated 
health' was included in the model, there was over adjustment which did 
result in underestimation of the risk of these adverse outcomes. However, 
frailty estimated these risks independently of self rated health. 
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Table 6.2: Comparison of hazard ratios for mortality per unit increase in frailty scores in 4286 BWHHS women using three 
different measures 
Frailty Total(N) 
Crude 4286 
Age adjusted 4286 
Fullyadjusted* 4280 
p-value ** 
Area under ROC 
curve 
British FI 
1.8(1 .7-2.0) 
1.7(1 .6-1 .8) 
1.4(1 .3-1 .5) 
<0.001 
0.64(0.6,0.7) 
CSHA FI(51) CSHA FI (36) 
1.4(1.4,1.5) 1.4(1.3,1.4) 
1.4(1 .3,1.4) 1.3(1 .2,1.4) 
1.3(1.2,1.4) 1.2(1 .1,1.3) 
<0.001 <0.001 
0.67(0.6,0.7) 0.65(0.6,0.7) 
*fully adjusted for age, socioeconomic status (SES), smoking, alcohol intake, marital status, living alone and housing tenure. 
**p value is for crude, age and fully adjusted hazard ratio (HR). 
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Table 6.3: Comparison of hazard ratios for all cause mortality per unit increase in frailty scores in the MRC Assessment 
study using three different measures of frailty 
Follow up time (years) 
0-2.5 2.5-5.5 >5.5 
Outcome Hazard ratio (95% C.I) Hazard ratio (95% C.I) Hazard ratio (95% C.I) 
Crude Age Full· Crude Age Full· Crude Age Full· 
British FI 
All cause mortality 2.0** 1.9** 1.8** 1.7** 1.6** 1.5** 1.5** 1.4** 1.4** 
(1 .9,2.2) (1.8,2.1 ) (1.7,1.9) (1 .6,1 .8) (1 .5,1.6) (1.4,1.5) (1.4,1.6) (1 .3,1.5) (1 .3,1.5) 
CSHA FI (44 variables) 
All cause mortality 1.6** 1.5** 1.5** 1.4** 1.3** 1.3** 1.3** 1.2** 1.3** 
(1 .5,1.7) (1 .4,1.6) (1 .4,1.6) (1 .4,1.5) (1 .3,1.4) (1 .2,1.4) (1 .3,1.4) (1 .2,1 .3) (1 .2,1.3) 
CSHA FI (35 variables) 
All cause mortality 1.5** 1.4** 1.4** 1.3** 1.3** 1.2** 1.3** 1.2** 1.2** 
(1.4,1.5) (1 .3,1.4) (1 .3,1.4) (1.3,1.4) (1 .3,1.4) (1.2,1.3) (1 .2,1.3) (1 .1,1.2) (1 .2,1.3) 
·fully adjusted for age, sex, smoking, alcohol intake, marital status, living alone, social contact and housing tenure 
**p value<0.001 
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Table 6.4: Comparison of hazard ratios for hospitalization and institutionalization per unit increase in frailty scores in the 
MRC Assessment study using three different measures of frailty 
Outcome 
First hospital admissiont 
Institutionalization* 
First hospital admissiont 
Institutionalization* 
First hospital admissiont 
Institutionalization* 
Crude 
British Fl 
Hazard ratio (95% Col) 
Age Full* 
1.6**(1 .5-1 .6) 1.5**(1.4,1 .6) 1.5**(1.4,1.6) 
2.0**(1 .8,2.2) 1.7**(1 .5,1.9) 1.6**(1.4,1.8) 
CSHA FI (44 variables) 
1.4**(1 .3,1.4) 1.3**(1 .2,1.4) 1.3**(1 .2,1.4) 
1.5**(1.4,1.6) 1.4**(1 .2,1.5) 1.3**(1.2,1.4) 
CSHA FI (35 variables) 
1.3**(1 .2,1.3) 1.3**(1 .2,1.3) 1.3**(1 .2,1 .3) 
1.5**(1.4,1.6) 1.3**(1.2,1.4) 1.3**(1 .2,1.4) 
*fully adjusted for age, sex, smoking, alcohol intake, marital status, living alone, social contact and housing tenure. 
**p value<O.001 
t refers to time to first hospital admission in the first two years of follow up. 
+ refers to time to institutionalization over a median time of 3.9 years of follow up 
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Table 6.5: Correlations between frailty as defined by the British FI and single markers of frailty in the BWHHS dataset* 
Frailty IL-6 CRP D-Dimer Albumin Glucose Cholesterol Hb WCC BMI WHR OH Est. life expo Self Rated Health 
Frailty 1 
IL-6 0.14«0.0001) 1 
CRP 0.16«0.0001) 0.37 1 
D-Dimer 0.1 «0.0001) 0 .18 0.18 1 
Albumin -0.11«0.0001) -0.15 -0.22 -0.13 1 
Glucose 0.16«0.0001) 0.05 0 .1 -0.01 -0 .04 1 
Cholesterol -0.08«0.0001) -0.08 -0.05 -0.04 0 .2 -0.05 1 
Haemoglobin(Hb) -0.03«0.05) -0 .05 -0.08 -0.09 0 .19 0 .06 0.08 1 
White cell count(WCC) 0.05«0.05) 0 .08 0 .09 0 .03 0 .01 0.03 0.02 0.03 1 
Body Mass Index(BMI) 0.32«0.0001) 0 .08 0.16 0.06 -0.14 0.15 -0.02 0.08 0.02 1 
Waist hip ratio(WHR) 0.26«0.0001) 0 .06 0 .15 0.02 -0.04 0.18 0.03 0.1 0 .05 0.37 1 
Orthostatic hypotension(OH) 0.01(0.58) 0 0 0 0.02 0.02 0.01 0.01 0 -0.03 1 
Estimated life expectancy -0.26«0.0001) -0.07 -0.09 -0.09 -0 .09 -0.1 0 0 -0 .06 -0.13 -0.13 -0.05 1 
Self rated health(5RH) 0.28«0.0001) 0.06 0.06 0 .05 -0 .05 0.09 0 -0.02 0 .01 0.09 0.05 0.01 -0.1 1 
~- ~--
* Correlations were conducted on 3331 women with non missing data on the variables above using Pearson's correlation. 
211 
The strength of relationships between frailty and single measures of frailty are 
shown in Table 6.5. The strongest relationship with frailty as measured using the 
8ritish Frailty Index, were with 8MI, self-rated health status, waist hip ratio as 
well as the nurses' estimation of life expectancy. 8MI, self rated health and waist 
hip ratio were positively correlated with frailty ranging from 0.26 to 0.38 
(p<0.001). The nurses' estimation of life expectancy however, correlated 
negatively with frailty(r= -0.26,p<0.001), meaning that those with higher 
estimated years of life expectancy had lower frailty scores and were therefore 
less likely to be frail (see Figure 6.3). 
Figure 6.3: The association between frailty and nurses' estimate of life 
expectancy in the BWHHS study 
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When comparing the frequencies of estimated life expectancy by frailty 
categories, there were more than twice as many respondents with a lower 
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estimated life expectancy(O to 9 years) in the severe frailty category compared 
to the not frailllow frailty category ( 34.7% versus 13.5%). Correspondingly, there 
were twice as many respondents with a high estimated life expectancy (> 20 
years) in those who were not frail compared to those with severe frailty (39.7 
versus 17.5) (see Table 6.6 below). 
Table 6.6: Nurses' estimated life expectancy by frailty category. 
Nurses Low/Not frail Mild frailty Moderate Severe Total (%) 
estimated life (%) (%) frailty (%) frailty (%) 
expectancy 
(years) 
0-9 117(13.5) 139(16.3) 188(22.1) 242(34.7) 686(20.6) 
10-14 223(25.7) 244(28.7) 280(32.9) 248(32.6) 995(29.9) 
15-19 183(21.1 ) 185{21.7) 164(19.3) 139(18.2) 671(20.1) 
20 or more 344(39.7) 283(33.2) 219(25.7) 133(17.5) 979(29.4) 
Total 867(100) 851(100) 851(100) 762(100) 3331(100) 
There was no correlation with an assessment of a postural drop in blood 
pressure with frailty. 
Blood markers that correlated positively with frailty were inflammatory markers 
such as interleukin 6 (IL-6) and C reactive protein (CRP), as well as the 
coagulation marker, D-dimer (p<O.001). Metabolic markers of frailty such as 
fasting blood glucose had a positive correlation with frailty whereas blood 
albumin and cholesterol level had a negative correlation with frailty (p<O.001). 
These correlations were confirmed when each respondent was assessed 
according to the level of frailty (low/no frailty, mild, moderate and severe frailty) 
as shown in Table 6.7. Levels of markers such as IL-6, CRP, D-dimer and 
fasting glucose were significantly higher in those classified as severely frail. This 
group also had significantly lower levels of total cholesterol, albumin and 
haemoglobin. Respondents classified as being severely frail were associated 
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with lower estimated years of life expectancy, poor perception of their health 
status (self rated health) and a higher BMI and waist hip ratio compared to those 
who were not frail or had low levels of frailty. 
The results of the Cox regression analysis in Table 6.8 showed that 'self rated 
health', frailty as measured by the British FI, and waist hip ratio were 
independent predictors of all cause mortality in the BWHHS respondents. Higher 
levels of IL-6, CRP and D-dimer were associated with a higher risk of all cause 
mortality (p<0.001). However, higher estimated life expectancy in years, higher 
albumin and a higher total cholesterol level were associated with a Significantly 
lower risk of all cause mortality (p<O.001). 
The analysis using area under the ROC curve was used to compare the ability of 
each measure to predict all cause mortality. Both the larger and reduced version 
of the CHS index had a higher calculated area than the British measure: 
0.67(95%C.I:0.65, 0.69) IO.65(95%C.I:0.62, 0.67) vs. 0.64(95%C.I:0.61, 0.66) 
(see Table 6.2), showing a moderate predictive ability. With the exception of 
markers such as self rated health and IL-6, the area under the ROC curve for the 
British FI was higher than most of the single markers which had values of <0.6 
(see Table 6.8). 
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Table 6.7: Single measures of frailty by frailty status in 3331 BWHHS respondents 
Single Frailty Measurest Low/Not frail (n=867) Mild Moderate Severe p value 
(n=851) (n=851) (n=762) 
IL-6,pg/ml 2.59 2.78 3.48 4.21 <0.001 
CRP, mg/I 2.44 2.81 3.46 4.85 <0.001 
D-Dimer, ng/ml 116.91 127.46 139.94 161 .66 <0.001 
Albumin, mg/I 44.22 44.20 43.87 43.64 <0.001 
Glucose, mmol/I 5.80 5.89 6.19 6.34 <0.001 
Cholesterol, mmolll 6.71 6.59 6.58 6.48 0.001 
Haemoglobin, g/dl 13.54 13.51 13.53 13.45 <0.05 
White Blood Cell, 103/mm3 7.23 7.03 7.25 7.23 <0.001 
Body Mass Index, kg/m2 25.78 26.76 27.75 29.67 <0.001 
Waist Hip Ratio (WHR) 0.79 0.81 0.83 0.84 <0.001 
Orthostatic hypotension( %) 24.30 26.36 25.49 23.86 0.50'" 
Estimated life expectancy,yr 15.80 14.82 13.55 11 .88 0.001 
Self rated health (%) 1.47 1.47 14.71 82.35 <0.001'" 
"'p value was derived from Pearson's chi square test for categorical variables; the other p values were derived using Scheffes test. 
tValues of the single measures is the standardized mean within each category of frailty. 
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Table 6.8: Estimated age and fully adjusted hazard ratios for all cause mortality associated with an increase of one SO and 
the area under the ROC curve using the BWHHS frailty measure and other single markers of frailty* 
Measure Hazard ratio (95%C.I.) Hazard ratio (95%C.I.) p value Area under the ROC 
Age adjusted Full~ adjusted curve 
BWHHS frailty measure 1.44(1 .33,1 .56) 1.38(1 .28,1.48) <0.001 0.64 
IL-6,pgtml 1.20(1.12,1.28) 1.17(1 .09,1.25) <0.001 0.63 
CRP, mgll 1.16( 1.11,1 .21) 1.14(1 .09,1 .18) <0.001 0.58 
D-Dimer, ngtml 1.17(1 .09,1.26) 1.17(1 .08,1.27) <0.001 0.60 
Albumin, mgtl 0.80(0.72,0.89) 0.83(0.74,0.92) <0.001 0.43 
Glucose, mmol/l 1.10(1 .05,1 .16) 1.11(1 .06,1.16) <0.001 0.54 
Cholesterol, mmol/l 0.82(0.74,0.91 ) 0.83(0.76,0.92) <0.001 0.45 
Haemoglobin, g/dl 0.94(0.86,1.03) 0.91 (0.86, 1.02) <0.05 0.47 
White Blood Cell, 103/mm3 1.04(1 .00,1 .07) 1.03(1 .00,1.06) <0.05 0.61 
Body Mass Index, kg/m2 0.95(0.83,1.09) 0.92(0.81 ,1.03) <0.5 0.47 
Waist Hip Ratio (WHR) 1.24(1 .15,1.33) 1.20(1 .11,1 .29) <0.001 0.57 
Orthostatic hypotension 1.06(0.99,1.14) 1.08(1 .00,1.15) <0.5 N/At 
Estimated life expectancy, years 0.72(0.61 ,0.84) 0.76(0.66,0.90) <0.001 0.35 
Self rated health 1.97(1 .67,2.31) 1.86(1.57,2.19) <0.001 0.63 
*data are mean ± SO unless otherwise specified **fully adj usted for age, socioeconomic status (SES), smoking, alcohol intake, marital status, living alone and 
housing tenure. tN/A(not applicable) as orthostatic hypotension is a binary variable and not suitable for ROC analysis. 
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Discussion 
Comparisons have previously been made between two widely known and 
widely used frailty measures; the CSHA frailty index which was first validated 
in the Canadian Study of Health and Aging (CSHA) and Fried's phenotype 
measure of frailty. This was in relation to their predictive ability for adverse 
outcomes and as well as their correlations with specific markers of frailty [129, 
138, 139].ln this chapter, I compared the British frailty index (FI) with the well 
validated CSHA frailty index using two British cohorts of older people and 
showed that the British FI had greater variance in the distribution of scores 
compared to the CSHA FI (see Figure 6.1 and 6.2). Hence, the British FI would 
serve as a better population metric than the CSHA FI as it enables those people 
with varying degrees of frailty from low to mild, moderate and severe to be 
better distinguished over a wider range of scores. The British FI was a better 
predictor of all cause mortality than CSHA FI in both cohorts independent of 
similar potential confounders. It was also a better estimate of the respondents' 
increased risk of hospital admission per unit of frailty score than both versions 
of the CSHA index. However, the outcome of hospitalization in this study only 
involved the time to first hospital admission for each respondent during the 
whole follow up period of the MRC assessment study. In view of the results, this 
would suggest that further analyses into those with multiple admissions, would 
indeed be of value in classifying the frailest among this population of community 
dwelling older people. Institutionalized older people are often labelled as frail 
and hence, the risk of institutionalization has become a recognized frailty 
adverse outcome[40]. Using the British FI, frailty also estimated a better 
increased and independent risk of institutionalization, per unit score than the 
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CSHA index. These findings serve to emphasize the advantage of the British 
Frailty Index over the CSHA index; in that it is a reduced measure which 
corrects for measurement error and assigns relative weights in the association 
of each indicator with frailty (see Chapter 3).ln developing this measure, the 
weighted latent variables that best explained frailty were captured, excluding 
those that did not. This resulted in a measure that attempts to measure frailty 
itself as opposed to being an indicator of an older person's global health status. 
As the two different measures of frailty are based on different theoretical 
constructs, they would certainly capture different groups of older people. Hence 
the results above suggest that the British FI would serve as a better predictor of 
adverse outcomes in community dwelling older people than an unweighted and 
additive type of index. 
Despite showing stronger associations with adverse outcomes, in the analysis 
of the area under the ROC curve, both the British FI and the replicated CSHA 
index showed a similarly moderate ability (0.64 and 0.65) to predict death (see 
Table 6.1). For example, in comparing how well each index separates those 
who develop the outcome from those who do not, the difference was only 1 %. 
However, area under the ROC curve may not address fully the question of 
whether one index is superior to the other in terms of clinical usefulness. Ease 
of making measurements, interpretation of output and additional clinical 
information provided by graphical displays of risk and the calculation of the 
numbers needed to screen (NNS) may be more helpful for the clinician in 
determining whether a new marker or measure is useful[140). 
I was also interested to examine the strength of the relationship between frailty 
and specific single frailty markers which related to the biological underpinnings 
of frailty[30]. The results were in keeping with other community dwelling older 
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population studies [31, 32, 84, 121] in that with increasing frailty, levels of IL-6, 
CRP, O-dimer and fasting glucose increased significantly (p<0.001).The frailest 
in the BWHHS population were also significantly associated with lower albumin, 
haemoglobin and cholesterol levels. As mentioned in Chapter 3, seven latent 
factors best explained frailty using the British FI, which among others, included 
signs and symptoms of cardio-respiratory disease as well as chronic disease 
such as diabetes and hypertension. Therefore the association of frailty with the 
markers used in this analysis is certainly to be expected as these markers are 
also raised in these diseases or states in older people [128, 130]. For example, 
the association of frailty with increased inflammation (IL-6 and CRP) and 
coagulation could possibly be influenced by any underlying cardiovascular 
disease and diabetes in this older study population. 
Although frailty has been conceptualized as a wasting syndrome with weight 
loss as a key component, the physical measurements of BMI and WHR were 
also highest in the severely frail in the BWHHS population. This finding supports 
a recent study which found that subjects with the lowest frailty index and the 
lowest prevalence of Fried's rules based measure were those with a high 8MI of 
25-29.9. They also found that in each BMI category, and using either measure 
of frailty, those with a high waist circumference were significantly more frail 
[121]. In this analysis, although frailty was positively correlated to 8MI and 
WHR, only WHR was an independent predictor of all cause mortality per 
increase in 1 SO of waist hip ratio (HR 1.19,95% C.I.:1.11, 1.28, p<0.001). In 
view of the rise in obesity in older populations, lifestyle modifications 
incorporating a healthy diet and regular exercise should be an important agenda 
in the prevention of frailty and its adverse outcomes. However these efforts 
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should not merely target the usual overweight/obese older adults but those who 
exhibit signs of central obesity, regardless of BMI category. 
Most significantly correlated to frailty was self rated health, with poor self rated 
health being highest in those respondents in the severe frailty group. This 
strong association with frailty was not surprising seeing that this marker is not 
only a strong independent predictor of mortality but also of successful aging 
and an independent predictor of the use of health services among older 
people[141]. Although self rated health lies on the causal pathway between 
frailty and mortality, when it was adjusted for in the model, the British FI still 
predicted mortality and other outcomes independent of self rated health. This 
indicates that the British FI was not simply measuring more general aspects of 
the health status. 
The analysis also introduced a novel marker of frailty provided by the BWHHS 
cohort. This was 'estimated life expectancy' where the research nurses were 
asked to provide an estimation of life expectancy that the respondent might 
expect. It was interesting to note that women with a higher estimated number of 
years of life expectancy were less frail and correspondingly, women with a 
much lower estimate of life expectancy had higher levels of frailty. This was in 
keeping with a lower risk of death (HR 0.76, 95% C.I:0.66, 0.90, P<0.001) 
among the BWHHS women who were estimated to have a higher life 
expectancy. 
The association of frailty with the specific blood and physical markers shown 
here do support the theories that frailty is characterized by dysregulations in 
multiple physiologic systems and increases an older person's vulnerability for 
serious adverse outcomes [16, 20]. The low correlations of these markers with 
frailty also support the theory that frailty is a complex phenomenon that cannot 
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merely be assessed or measured using a single or simple tool. It is suggested 
here that these markers constitute one of many interrelated precursors of a 
pathway that leads to a pre- frailty state. Recognition of the centrality of the 
interrelatedness of these markers to frailty is a key to providing guidelines for its 
prevention and therapy among community dwelling older people. 
There are some limitations to this part of the analYSis. Firstly, frailty was only 
calculated from variables taken at baseline (at start of the study). Prospective 
calculation of frailty and collection of the specific markers would enable a more 
comprehensive analysis that would help further understanding as to how they 
would change over time. 
Secondly, in the part of the analysis, the BWHHS cohort was confined to 
respondents with only complete data on all blood and physical markers of 
interest, introducing a possible bias in the results of the study. The missing data 
was due to the fact that some respondents (who may represent a portion of the 
severely frail in the BWHHS study), had replied to the questionnaires via post 
as not all were able to attend the interview and have their blood taken. 
The study findings provide further evidence of the association of a weighted and 
measurement error adjusted frailty score with important adverse outcomes. The 
British FI can be rescaled, reduced and refined into a short questionnaire which 
would include only questions pertaining to variables with higher weights. In this 
shorter form it would be amenable for use in a primary care as a quick, easy 
and none invasive measure for screening frail older people at risk in the 
community 
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Summary: 
• The more internally reliable British FI (weighted and adjusted for 
measurement error) is a better predictor of all cause mortality than the 
CSHA FI in two well representative older British population cohorts. 
• The British FI is also a better predictor of risk of institutionalization and 
hospitalization than the CSHA frailty index in both older men and women 
of the MRC assessment study. 
• The British FI has greater variance which produces a more refined 
distribution of frailty and serves as a better population metric compared 
to the CSHA FI. 
• In keeping with similar study findings, frailty, as defined by the British FI, 
is significantly correlated with specific physiological markers which are 
highly associated with all cause mortality and implicated in the 
pathophysiology of frailty. 
• The British FI confirms the concept of frailty as a complex multi-
dimensional one and is a better predictor of all cause mortality than 
single markers of frailty. 
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Chapter 7: Overall discussion and conclusions 
What are the contributions made to identifying frailty from 
concept to measure? 
It has been five decades since the term 'frail' was first coined to describe the 
vulnerable state and needs of older people in British hospitals[8]. Although the 
reasons behind the identification and measurement of frailty have generally 
remained the same, its complexity remains a limiting factor in reaching a 
consensus definition. Geriatricians who have long appreciated the complex and 
heterogeneous nature of health problems in the older person still have problems 
in translating the clinical profile of frail elderly people into a quantifiable clinical 
assessment tool. This complexity is one of the reasons why it has been so 
difficult to assess frailty with a single indicator or simple clinical tool. 
Furthermore, the various opinions thus far have led to a 'fractured' message 
being conveyed as to what frailty truly is. This situation arises as a result of 
different researchers providing different reasoning behind their definitions. 
These conflicting ideas have resulted in the development of numerous 
measures which were designed for different settings, purposes and priorities. It 
is therefore not surprising that it has been a challenge to reach a consensus 
definition and develop a common frailty assessment tool that could be utilized 
not just by clinicians in primary care or tertiary centres but by research 
gerontologists as well as public health practitioners. The failure in reaching this 
consensus is a major barrier for developing more effective and efficient primary 
and secondary preventive measures[26]. 
Despite the uncertainty around the idea of frailty, there has been progress made 
in its identification in older people, from its concepts to its measurement. 
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Various concepts and measures have attempted to map out important 
associations with the aging process[2], its pathophysiology [16, 129] and 
associations with co-morbidity [62, 88] and disability[16, 20], sociodemographic 
and lifestyle factors[51, 126]. The prognostic value of measuring frailty has been 
evident in its relationship with adverse outcomes such as hospitalization, 
institutionalization and death [1, 20, 40, 41, 94] . This has led to a general 
agreement that the core feature of frailty is 'an increased vulnerability to 
stressors due to impairments in multiple, interrelated systems that lead to a 
decline in homeostatic reserve and resiliency[16, 68].The level of commitment 
made to the detection, prevention and treatment of frailty in older people is seen 
as an important step closer towards reducing the increased burden of cost and 
care to the providers of healthcare services, social services, the economy and 
to the society in which the individuals themselves and their carers live in. 
Findings from this study: similarities and differences with other 
measures. 
The question posed prior to conducting a systematic search of all possible 
definitions of frailty in older adults was whether there was a clear pattern 
between the early to current concepts of frailty and the operational definitions 
that have resulted from them. As frailty remains undefined, the systematic 
literature review was extensive as it incorporated a wide range of terms so as to 
capture articles that had attempted to define or measure frailty. Although 'frailty' 
or 'frail' was the major descriptive term used, this review revealed that other 
terms such as 'vulnerable'[43, 44], 'functionally impaired', 'functional limitations' 
or 'functional disability'[22, 45, 46] were often used to describe or identify the 
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same frail older population at risk of adverse events. This explained the overlap 
between frailty and disability and efforts made to distinguish between them[88]. 
This thesis argues that the incorporation of indicators of functional impairment 
into a frailty assessment tool is appropriate seeing that there are varying 
degrees of functional impairments in the frail older person. This is evident in the 
various measures of physical function used in existing frailty measures [20, 47, 
83]. To exclude these indicators would be denying their importance in the 
assessment of frailty in people belonging to much older age groups. 
The systematic literature reviews and meta-analysis in Chapter 2 confirmed 
that there was little coherence in the many frailty studies conducted over the 
whole search period from the 1960s to this current time. The original concept of 
frailty as a multi-dimensional syndrome had been transposed to a focus on 
physical/physiological function and biomarkers of frailty reflecting the move 
away from the original idea of holistic geriatric medicine practice and a patient-
centred approach. This may have been in response to more technological 
approaches and a need to be more objective in applying the science of 
measurement. It could also be due to the physicians' desire for more tangible 
and objectively confirmed evidence of patients' needs, which were more likely to 
be treatable by medical means. 
In the last two decades, there have been more validation studies focused on 
two main types of frailty measures; the frailty index which is a measure of deficit 
accumulation[107] and the rules based phenotype of frailty(20). To date there 
has been no formal meta-analysis of prognostic studies of various frailty 
measures. All the studies which met the search selection criteria demonstrated 
significant associations between their respective measures and all-cause 
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mortality. In the meta-analysis conducted here (see Chapter 2), 18 prognostic 
studies which used different frailty measures in large study populations 
confirmed the lack of coherence between studies by demonstrating extensive 
heterogeneity in the prediction of all-cause mortality even after considering 
factors such as age, sex, type of measure used, number of covariates adjusted 
for and duration of follow up. 
The development of the various frailty measures found in the literature had 
involved the additive combination of indicators or separate measures to form 
either a rules based or an unweighted index of deficit accumulation. Although 
these types of measures demonstrated validity especially in relation to 
prediction of adverse outcomes, there remained a major issue of measurement 
error associated with frailty measures that combined several directly observed 
variables together. I also questioned whether these measures were truly 
measuring frailty alone or were measuring a combination of other entities such 
as co-morbidity or disability. Furthermore, from a clinical perspective, the 
identification of frailty in an older person may not be directly obvious and its 
complexity may require further investigation of other 'latent' or not directly 
observed factors. For example, an elderly diabetic patient who may appear 
relatively well and mobile could have an underlying degree of cognitive 
impairment or hypertension from macro-vascular complications of diabetes or 
visual impairments due to diabetic retinopathy. These factors could render him 
more vulnerable to certain stressors (such as an acute infection or surgery) that 
lead to the occurrence of adverse events. In this example, the clinical 
presentation may be subtle, often asymptomatic and only evident over time 
when excess vulnerability to stressors reduces the older person's ability to 
maintain or regain their homeostasis[2]. Bearing these factors in mind, the 
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development of a measure through the combination of directly observed 
variables or frailty indicators may not fit well with the concept of frailty as a 
'latent vulnerability' in older people. 
Hence in Chapter 3, I developed a measurement model of frailty using the 
statistical method of factor analysis. Exploratory factor analysis was used to 
develop the hypothesis on frailty from a wide range of frailty indicators which 
were identified through 'a priori' hypotheses and previous literature. This 
method derived subsets of indicators that correlated strongly with each other 
and weakly with other indicators in the dataset, providing meaningful theoretical 
'explanations' or 'interpretations' linking them to the overall construct of frailty. 
These indicators were corrected for measurement error and assigned relative 
weights in their association with frailty. Seven subsets or factors explained the 
association between frailty indicators: visual impairment, respiratory 
disease/symptoms, cardiac disease/symptoms, physical ability, physiological 
markers, psychological problems and co-morbid disease. This hypothesis was 
tested by confirmatory factor analysis which confirmed the General specific 
model as the best choice to form the conceptual basis for frailty in older adult. 
The implication with this model is that frailty serves as the underlying factor that 
contributes to different forms of frailty indicators, and in addition, there are 
processes separate from this that contribute to the development of the seven 
specific factors, which vary independently of frailty. In the clinical example given 
above of the elderly diabetic patient, his degree of frailty is contributed by frailty 
indicators belonging to factors such as 'visual impairment', 'psychological 
problems' and 'co-morbidities' which by themselves are mutually uncorrelated. 
Although the identification of these seven factors was in keeping with other 
measures based on similar domains [40, 43, 62], the development of a tool 
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(using indicators which are both weighted and corrected for measurement error) 
lends added credibility to it being a more reliable measurement of frailty. The 
reliability or internal consistency of the 'General Specific' model was shown by 
the goodness of fit of the confirmatory factor analysis. The validation of the 
model as a measurement of frailty was reaffirmed when the same model was 
tested in a larger independent cohort of the MRC assessment study whose 
respondents was older and comprised both sexes. Furthermore, the higher 
weighted frailty indicators higher weights associated with them may provide 
more precise information as to which cluster of frailty indicators are important in 
identifying frailty in older people. 
This newly developed British frailty index had expected associations with 
sociodemographic and lifestyle variables and demonstrated both construct and 
external criterion validity (see Chapter 4). These confirmed the findings of 
similar large study populations [74-76, 78, 105] especially in the association of 
frailty with increased age, female sex, smoking, living alone. poor social contact 
and not owning one's own home. This study provided greater evidence for the 
association of frailty with socioeconomic pOSition by using the BWHHS SEP 
score. a comprehensive assessment of socioeconomic pOSition which 
incorporated various markers of socioeconomic position[125]. It strongly 
confirms similar associations between frailty and socioeconomic markers such 
as low education[1, 41] and income[20, 45].non white collar occupations 
[126]which had been assessed separately in other studies. 
Low socioeconomic position was associated with being in a higher frailty 
category among the BWHHS women. 
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This new measure demonstrated predictive validity in the association of frailty 
with all-cause mortality (see Chapter 5) in both study cohorts. However, in the 
initial assessment of the distribution of frailty among all respondents at the end 
of each analysis period, there was great overlap between respondents who 
were dead or were still alive at that time (see Figures 5.1 and 5.2 in Chapter 
5). This enabled cut-off points of varying degrees of frailty to be established with 
respect to all cause mortality. A distinct finding in the MRC study respondents 
who were older and followed up for a longer period of over 12 years was that 
frailty(measured at start of the study) was a stronger predictor of all- cause 
mortality at earlier periods of follow-up (within the first 2.5 years from baseline). 
Those with a severe degree of frailty were already dead earlier in the follow up 
period, leaving the more robust, mild and moderately frail who were still 
surviving in the community. Those who were severely frail and predicted to 
have a higher risk of mortality earlier in their follow up may be at a stage where 
they would benefit from more palliative or rehabilitative services rather than 
preventative or curative services. It is the frail survivors (with mild to moderate 
frailty) who could be potential targets in the longer term for preventive or 
therapeutic strategies aimed at reducing their risk for further adverse outcomes. 
These cut offs in relation to time to event would be especially useful in aiding 
the clinical decision making process. This would allow for more informed and 
cost effective allocation of scarce but valuable resources for older people. 
The British frailty index is also the first frailty measure that has been used to 
independently predict cause-specific mortality among community dwelling older 
people after adjusting for possible confounding with age, sex, SEP score, 
smoking, alcohol intake, social contact, living alone, housing tenure and marital 
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status. This index was an independent predictor of cardiovascular and 
respiratory deaths in all three time periods of follow up in both the men and 
women of the MRC Assessment study. Frailty was also an independent 
predictor of death from cancer in the MRC respondents but only in the first two 
and a half years of follow up. This effect may be due to the reason mentioned 
earlier that the frailest in the population especially those suffering from rapidly 
progressive cancer tend to die early in the follow up period. 
Another important finding was that the British frailty index was a strong 
independent predictor of 'time to first hospitalization and institutionalization in 
both older men and women. The risk of both events was especially high among 
those categorized as severely frail at the start of the study. This also confirmed 
the findings of other large population studies [1, 20, 40]. Identification of those 
at higher risk of hospitalization and institutionalisation could help allocation of 
appropriate community resources according to their degree of frailty which 
might then prevent these adverse outcomes. This includes interventions by 
social services, palliative care or home or specialist nursing services that 
provide patient and carer support so as to prevent unnecessary admissions into 
hospital or an institution. 
The British frailty index estimated a higher risk of all these adverse events 
compared to the well known and much validated CSHA additive index of deficit 
accumulation, regardless of whether a larger number or smaller number of 
indicators were used to form the CSHA index. In keeping with similar study 
findings [31, 32, 84, 121], the association of frailty with the specific blood and 
physical markers shown here do support the theories that frailty is characterized 
by dysregulations in multiple physiologic systems and increases an older 
person's vulnerability for serious adverse outcomes [16, 20]. The low although 
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significant correlations of these markers with frailty support the theory that frailty 
is a complex phenomenon that cannot merely be assessed or measured using 
a single or simple tool. Hence, the British FI confirms the concept of frailty as 
complex and multi-dimensional functioning as a better predictor of all cause 
mortality compared to single markers of frailty (see Chapter 6). 
Strengths and Limitations of the study 
Both strengths and limitations have previously been addressed in relation to the 
topiC of each specific chapter but are generally discussed here. 
Strengths 
To date, the British frailty index is the first measure of frailty developed in a 
large population study in the United Kingdom. The BWHHS and MRC 
assessment study participants were drawn from 23 and 53 general practices 
respectively from across England, Wales and Scotland and therefore are fairly 
representative of the British community dwelling older population. In the 
BWHHS, the 60% response rate is moderate but consistent with other baseline 
data collection in large epidemiological surveys[142]. The findings were 
reaffirmed upon validation of the method of measurement in the independent 
MRC assessment study cohort of older (75 years and above) community 
dwelling men and women. The frailty indicators included in the factor analysis 
were limited to inclUde ones that were only available to both datasets. However, 
as factor analysis captures unobserved heterogeneity in the latent variables, if 
we were to include other relevant frailty indicators to the model, the relative 
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ordering of individuals would still remain unaltered, and the frailty indicators 
would still fall under the same seven factors. 
To address the problem of missing data in the BWHHS covariates that were 
adjusted for in the Cox regression model, a multiple imputation procedure 
provided unbiased estimates of the parameters and their standard errors in the 
model. This was not necessary for the MRC assessment covariates adjusted 
for, as they had less than 2% missing data. 
This multidimensional measure identified seven key factors associated with 
frailty which by themselves are amenable to modification through their 
prevention, treatment or intervention. In comparison to the CSHA FI, the British 
FI has greater variance, giving a more refined distribution of frailty and thus 
serves as a better population metric (see Figure 6.1 and 6.2 in Chapter 6). 
This new measure also demonstrated internal construct, external criterion and 
predictive validity in these two large cohorts. Furthermore, it provides important 
information about the survival prediction of older people over long follow up 
periods which makes it a good prognostic tool that would aid in the planning and 
allocation of health care services for them. 
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Limitations 
As nearly all our participants are older Caucasians, our results may not 
necessarily be generalisable to younger adults or other ethnic groups. The 
BWHHS study respondents were those who were able to attend the interview 
and medical examination at baseline suggests that they were relatively less frail 
compared to non-responders. Therefore, this study cohort may underestimate 
the degree of frailty among the population it derived its sample from. 
Frailty was only calculated from variables taken at baseline (at start of the 
study). Prospective calculation of frailty and collection of the specific markers 
would enable a more comprehensive analysis that would help further 
understanding as to how they would change over time. A comparison of a static 
version of frailty (measured at a single point in time) with a dynamic 
version(which changes over time) could demonstrate whether older persons 
who retain the capacity to improve still have considerable reserves and are not 
fraillless frail[73]. 
Another limitation is that only the risk for a first or single hospitalization was 
examined in this study. As frailty strongly predicted risk of first hospitalization, 
future work with this new frailty measure should perhaps focus on repeated 
hospital admissions which are a common problem among older people and 
drive a large part of the burden and costs associated with frailty. 
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A theoretical causal pathway of frailty 
The main part of my analysis dealt with the association between frailty and 
death. Figure 7.1 illustrates the causal pathway in the relationship between 
frailty and its adverse outcomes, by incorporating the International Classification 
of Functioning, Disability and Health (ICF) framework (see Chapter 1) as a 
guide to this pathway[98]. We can describe frailty within the context of this 
framework by the interaction between the health condition (disease) and 
contextual factors (environmental including physical, social and attitudinal 
environment and personal factors). These interacting factors affect a person's 
bodily functions and their degree of activity and participation. All these in turn 
contribute to the experience of frailty in older people, which depending on 
certain stressors, may lead to the occurrence of adverse events such as death. 
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Case scenario 
I illustrate the causal pathway for frailty with a case study of a 70 year old 
widowed gentlemen suffering from congestive cardiac failure. This health 
condition resulted in his symptoms of short of breath on exertion and swelling of 
his legs. He was limited in certain activities of daily living and had to take time 
with his personal care as well as gOing up and down the stairs. He lived alone in 
a third floor flat in a building with no elevators and this limited his social outings 
with friends and family. A recent fall had reduced his confidence after which he 
mostly confined his outings to visits to the general practitioner. At a recent visit 
for a bout of cough and fever he was diagnosed with a bronchopneumonia and 
was admitted to hospital. His condition did not improve; he passed away after 
two weeks in hospital. 
This scenario demonstrates how the interaction of various factors can lead to 
frailty and how a stressor (in this case bronchopneumonia) can affect a frail 
individual's risk of an adverse event. As illustrated in Figure 7.1, the individual's 
experience of frailty is described as an interaction between his heart condition 
and his environmental and personal factors which in turn affects his function 
and participation in certain activities. These factors determine his degree of 
frailty and indirectly, his risk of an adverse event. Personal factors on this 
causal pathway include age, sex, marital status, living alone, smoking, and 
alcohol intake. Environmental factors include those that constitute the phYSical 
environment such as type of accommodation (housing tenure); interaction of the 
individual to their social environment in terms of social contact or partiCipation, 
as well as socioeconomic position status. 
Another factor on the causal pathway is 'self rated health' which is an indicator 
of the global health status. The level of frailty experienced by the individual can 
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result in either a good or poor self rated health. Disability which is classified as 
'activity limitation'[98] is also on this pathway indicating why there exists great 
overlaps between frailty and disability. The inclusion of specific biomarkers on 
this pathway provides more biological plausibility to the association of frailty and 
its adverse outcomes. 
Figure 7.1: Theoretical Causal path-diagram of frailty 
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Implications of frailty to clinical practice, research and polley. 
The British FI has attempted to return the measurement of frailty back to a 
more holistic geriatric approach. It has done so through the reliable identification 
of seven specific domains which present frailty as a mUlti-dimensional and 
complex phenomenon. The identification of the seven factors that best 
explained the concept of frailty provides many possibilities for its specific 
prevention, treatment and intervention. 
Following the development of the British FI, primary prevention of frailty, its 
treatment and intervention may include: a) neuromuscular training (includes the 
increase of muscle strength and mass as well as balance) b) the promotion of a 
healthy lifestyle that provide nutritional and dietetic support to ensure adequate 
nutritional intake in those who are underweight with protein energy malnutrition 
and vitamin deficiency as well as improvement of nutrition in those who are 
overweight with increased abdominal girth c) other healthy lifestyle 
modifications such as reduction of alcohol intake and stopping to smoke d) 
treatment of subclinical cardiovascular risk factors. These efforts should be 
promoted early in those who are pre-frailllow levels of frailty but may still benefit 
those with mild to moderate frailty. Secondary measures would include a multi-
disciplinary approach in the assessment, prevention and rehabilitation of falls 
and instability, management of multiple co-morbidities especially in older people 
with evidence of underlying cardiovascular, respiratory disease and visual 
impairments as well as problems associated with incontinence. Palliative care 
services should also be available at a later time for the management of pain and 
other concerns associated with end of life care in the severely frail older person. 
Other considerations should certainly include the psychosocial aspects of frailty 
through assessment of interaction of the older person with their physical, social 
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and attitudinal environment. This is through early assessment and treatment of 
cognitive impairments, anxiety or depression especially in older people who are 
socially isolated; as well as the assessment of the physical environment in 
those who are physically isolated and living in poor housing. Social services 
with the help of primary care professionals and independent bodies such as 
'Age Concern' could identify older people who are socially and physically 
isolated and improve their social participation by promoting activities at home or 
at a community or day centres for older people. These activities could include 
improving existing skills, group exercise and other efforts that would help 
maintain their independence at home. 
The implication of frailty on research involves the identification of its underlying 
causes and the discovery of ways to prevent it. Ultimately, this would enable the 
treatment of primary causes of frailty which is still currently under investigation. 
Efforts in this direction have been in understanding the pathophysiological 
foundations of frailty through identification of specific biomarkers associated 
with it. The association of frailty with cardiovascular risk has been shown with 
inflammatory markers such as IL-6, TNF-alpha and CRP as well as coagulation 
markers such as D-dimer and fibrinogen [128, 130). This finding has been 
consistent across the different frailty measures including the British frailty index. 
Certainly this thesis provides evidence in support of this by the strong 
association of frailty with cardiovascular signs and symptoms and the 
prognostic value of the British frailty index in predicting cardiovascular mortality 
in both older men and women. The identification of biomarkers associated with 
frailty brings about the question of whether they would be appropriate as a 
suitable tool for its assessment. The complexity and mUlti-dimensional nature of 
238 
the frailty concept demonstrated in this thesis suggests that this idea is still in 
very much need of investigation and debate. 
As this measure was highly sensitive in capturing those who were frail but still 
alive, it has the potential to identify the severely frail from the mild/moderately 
frail in the population; enabling more informed, sensible and cost effective 
clinical decision making. This index would serve as a guide in the allocation of 
appropriate healthcare services to the patients in the appropriate frailty 
category. These may include primary prevention of frailty as mentioned earlier, 
with targeted treatment of risk factors in those who are not frail (pre-frail); further 
treatment and intervention for those with mild or moderate frailty; and home 
nursing, rehabilitation or even palliative care for the severely frail at the highest 
risk for adverse events. These efforts are in response to the public health 
implications of frailty as a significant and modifiable economic burden on health 
care services. The British Frailty Index could potentially serve as an important 
public health indicator and in view of its prognostic value, it can serve as an 
indicator monitoring the results of health interventions. Randomized trials of 
such strategies would be required to determine their cost-effectiveness. 
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Areas for future work 
There are ways in which work presented in this thesis could be further 
extended. These include the following recommendations: 
The life course approach 
The life course approach to the epidemiology of chronic conditions is built on 
the premise that various biological, behavioural, social and environmental 
factors throughout (early, adult and late) life can independently, cumulatively 
and interactively influence health and disease in old age[143]. The interest in 
the life course determinants of ageing stems from the general idea that its 
process occurs from the beginning of life, driven by the rate of accumulation of 
molecular and cellular damage[144]. This idea is supported by growing 
evidence from life course and historical cohorts showing that adult health, 
function and risk of age related chronic diseases have their origins in early life 
experience, sharing common risk factors and causative mechanisms[144]. The 
focus on the life course determinants of aging has led to its application in the 
study of frailty. This is due to the fact that frailty has been seen as a 
consequence of accelerated ageing and therefore lies on the causal pathway 
between ageing and death. Linking life-course factors to frailty will increase our 
understanding of its origins, its lifetime determinants and enable the study of the 
evolution of frailty through a person's life course. Life-course determinants of 
frailty would involve biological factors such as biomarkers (including genetic 
markers), psychological, social as well as environmental factors. For example, 
or the development of type 2 diabetes depends partly on environmental 
influences and behaviour in early Iife[73]. Another example of risk factors or 
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markers across the life course include evidence such as the association of 
decreased grip strength in mid life with an increased risk of functional decline 
and disability 25 years later[145]. 
Research on frailty has been aimed at identifying 'clusters of vulnerability, 
weaknesses, instabilities and limitations with shared causes' [27]. The British FI, 
derived from subsets of indicators that correlated strongly with each other and 
weakly with other indicators in the dataset, identified seven latent factors or 
'clusters' of indicators which best explained the concept of frailty. Empirical 
testing of these seven latent factors could provide inSight into the concept of 
frailty from a life course perspective. A life course approach could examine the 
relative importance of these individual factors/components of frailty and assess 
whether they present or cluster together at different stages in life, more often 
than would be expected if they were independent. These latent factors could 
also be examined for shared common causes and their outcomes later in life. 
Identification of the causes of frailty early in life would suggest that its 
prevention in later life would need to occur early. Based on current evidence, 
the occurrence of frailty in later life can be delayed by interventions such as 
neuromuscular strength training which is associated with improved physical 
performance in older people [146-148]. Targeting training interventions at 
strategic times for example at retirement which may coincide with the pre-frail 
stages would be worth evaluating. Early life determinants of frailty have 
important implications for the policy makers in terms of planning effective 
prevention or treatment strategies for populations. 
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Future studies specific to frailty 
Further to the life course approach to frailty mentioned above, a more complete 
understanding of the important domains of frailty might be better served by 
conducting a prospective cohort study which is designed to answer specific 
questions on frailty. However, this would of course involve a considerable 
amount of time and it is questionable whether expending resources on setting 
up new studies would be feasible. The existing World Health Organisation 
Study on Global Ageing and Adult Health (SAGE)[149] set up by the Multi-
Country Studies unit will provide extensive data to examine the associations of 
a wide range of variables on relevant outcomes. Ensuring a strong focus on 
frailty in the SAGE studies would be helpful. 
Refinement of the British FI 
The British FI could be refined by reducing the number of frailty indicators 
needed to explain frailty under its seven latent factors by retaining those with 
higher weights relative to the others. The resulting shorter index could then be 
converted to a short questionnaire which could be easily applied for use in a 
primary care or hospital setting in the detection of frailty in community dwelling 
older people. It would be particularly important to develop and evaluate simple 
and non invasive versions of the British FI for use in developing countries where 
the rate of population ageing is occurring at a more rapid pace than in the 
developed world and the cost of measuring frailty using more sophisticated 
measurements of physical function would be less feasible. 
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Conclusion 
Frailty is a useful concept and its wider use would be promoted by a consensus 
on its definition and method of measurement. This thesis provides a better 
understanding of the multi-dimensional domains of frailty and its concept as a 
latent vulnerability in older people. It does so by providing a more reliable 
method of its measurement which demonstrates validity particularly in relation 
to serious adverse outcomes. This new frailty measure may provide the impetus 
for similar research in different settings, particularly in developing countries 
where contextual factors differ. The British FI provides further opportunities to 
develop strategies for prevention and health promotion at a population level as 
well improved detection, treatment and intervention of frailty in older people at a 
clinical level in developing countries. 
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Appendix 
Questionnaire Number rn 
Study Number: 1.-1 --..J..I----I.----J.....-..J 
Town: rn 
BRITISH WOMEN'S HEART & HEALTH STUDY 
BASELINE SURVEY 
• This questionnaire asks about your bealth, your life-style and your social back~und. 
This will give vital information for our research. 
• Most questions can be answered simply by ticking the correct box 62f 
• All the information collected will be treated as strictly confidential. 
• Please ('omplete tbe form today, or as SOOD as possible, aDd retarD ID tbe reply paid 
eDvtlopt. If you have any difficulties with the questions. please pbone us on 0117 9287327 and 
leave your pbone number so that we can call you back and answer your queries. 
Thank you for your help. 
BrlUsb WomeDS' Heart .. Health Study 
~partmeDt of Soc:llI MedklDe 
CaDYDltHaU 
Whlttladles Road 
Bristol BSS 2PR 
Plf'a~f' Kin tllf' followinl: infol'malion 10 IIdp u~ cOlllacl ~'ou III Ihf' fulu.-e. 
1.0 Your telephone \lllmber 
1.:2 Your date of birth rnrnrn 
Day Month Year 
1.3 Today'.s cL,te rnrnrn 
Day :violllh Yenr 
1.4 Your maiden 11<1111e, if you nrc ulaJl·jed, divorced or wido\\"ed: 
:\"mDe aud addJ'f'ss of family 1Df'lDbf'I' 01' fl'lf'nd WI' could COlllact Dilly Ir IIt'Ct'~ nl'~' : 
1.5 Sumame 
1.6 First name 
1.7 Address 
1 .. 8 Po~t code: 
1.9 T c:lephone NtUuber: 
Plt'ast' anSWl'I' tbt' followiu~ qUl.'stious by fiUin& ill tbt' appl'opriatt' box with a tkk0 01' 
writini tbt' answt'I' in tbl.' ~I)are proYidl.'d. 
Excellent 01 2.0 Hraltb at prrsrut How would you describe your health at pre~ellt ? 
Good D _ 
Fair OJ 
Poor 04 
.to Couditiom affl.'ftiug tbl.' 111.'111" 01' ril'Clllation 
Hnve you ever been told by n dOCTOr that you haH or have had lilly of the following conditiom . 
If YC\, please give yenr 
Ye~ No wheu fir~t dingno~ed. if PO\ ible 
3.1 Heart attack (coronary thrombosis D D 3.7 19 
01' myocardial infarction) 
3 .1 Heru1 fnihu'e D D 3.8 19 
3.3 Angina D D 3.9 19 
3.4 Other heru1 trouble D D 3.10 19 
3.5 High blood pre~5w'e D D 3.11 19 
3.6 Stroke 0 D 3,l.2 19 
4.0 Cancrl's 
4.1 Have you e\'er been told by a doctor thai you have or have had a canCel'? 
Ye\ No 
o D If yes. please state what kind of cancel'(s) : 
Please give year when fu!>t diagnosed office me 
4.2 I I 4 .5 19 ______ _ 
4.3, _________ _ 4.6 19 _______ _ 
4.4 ________ _ 4.719 ______ _ 
PIt'lIst' auswt'!' tht' follmlinK qllt'~tlons by fillhlK in tht' appl'opl'iatt' box with II tlck0 01' 
wl'itini the answt'l' in the spact' pl·oYided. 
5.0 Other IPt'rlical conditions 
Have you evcr been told by a dociol' that YOll have 01' have had lilly of the following conditiom? 
Plca~e give yenr when fil;t 
Yes No diagnosed. if possible 
S.l Asduua 0 0 5.11 19 
5.2 Bronchitis D D 5.12 19 
5.3 Dcpression D D 5.13 19 
5.4 Gastric. peptic 01' duodenal ulcer 0 0 5.14 19 
5.5 Gout D D 5.15 19 
5.6 Gall bladder disca~c 0 0 5.16 19 
5.7 O~tcopol'osis D D 5.17 19 
5.8 Thyroid di~ease 0 0 5.18 19 
5.9 Cataract 0 D 5.19 19 
:UO Glaucoma 0 0 5.20 19 
6.0 FaDs and FractUl'es 
Yes No 
6.1 Haye you had a fall in the last 12 months ? o 0 
6.2 J(l'es. bow mallY timcs ? 
Yes No 
6.3 Did you have medical attention for any of thesc fnlh ? 0 0 
fractlll't's: Ye:s No Please: give: ~ar 
6.4 Ha\'c your ever fractured or broken your hip? D 0 6.61 9 
6.5 or, your ,nisI? D D 6.71 9 
3 
Plu~1.' aoo;wpl' thp follo"iu& qUl.'stiOO'i by nlllnK In thl.' IIPPI·Opl'illtl.' box wltb II Ikk~ 01' 
wtitiUI: thp ano;wpl' In thl.' spacp pro,·idl.'d. 
7.0 Arthriti'i 
Ye~ No 
7.1 Han yO\l eHr b.:eu told by a doctor that YOll have or have had nJ1lulti~? D D 
JfYes. please state what kind of aJ1lu-iti; : 
Yes No Don't know Plcose ~i ... e year fim diagnosed 
7.2 rheumatoid aJ1lultis D D D 7.5 19 
7.3 o;teoatthritis D D D 7.6 19 
7.4 oth.:t· type of rutlu'iris D D D 7.7 19 
Whicbjoiuts are or were affected? 
Yes No 
7.8 hips D 0 
7.9 kuees 'nnkle; D 0 
7. 10 shoulders D D 
7. 11 hruld s 'fUl~.:t' D 0 
7.12 back/spine D 0 
8.0 Opf'rations 
Ye~ No 
8.1 Haye YOll ever had an opemtion(s)7 o 0 
J[Yes. please ~ive details includinll the year: Please give year of op':l1ltiou(~) 
8.2 ____________ _ L-I ..1...1 --,--,I 8.5 19 
-------
LI ....1...-.1--J1 S. 6 19 
-------
8.3 ___________ _ 
8.4 ___________ _ '---'--'-....Jls.7 19 _____ _ 
Please list allY other operatioll." here: 
4 
Plt'a~e an~wt'l' tbe followin& qut'~tjous b~' fillill& in the IIPpl'Opl"ifltt' box with 1\ tick0 01' 
wlirill!: the answer in tbe ~pn('t' pro,·idt'd. 
9.0 HearinD alld ,Noli 
Do YOll have trouble with Yes No 
9.1 yom' hearing o 0 
9.2 yom' eyesight o 0 
(llot simp~l' lleeAing spec.s) 
I(Yes, please giye details : otfice U~t 
9.3 Heming. ______________________ _ IT] 
9.4 Vision, _______________________ _ IT] 
10.0 Diabett's 
Ye~ No Don't know 
10.1 Has anyone in YOlU' do~e family (your parents. D D D 
brothers. sisters) eva ' had diabetes? 
Yes No DOll 't kllow Year first diagnosed 
10.2 Hayc: you ever beal told by a doctor 0 0 0 tbat you have or have had diabetes? 
I[Yes: 0 0 0 10.4 Are YOll on a regular diet for your diabetes? 
10.5 Are YOll 011 regular tablets for your diabetes? D D D 
10.6 Are YOll on regular treatment with insulin? 0 0 0 
10.7 Do YOli anelld a hospital or OP diabetic clinic? 0 0 0 
11 .0 BI'eathlt~snt~~ 
11.1 Do YOli get sholt of breath walking with other people of yom' 0\\11 
age on levc:l ground? 
11.2 
11.3 
On walking uphill 01' stau'S do you get more: breathless th.111 people of 
yom' o\"n age? 
Do you ever haye to stop walking because ofbl'i:athlesslless ? 
5 
10,3 19 
Yes No 
D 
D 
D 
D 
D 
D 
Ullnble 
D 
o 
o 
Pit-lise answel' the follo"in~ que~tions by fillill2 ill tbt' appropriate box wltb a tird~ 0 1' 
Wl'irill~ Iht' all~wt'l' ill tbe spact' pro,i dt'd. 
12.0 Leg paill 
12.1 Do you eyer g.:t pain or discolllfol1 in YOIU· leg. thighs 0 1' buttocks 
when you WAlk? 
If, ;"0 or rnable to walk go 011 to queslion 13 "Ankle swelling" on nexl J1tlie. 
12.2 Do YOll know the cause of the pain? 
12.3 If Yes. " 'hat is the calise? 
12.4 Does this pain e\'er begin ,,"hen you are standing still 0 1' ~itting? 
12.5 Do you get the: paul if you ,valk up hill or hml)'? 
1_.6 Do you get the paill walking at an ordUJal)' pace on the level? 
12.7 What happens to the pain if YOll stand still? 
Yes No 
o o 
Yc~ No 
0 0 
officr "'r 
CD 
Yes No 
0 0 
Ye:s No 
D D 
0 0 
US11.111y continues Illore than 10 minutes 0 1 Usuollydisappenr;, ill 10 m.iullte~D ~ 
12.8 Where do YOll get the pain? Shade l'e~ons affected 
Front Back 
RIGHT 
SIDE LEFT SIDE 
LEFT 
SIDE 
6 
RIGHT 
SIDE 
w 
llAble 
o 
noble 
D 
0 
Plea~e an~'nl' tht (oUo\\in& questions by fillin& in the IIPpl'opliatt box with II tkk0 01' 
wlitin& the nnsw('I' in Iht spa~t pl'o,1dtd, 
13.0 Ankle ~welling 
13 .1 Do your nnkk" ; we 11 IIp regularly ~ 
13.2 If Yes. i~ tlus beca\l~e of '\iarico~ veins? 
14.0 Congh aDd Wbttrt 
14.1 Do you \I~uaUy bring up phlegm (spit) from YOIU' che~t first 
Ihing in the moming in the " 'inter ? 
14.2 If Yes. do you bring up phlegm like this 011 most day~ 
for a~ mllch as 3 monlbs iu Ibe wiutel' each year? 
14.3 III ille past 4 yem'!. have you ever had a period of increased 
cough and phlegm lasting for 3 wed.:s or more? 
14.4 Doe~ YOIU' chc~t C\' er SOlmd wheezy or \\'hisilil1~? 
14.5 If Yes, does thi!> happen ou most days or uighls? 
15.0 TI'utmf'nt with IIspbin 
15.1 Do you take aspirin regularly? 
15.2 Is this on doclor's advice? o o 
Yes 0 000'1 know 
o 0 0 
o 0 0 
Yes No Don', know 
0 D 0 
D 0 0 
Yes. Yes. Neve:r 
Ollce more often 
0 0 0 
Yes 0 Don't kno\\' 
0 D 0 
Yes No Dou'l know 
0 0 D 
When did you start taking a~pirin regularly ~ 19 ____ _ 
15.4 On how many days each wed.: do )'Qutake aspirin? 
daily 0 1 altemate daysD 2 other 0 > 
15.5 W11.11 dose of aspirin do you take each (by that you take it? 
othe04 
15.6 For what condition are you taking 8!>-pirin ? 
ofijc~ U~ 
Plcase slate __________________ CD 
7 
Plt'a~t IIn~wt .. tbt' followin¥ qutstiom b~' fillin& lUlllt appl'opl'iatt box with II IIck0 01' 
wlirin¥ ,bt' IIn~Wtl' iD tht spart pro"ldtd, 
16.0 HorlDont I'tp1actIDtDt t"fmll" CURT> 
Yes No DOll', know 
16.1 HaYe you eyer taken HR T? 0 0 0 
16.2 Are you ~tiJ1 raking ir? 0 0 I(Yes, 
16.3 Ho\\' long have you (or did you) taken i, ? yenr., 
lfsropved nQ\\' 
16.4 How IOl1g ago did you stop taking ir? ___________ _ years 
office lilt 
16.5 Which preparntion dofdid you u~e? __________ . _____ _ OJ 
17.0 "hamin ol' mintral tablrts 
Ye~ No 
Ii. I Do you take any vitamin or mineral tablets or supplcmellg? o o 
officI' lilt 
I(Yes, please giw derails : _______________ 17.2 CD 
18.0 Wtlghl 
18.1 Whar is your present weight ? _____ St0l1e5 ____ Pounds 
18.2 Wh,,! is yo\U' CtUl'Cnt dress size? 
18.3 Wbat \Y8S )'O{u' weight as a young woman aged 21? _____ ,SroIlO:s ____ Pounds 
18.4 Whai W~$ your dl'Cs s ,size as a YOlIIlg WOITk'l1l aged 21 7 ____ _ 
18.5 Ha~u dided duriug your adult life? 
Ul OZ 
ye<;. regulru'ly yes, 011 aud off 
18.6 Has your weight chauged ill tbe IMt fOllr years? 
01 0 2 03 04 05 
1I0t changed increased decreased up/doW1l don't know 
s 
Plus~ auswt'l' th~ (01l0\\iu2 qu~stious b~' fillln2 in tb~ appJ'opriat~ box with 1\ tick 0 01' 
wlitiul: thl' auswC'J' in thl' spa('~ p .. o'id~d. 
Wl'iiht «'ontiuul'd) 
18.7 l(vol/rll'eighT has increased or decreased ill The lasT 4 vears, 
ho\\' much weight han you gained or lo<,t? ___ "tones Ib~ 
Yes No 
18.8 If 1'011 hm'e lost weight. was this intentional? (eg. dieting) 0 D 
19.0 Smoking 
Yes No 
19.1 Have you ewr ~lUokcd cigarettes r~gularly (at lcast I /day)? D D---i 
I(Y"s: 
19.2 Do you >Illokc cigarettes at pl'esem? 
I(Y"s: 
19.3 How lIlauy cigarettes do you smoke a day? _____ cigArette; 
0 I 
Ullio. 
10 to 
19.6 
19.4 If hand-rolled, how much tobacco do you use a week ? 
J _______ ounces 19.5 ______ ...!gram\ 19.6 Howald were you when you stalted smoking regularly? ____ yelll'> 
19.7 Ha ... ·c you chamtcd your cigarctte smoking habit" over the laM 4 yenrs ? 0 1 0 2 0 3 
Yes. incrca>ed Yes. cut dowlI Y c>. given lip 
a 
o 
19.8 Do you cU1'fCll tly smoke tobacco in any other £01111 
(e.g. pipe:. cigar)~ 
Yes 
o 
I(No. Yes No 
19.9 Have you eye:r regularly done so? o 0 
9 
1(;0;0. 
10 to 
IP.8 
Please answel' the foUo"illi questions b~' flUln, in the appl'opliale box with R tkk0 01' 
wIitiu~ the 1IIHWt'I' in the spllre pl·o'ided. 
Smokiu~ (routillut'd) 
For ex-smokt'rs 
Yes No 
19.10 Were you pre\'io\l>ly a regular ci~arelte >moker? o 0 
How 111<1UY cigarerte> did you usuaUy r.moke each day ? _______ ci~re!les 
19.12 At whnt age did you give up? _______ yean old 
19.13 Why dQ'd ou gi\'e up? Tick one m.nin reason only. 
1 ~ 3 
Pc:I>O choice Fin8ncQ n:asollS HeaJQreCl\ution 
0 4 0 5 . 0 6 DoctOr> ad\;ce DInes> or ill-health Other I'enson~ 
19.14 Docs, did yOlu' hmband/pat1ner ~moke cigarettes? 
0 2 0 3 04 
No EX-~Illoker ot applicable 
::0 .0 Akohollutllkt 
.20.1 Would you describe your present alcohol intake a~ 
DailY/lllost d:lYs 
\:1/ eekcnds 0111 y 
Once or twice II Illonth 0 3 
Specialoccnsioll.s 0 -I 
Never 0 5 
20.2 One drink is HALF a pint of beer. a S~GU: whisk-Y. lIin elc .. or 0;\'1: GLASS of wine 
.0.3 
or shell)'. How much do you usually chink each day 7 0 
Morc dum 6 drink> a day 1 
3-6 drinks n day 0 2 
2 drinks /I day or less 0 ) 
None 04 
HO\\' matlY alcoholic drinks do you lake dlU;ng rut l\\'crage wt't'k? ____ chinks 
10 
Please ansWtl' tbt' rollo,,1o& qUtstions b~' fillina in tbt IIPIIl'opl'iatt' box "ith It tl<-k0 01' 
"TitinK the nuswel' in the splice pl'o\idtd. 
Alcohol (continued) 
20.4 What type of ru-ink do you usually tllke ? Beers, L.'ger~ 
Sherry, wine 
Spirit.s 
Variety of beer. \\"ine~ 
or spilits 
Low alcohol ru-inh 
20.5 Do you ruulk white wine':' 
Yes No 
DD 
00 
If Ye~, ~l:in~ses per week 
______ ._~Illasses!week 
20.6 Do you ruulk red wine? ______ -!glnsse~.lweek 
20.7 Haye you changed your alcohol intake in the last fo\u' years? 
No 
Yes. increased 
Yes, cut down 
Yes, given up 
Ifyo/l hare Cl·T DO"'" or GIVLN C"]> 
20.8 Was this due to : Tick one main rea.,ol1 only. 
FinancQ I~a sons 
0 5 mlles.~ or ill-health 
For ,"ou not drink;", at present 
Yes No 
20.9 
[[Yes. 
20.10 
20.11 
20.12 
Did you drillk in the past? D 
would you desclibe your previous alcohol intake as 
DailY/lllost days 
Weekends only 
Ouce or twice a month 
or special occasions 
D 
Ho\\" Illallyalcoholic drink» did YOIl take during an average \\'eek? ____ drinksfwcck 
How many years ago did you stop? __________ .-lyears ngo 
11 
Plu\t' IIn~wt'l" tht' foUo\\;u, qut'~tiom b~- liUin, in tht' app.·oprlate box with " ti('k~ or 
wJirin, tbr lIn~wt'r in tht' ~pa('t' pro,;dt'd. 
21.0 Your dirt 
Yes No 
21.1 Do YOll eat allY special diet? o 0 
21.2 J(Yes. pica e specify 
01 0- 03 04 0 5 06 
low fat high fibre vegetarian diabetic slillliugi10w calorie other 
21.3 'Vhat kind ofbre;ld do you eat? 
0 1 0 - 03 0 4 
White BrO\\11 Wholemeru Variom 
21.4 Spreading fat : What kind do you use at home . 
0 3 
Marg;lrine 
0 4 
L<>w calorie 
0 5 
Vruious 
0 6 
None 
o 
Burter 
(Soft) spread 
(~ . &- Dr.l.tght) 
How often do you eat the following foods? (plea~e tick the appropriate box for 1:<1ch food item) 
1 2 3 
" 
5 
Morcthau Onccndny MostdnYf> Oue or I\\'o Les~ than 
ollce a dny d.'\)'!; a week ollce a week 
21. 5 Fresh flui I slll1uner 
2 1.6 Fre~h fmit winter 
21. i Salads in ;\Ullmef 
2 1.8 Salad; in " 'inter 
21.9 Green yel/etables 
21.10 Fish (all kind;) 
2 1.11 Poultry (eg. 
chicken. lurkey) 
21.12 Red meat (eg. 
bee( POrk. ham. bacon) 
2 1.13 Processed meat 
(eg. burgers. ~mage . 
pies. pasties. pate) 
21.14 Cereals 
21.15 Nuts 
2 1.16 Cheese 
12 
6 
Never 
Please IID~'nl' the CoUo"ini questions b~' mUna in the appl"opl"inte box "ith II ti("k0 01' 
""1i1inll the answer In the spare pl"Olided. 
Your diet (continued) 
21.17 What kiud of cooking fat do you mually u~e M home'? 
01 0 2 03 04 O s 
Lard. butt.:r. Vegetable Olive oil Variolls fats Other fat~ 
animal fat oil 
21. 18 What type of milk do you mually me? 
01 0 2 0 3 0 4 0 5 06 07 
Full cream Semi· Skimmed Dried TimId None Other 
skiuuned 
22.0 Phniclll ANhi"' 
22.1 Which of the follo\\"iug fonns of transport do you usc mmt often? Please tick only one box 
01 0 2 0 5 
Car Public Tnmsport Not applicnble 
22.2 Do you make regular jOlUllC)'S evety day or lUost days either walkiug or cycling' 
0 4 
Both 
22.3 Which of the following best desctibes YOlU' uSWlI walking pace? 
Slow Steady average Fairly blisk Fast (ai lea~t 4miles,'hr) 
22A I( )'011 ode reglllarlv, ho\\' long do you spend cycling in nn average week? _____ hours/wcck 
22 .S Do you take physical activity such as l1UlUing. swinmung. dancing, golf. 
tetmis. squash. jogging, bowls? 
0 2 03 
Occasionally Frequetllly 
(lcs~ than monthly) (once a month or more) 
1(1'011 rake part ill these pnl'siC'al actil'ities ""1'9"l'lItl],. (once a month or Illore): 
How many timl'S II Illouth 011 3\'et'3ge do you take part in these activities? 
2:! .6 SlUllUler _______ times/month 
22 .7 Winter _______ tinle ' mouth 
\3 
PIf'Il~e Iln~Wtl' .he rol1o"in~ qut~tion~ by fillina in .ht appl'opI'iR't box wi'" a tirk0 01' 
wliriu: the auswel' in the sparr pro"idtd, 
P"~'~iral arthitits (rontinut'd) 
In a ',"piral wtek dUling the past year, how many houn did YOII spend each week 
ill the follo\\'illg llcti\'ities"? Write 0 if no activity. 
Walking to work, shopping and leisure: 
Cycling. including to work and lei~lu'e: 
Gardening. light ego pruning. waterulg 
Gardening. hea\'y ego digging. 1l10\\'ing 
Phy>ical exercise ego fitl1~s. acrobics. 
swinulling. joggulg. tennis 
DIY ego on house. car 
House:work actl,·iries. light ego cookiIlg 
washing up. dusting 
Housework. he3')', eg. hoo\'eriug. floors 
window cleaning 
22 .S SUlluller ___ hOlll; !week 
22 .9 Winte:r ___ hom..,Iweek 
22.1 0 SllIlUuer ___ bolll'S /week 
22.11 Wiuter ___ holll'S/week 
22 .12 Suuuue:r ___ houl'\iwcck 
22.13 Winter ___ hom'S /",,:ek 
12.14 Suoullel' ___ hom week 
22.15 Winter ___ houl..,!wcck 
22.16 Sluluner ___ holll..,/week 
22 .17 Wiuter hom . week 
22.18 ___ holll'S/week 
22 .19 hour~ /week 
::2 .20 ___ ho\U; /week 
14 
Pll.'a~1.' an~wt'l' thl.' foOo\\inil qntstioDs b~' fiUinS In tbl.' appl'opl"iall.' box with a II('d~ or 
wlitlnjt Ibl.' amWl.'l' in Ihl.' Splt('1.' pl'o,idtd, 
22.2 1 In a ',pital WI.'t'k ill tbe la~t year, did you do allY ofthe.se acti\"ities \igoroll.sly 
enough to cause bl"eathle~slles ~, m 'eating or a fa ster heart beat? Ye~ No 
o 0 
12.22 J(Yes. fOI' hm ... many minutes each week did you pelfollll vigol'Ou~ acti\'ity'? ___ uulI\lte~ 'week 
22.23 In a typical week in the last year, how Ulany flights of stairs 
do you climb a day? ___ flights day 
22 .24 Compared with your activity level ofdu'ee yean ago, are yO\l doing 
0 2 3 
Same 
offier U~ 
22 .25 I(fess, plea.se give the rcnSOll, ________________ _ o 
22.26 Compared with odler woman of your age, are you: 
o o 2 0 3 04 Os 
Much mOI'e active More active Similar Le~s active Much less ",ctive 
23 .0 Yom' he-Itlth 0\"('1"1111 
Thinking abollt yow' health TODAY which of the fo11o\\"iug i~ the most applicnDle. 
23 .1 
23 .2 
I have no pain or discomfO!1 
I have moderate pain or discomfort 
I have extrenle pain 01' discomfon 
I b..we no problems with perfomtiuit my mu.,l ",ctivities 
I have some problem~ with perfomtiuit my mlL,l nctivities 
I am tutable to pClfomlmy \lsual activities 
15 
Plt'ase amwel' 'be follo\\ing qut'stions b~· filling in tbe nppl'opl'iate box \\itb " Urk0 01' 
wlitini Ibe answer ill Ihe spact pro,idl"d, 
YOIII' health OH'1':I1I (routinul"d) 
23.3 I hoye no problems with washing and dre~sing 01 
I have some problem~ with wailiing and dressing 0 2 
I am unable to wash and drcss myself 0 3 
23.4 I haye no problems in walking about 01 
I haye some problems in walking about 0 2 
I am confined to a chair , ·heelchair 03 
23 .5 I am not nnxioll s or depressed 0 1 
I am moderately anxious and/or depressed 0 2 
I am extremely atlxious andror depressed 0 3 
23 .6 Compared to fiye years ago, is yom memOlY 
0 2 03 04 0 5 
SlUllC Ahnost a~ good \Vo1"Se Much wo~e 
24.0 Disabilio· 
Yes No 
A .I Do you have any long-standing ilhless, disability or infinuity '? D 0 
(lone-standing' 1MID$ aD~ibin& which Ia." tnubJ.d you o\·~r a pniod of lilM 0.· is JibJ~. to do 50) 
/fJH 
Yes No 
24 .2 Does this ilhles, or disability limit yom activities in any way? D D 
24.3 What is the mail! medical problem causing this disability? If you have severl11llledico l problems. 
please give the most seven: one. 
oflkt\l~t 
CD 
Yes No 
24.4 Do you receiYe a di.sabiliry or other allowance for this'? o o 
16 
Plt'a~t' an~wer the foUo"i n: que~tions b~' fillinK in the appropli att' box with a tirk0 01' 
wlirin: tht' all ~Wt' .. in tbe ~part' pl·odded. 
Disabi1i'~' (rontinut'd) 
Do you cun-ently have difficulty canying out any of the following activities on your own 
as a resuli of a long: !etUl health or medical probletllS. or due to old age? 
Yes No Plea!.e give the year thi~ first started 
24.5 Going up or down stairs D D 24.1 1 19 
----
24.6 Bending down D D 24.12 19 
24.7 Strnightetuug: up D D 24.13 19 
----
24.S Keeping yom' balance D D 24.14 19 
24.9 Going out of the house D D 24.15 19 ---
24.10 Walking 400 yards D D 24. 16 19 ---
Do you currently use any aids or applianc~ to help \\:ith d:lY to day activities? 
Ye~ No 
24.17 Walking: stick D D 
24.18 Walking franle D D 
24.19 Wheelchair D D 
24.20 Toiler raised seat D D 
24.21 Bath bonrdfshower D D 
24.22 Extra rails in bathroom D D 
24.23 Stair lift D D 
17 
Plt-ase answel' the Collo\\in& qut'stions by mIinll in the appl'opI'iatt' box with a ti"k0 01' 
wlitiu2 the aoswel' in the spa"e PI'odded. 
Health problelDs 
Is your present ~tate of health caming problems with allY of the followin!.Z ? 
Yes No 
24.24 Job (paid employment) 0 0 
::!4,25 Household chore, 0 0 
24.26 Social life 0 0 
24.27 Sex life 0 0 
24.28 hlterests and hobbie, 0 0 
24.29 Holidays and outings 0 0 
24.30 Family relationships D D 
25.0 YOllr pI'eseut t'il'"umstao"es 
25.1 Are you: 
o:! 
M:ul'lcd 
25.2 Are you at present li .... iug alolle 01 
living with a hm.band or prutller 0 2 
li .... ing ,,"ith other family member(..,) 0 3 
li .... illg with other people 0 4 
Yes No 
25 .3 Do you have a car available for use ill your household? 0 0 
25.4 Your accoU1modation: are you au owner occupier 01 
relltiug from a local authority 0 2 
reutillg pri .... ately 03 
other (please r;pecify) 04 
18 
Plt'a~e an~wel' the foUowin~ qUt'stions by nllhl~ in the 1ll)l)l'OpI'Inte box with II tlrk0 01' 
wl'itin~ the answel' in tht' ~pare pl'oddt'd, 
Education nnd t'mplonnent 
25.5 How old were you wben you finished full time educatioll, _____ years old 
25.6 At pre~ent are you 
25,7 If you are J'ftil't'd, is tills due 10 
:I housewife 
retired 
employed, fult time 
employed, pm1 time 
1l00mal retiring age 
em'ly retirement, \'OhUlt llly 
em'ly retirement, compulsolY 
illnessldii>ability 
other reasons 
not applicable 
25.8 U' you are l'eriJ,t'd, please give the year in wIDch YOllrelired 
25.9 \Vhai job ha\'e you done for the longest period of time ? 
25.11 Would you describe tIlls work as Manual 
Non-Manual 
Conrel'ninK ~'OUl' husband 01' PRl'tDt'I': 
19 ___ _ 
0 25.10 00 
25.12 Has your husband or pm1ner ever suffered with any of the following? Please nmwer evell if YOII tire 
now widowed or divorced/separated. 
Ye!. No 
Heart attack 0 0 
Stroke 0 0 
Canccr 0 0 
19 
PIt'II~t' answt'I' .he (oUowinl: questions b~' filling in .ht' appI'oplill't' box with II 'icd~ 01' 
"'titing .he amwer in the ~pa('e pro\'idecl, 
COllcernulg yOul' husband 01' plll'tntl' (continut'd): 
25 .13 At present is YOlU' hmbandlpaltner 
2~.14 Ifhe is arc J'Nil'ed. is tlus due to 
retired 
employed, full time 
employed, pRl1 time 
uucmployed, seeking work 
lUlemployed, lIot seeking work 
not applicable (eg. widowed) 
nomlal rctiruIg age 
early retirement. voluutary 
em'ly retiremeut. compuholY 0 J 
illnes!.fdisability 0 -t 
other reasons 0 5 
not applicable 0 (\ 
25.15 Ifhe is retired, ill which year did retired ? 19 ____ _ 
25.16 Ifh.: is uueJDployed. is tIus due to 
I'eduudnncy 
iUne, disabiliry 
odIeI' reasons 
25.17 What job ha.; YOlU' hmbffild or pmmer done for the longest period of time'? Plctlsc am",cr c\'en if he 
is now decea.r,ed. or you are now divorced or separated. 
25.19 Would you d,:sclibe tins work as Mffil\1II1 
Non-MlUlual 
20 
Plt-ast' auswt'l' .bt' follo"iu, qut's'iou~ b~' fillillZ ill .ht' appa-opria.t' box "ilb n drk0 01' 
wlilinl: tht' amwt'r in tht' spart' pl'o,idt'd. 
25 .20 \Vhm type of financial income do you (and your husbaud/pal1ner) have or will you have 011 
retirement ? state pension only 0 1 
occnpational pension. fixed amount 0 ~ 
occupational pension. index linked 0 3 
private pension 0 -I 
occupational and private pemioJl.\ 0 5 
don ' tleno\\' 0 (5 
Coutact with "t'latins aud frlfuds 
Ho,,' often do you see or speak to :-
Plea.se tick the appropriate box in each ro\\' 
Every day Evel'y\veek EvelY few Every year Ral'e1y or 
1 2 months 3 4 nevel' 5 
25 ,21 Y ollr children 
25 ,2~ Brothers ,i,ter\ 
25 .23 Friends 
~5 ,24 Neighbours 
Is the amOlmt of contact you haye with each of these:-
Please tick the appropriate box in each row 
Too little Abollt right Too Illllch Doe 
1 2 3 4 
25 .25 Y onr children 
25.26 Brotherv'sisters 
25.27 Friends 
25.28 Neighbours 
2 1 
D e\ 1I0 t 
~6 
not apply 
Plea~e au~wel' the followini que~tious b~' fillini in thE' apilropliate box with n tirk0 01' 
wI'itin~ thE' an~wel' in tht' ~pn('E' pl'oYided. 
26.0 Your t'arlit'I'llfe and health 
Recent re"earch \uggests that YOlU' weight at bilth may be illlpoltant in later life. We need to ask YOIl ~Ollle 
que, tion> about YOlU' eady life. 
26.1 How much did you \\'eigh when you were bom? 
Write OOiOO if you don't know. _. ____ .lbs ____ OZS 
AI. a child, did the home you Jived in longest haye: 
26 . ~ A bathroom 
16.3 Hot \\ 'ater 
26.4 Your own bedroom 
26.5 Use of a car 
Your p(,l'iod~ 
Yes 
D 
0 
0 
0 
No Don't know 
D D 
0 D 
0 0 
0 0 
26.6 At what age did your pel'iod~ stut '? _________ _ 
26.7 At \vhat age: did YOllr pc:rioru stop ? 
26,8 Did your periods stop nann'ally D 1 
becau!>e of an ope1'lltion D:2 
(please give details) 
26.10 Have you eyer taken the oral contraceptive pill ? 
26.11 If Yes, which type of pill did you take? 
Combined pill 
Progestogen only (miui-pill) 
Don't know 
Yes No 
o D 
0 
2 D 
3 0 
26.12 I(Yes. for how long did you take it 7 ______ ---J yean. 
26.13 In what year did you last take the pill ? 19 _____ _ 
22 
oflic~ u ~ 
_6.90 
Please answeI' the foUowini questions by ('allin, in thf' appropl'iatf' box with II tirk0 01' 
w!irinK tbe auswel' in thf' spare proddf'd. 
:27.0 YOIII' prf'gnancif's 
27.1 Ho\\' many pregnancies did you have? Giye number ___ _ 
:27.2 How IUany live births did you have? Give number 
----
For you fif'>1 bom child. please give the following details: If no live bilth~. plen\e go 10 27 .7 
2 .3 Boy D GirI D 27.4 Bom on timeD 
:2 .5 Bitthweight Ibs oz~ 
Did you have any of the following complications during any of YOlU' pregnAncies? 
:27 .3 High Blood Pre;;lu-e 
:!7.4 Sugar in the luine 
27 .S Di:lbetes 
:27.6 Swelling of the hands or feet 
27.7 Pre-eclnlllpsia 
:28.0 FRlDiI~' blstory' 
YOlll' fathf'1' 
28 ,1 Is yow' father still alive 
Yes No 
0 0 
0 0 
0 0 
0 0 
0 0 
Yes No 
o 0 
~. 28.2 How old was he when he died . _____ years 
:28 .3 What wO'e you told was the cause of his de:lth. Plea,e tiel.: only ~ came. 
Heart attack 01 Other canco' 06 
High blood pressw-e 0 2 Accident or injlllD 7 
Stroke 03 Other c:luse Os 
Re~pirntory disease 04 Don't know 09 
Cancer of hutg 05 
Early 0 
28.4 What job did your father do for the longest petiod of time? office u\e 
o lS.Srn 
----------------------------------
28.6 Would you describe this job as: Manual D 1 Non-mauual D 2 
23 
P)ea~t' auswt'J' thl' follo"il1~ questiom br fillill~ ill tbt' np)ll'opl'inte box "itb n tkk0 01' 
wJ'itil1~ tbe nmwl.'l' lu tbt' 'pact' pl'o,idt'd, 
YOUl' motbt'1' Ye~ No 
28.7 Is yom mother still alive D 0 
How old wa~ she ",bt'u bt' dit'd~ _____ yE'nl'~ 
28.9 What were YOll told wa, the cause of her death. Plea,e tick only one came. 
Helin attack 
High blood pre;SlU'e 
Su'Oke 
Respiratory di,e3se 
Cancer of breast 
Fnmil~' biHOI~' of beal't attack~ aud stl'okt' 
Other callce!' D 6 
Accident or iujl1lD 7 
Other call,e D s 
Don' i kilO\\, D 9 
Are any of YOllr relations affected by heart attach alld stroke, either now or before they d ied . 
lli!!!ll Yes No Don't know 
28 .10 HC31t attack D D 0 
28.11 Strokc D D 0 
L!!!!!!: D D 0 28.12 Heart attack 
28 .13 Stroke D D 0 
~ Yes No DOll ' t kno\\' ~o sister 0 1' brolher~ 
28.14 He31't attack 0 0 0 0 
28.15 Stroke 0 0 0 0 
BI'otbel'~ 
28.16 HC31't attack 0 D 0 0 
28.17 Stroke 0 0 0 0 
THAi''X YOlT FOR CO~1PLETTh"G THIS QUESTIO~~AIR£. 
CHECK CAREFULLY THAT YOlT HAVE .;\'~SWERED EACH PAGE AND THE1\' 
RETt;R.t," IT Tho THE REPLY PAID ENVELOPE PRO' IDED. 
. l\I RC r\ SSESSMENT OF ELDEHLY PEOPLE IN GENE RAL PRACTJCE . 
L--_ ___ --!D~E~T~A~I~L~ED ASSESSMENT 
Patient iame Label 
Date of birth 
V 1 Z ;l 
Day 
U ! i I · ~ 6 , 8 • 
.,,, iii I I I i 
f\10nth 
Year 
PLE E TICK APPROPRI ' TE BOX · 
Interview completed wi lh ubject 
Barcode Lnbel 
c ': 1ai 0 Female n 
1arital ta tu 
Single 
1:lrried 
. erarate divor 'cd 
Wid wl~d 
Livin) Wllh a pannel 
C) 
o 
o 
D 
o 
o 
o 
o 
o 
o 
TotaU prox il1ler\'ie'> f7. emoll!' or prox)~ I 
Panl. prox intervie .. v (Reasons/or proxy' L. I 
ubjcct unable to omplet interview (' '0 proxy) ~I ===============J= 
ubject n t found rReascm not found), , ___ _ 
. t1bjcct refu. cd interview 
ubject died 
ubject moved to long stay care 
ubject a~milted to ho pital 
Subject moved away (N(,)l address) 
0'ew GP rW,'A) 
• 'ur. e !lumber 
C'1.).t$G11!9 
LID II I I I 11'0 
ITT i 1111 11] ' 
Date of intcr.; ew 
Day ~f+f+l ~ 1 1'l el~ 1 
o 1 .2 ,} 4 ~ tJ 7 8 9 10 l' 1,2 
10nth I II 1 1 II I i I I I I 
o t .l) 4 Seli.9 
Year 111111 11111 
\ 'i it an time (use N hour clock) 
Hours 
1inules 
Sur\l'C) 103 
,lufse name r---
Place of interview 
urgery 
Residential home 
Own home 
o 
o 
o 
Other (, ·peCl.M Dc=] 
Interview tan lime /I, e 2-1 hou/' clock) 
Hour 
Minute 
S. ",1 : 11011 
o I 1 
rTn"547aQ 
L-ITDL-L.L.LI .LI LLLD 
01 2)'~ 
II II H 141 \:6 
Po • I 
[ 111 11U 1 nnJ I r.T.·. LIJ~_._., .J,. J • I ll lIl l • 
• • Scanning by FormiC Ltd, London (+44 01 7 1 92'-11730 ./ 
• • After minute re 'I. taJ..e the palient's ining blood pre .. ure Repeal ~illing blood pre, . ure aOcr alll"l llwr 
3 minute re .• and th n take tanding blood pressure fter minutcs rest 
Record 10 Ihe neare. 1 2rnmHg 
. itting 
) lolic 
Din toile 
Zero error 
A lion: 
Kepeal in J week if B \ ' rage sitting s 
T repeat fl r either . tanding . ' toli 
Repe:1l hlood pressure: 
) , toli 
Dla toli.: 
Zero error 
alculat' ons 
Immr-d ia te ction: 
itl ing 
vcrag corre ted ittlng rend ing 
True y loli c 
True Diaslo li 
10'-, 
I Ii 
, I lndlllg 
[ II ] 
[IJ~ 
m 
r 3H'rag itt ing din tolic i!. >- 1 Omnlllg 
Average corrc ted si tting reading 
Truc S stolic 
Tn.le Dia~ tolic 
DTI 
r- i I I 
tun Illig 
(A ny age) If average repeat si tting " tolic >=220mmHg r illing dia oli ~ Il mm l Ig. inf rm lP 
within 4 hour 
AClion : 
Reier to team if . ubjecl i Ie 
ilt ing dia I Ii >= 1 OOnunHg 
.,U "'C), JOJ Stnal . 110 J Papt J 
U j 11 JJJJJJ Lill_ [ II • I II I Ll .-. _ • I II I • r I J II f • 
• • SC3Ilnn)QbyFormlC Ltd London,(.44)0171 9241 730 
• 
2(a Pu) I! ra te 
012' . 6 1 !5a 
LI I I I ! 1 : 1 1.00 
i IIICO-Tn ·O 
I ; jill! I 1 I I ' 
hnnH'lI ia tt' Ac tion: 
If pulse <40 or -' ) ' 0_ infonn Gf> within 4 hou 
Action : 
Refer 10 tcam if pulse 40-49 or 11 0-129 
2(b) Continuol! Iy irregular pul e'l Ye~ 0 
Act io n: 
• 
00 
If -,,<,so do -CG if surgery ha facili tie . Refer to team if - ,repon . <l trl AI fibnll ation , At ria l n llttet 1 
11m ofvemricular c\1rru y tole If urgery ha no ECG fa ililY, refer t team 
4 
\1 a ur patient 's standing height to the neare t 0 1 em 
Mea ure patient's weight wit.hout coa t and sho . 
10 the nearest 0 I kilogram 
5(a ~1ca ure patient' demi span io nearest I em 
5(b) Repeat demi . pan measurement to ncare t 0 I ern 
(a Mea 'ure patient' mid-arm eir umference to nearest 0 I em 
(b) Repeat mid-ann circumference measurement to ncare I lem 
"<1 20J 
o 1 '} .. "\ ~ 1 ~ \I 
U-=:J::I I 1 I 1 IlJ \OC' 
o 1 1 1 J I"rJ 0 \0 
0::J1 1 11 11 0' 
LTTO:CrrnJ 0 \ f ill 
o 1 '). 1\ (J 7 • $ 
[::JIll] ] 1 1 1 I H)J 
[1 I ' J' [ 1 TI]]] '0 
Gil! ill} IJt 
W I I I I II I It\ Kg 
,~ 
I 1 I LJ o. 
O liSise 1" 
1 1 1 I I 1 I I 1 [I·e 
I I I i [1: 1 I II· 
r ill 
ern 
1 1 1 1 1 1 ] o. CIll 
0'':' " &r&" 
I 1 I I 1 1 I 1 1 IJ '( 
I 1 I I 1111 'I]' 
UJ 1.1 1 ITITI~ 111 
l LWTlll111 rr[ ..:I -=- LJ eerr.-=:. -=-=--. I • f rlili . 
• _ S<::onnlnatw FrumicUd l.o<\don 1+44\0171924 1730 
• 7(a) 1\ lea ore patient's wlli t circumferen 'C to nearest 0.1 ern. 
7(b) Repeat waist eircumferenc,e measurement to nearest O. I em. 
(a) i'-feasure patient's hip circumfi rence to nearest 0.1 em 
(b Rep at hip ci rcumference m a urcment to ncare t 0 1 rn 
Plea e indicate if there were any special circum tan e that might 
have affected any of the above anthrop metn measurement . 
Plea 
\ U'U) 20 3 Senal : I IOIJ 
O'~J""t-'8' L.J I I I I TTIIJ 100 [ I~TIIlDlJ I. 
I I I I I 1 TD_ - , 
lJ LWJ'TTI I f1 
o 1 ~ :t 4 ~ 7" v 
m-J -r r n I] "l' 
• 
". 
I' m 
[CarLLI [J ) Ie 
rrrn I r T ill 1 
o=rrD ITT] 0 I l' !II 
Yes [J 
[ 111 Il If] I] IllTC-=r ... :::. rTrrl] =.-.~_ • r . 1 • LI llI . I 
• • Seanni!1g by Formic Lt<l, LondOn, (+44) 0171 924 1730 
v 
• 
9(a) 
9{ b) 
Q( ) 
9( d 
9( e) 
9( /) 
9(g) 
Q(h) 
(i ) 
a) 
IO/b) 
• 
"10111 11011 !!Olllg fO a * YOII ~'om qu _,lion ' aboUl YOllr re ' nI health, that IS. (wer Ih~ BP." /II )//1/ . " 
Hat 'YUII (,I '( ' r had 111} I /III or dis omfon 111 yOl/r che.l t." Yes 
0 
f)o you gel Ih/~ pam or dls,on!fort \l ht!1I you )1' Ik "phill Yes 
or hurf) ? to 
j)O) 0 11 gllf II 1\ hen) ou It alk al an ordmary pace 0/1 the Ye. 
/eIVP 0 
WII, 'II )011. ',' I {/II)' IXlIII or diS o/J?(Orl In your tol ( lit] If. \I hal do y O/I do :l 10\, down 
Continue at lht: ame pl e 
D Ol! If go away \I hen ,\ \ 1/1 'land , 1111') Yes 
() 
H all soon '> 10 minute ' or Ie 
What' do y OI/ gel 1/11 ,,0111 or dlsC(}mjorl? 
(Ti k all place mentioned) 
tr "other". pe if)' 
Ar y u re ell'in T I reOlmt'lI' jor IhL :> 
!L!iillJ..;. I f to. reCi r to l eam 
More Ihan 10 minu te 
I{'mum 
Left he t 
Left ann 
th ' r 
'--------
Yes 
o 
B go 10 
B gOIO 
[-3 
,........, 
t1 g 1 
n go t 
tJ gO lo 
_=:J 
[J 
Have 1'011 t.'1 cr h '" a .!on-ere pam a ross 'he fro/ll oj 
I 'our ~h(!sl 1a.\I/I1g or half an hOllr or more Y . B 0 
Ye B gO lo 0 A re you Ii ('arlll ' a hl·armg aid 11011' ) 
es B . -go to ( ) 0 Do) ym haw u /lI!Orill atd (J/ home for your 0 1l'1l u c? 
Yes B 0 I 0 )'011 /I i! lhe hearJIIg atd regularly? 
i) 
i) 
(i) 
i) 
IO(d) f)c _, Ifh Ip ? 1010 lillIe 0 lal all 0 
Only a k (e) if "~o" to (a) aud (b). Othenvisc ~o to Qll. 
I (e ) Haw)'011 c I'Cr tried me ') Ye· D 0 0 go I II 
IOU) f)ld /I he!,, ? . lot D A little D 
kll.1 ' 110 I 
CLUllU [ L1 J I J U _T. _ DlJJllI .... ___ ..• 1 • ] • 
• Scanning by Formic Ud, London, (+44) 0171 924 1730 
01 <I I ull 0 
[1 111 •• 
• 
• • I 1 '" am nOli 'Oll/~ /(J do som 'he ks 011 .1'0111' h arillg hy Whl.I/JI.·rll1J; some Il!lIer.1 aJld IIl1l11b"'I'.I . 
Pleaw kl'ep look/ll[! ol'll'Grd". 
tand behind ubj t at a di taIl e of in hes Take a deep breath in, brcath right oUI and then whi pcl 
at one item per co~d ' "3.A .2" A~k the subject to repeat this. The .. e I is pas. d if Ihe cquenc i 
repeatcd corre Ily If Ihey rc 'pond rncorre Ily M not at all , Ihe test IS repealed on e more II ing "I. F.J". 
Pa d fir I lime 0 
ction: 
I pallenl rrul , examine the ear 
E>..aminalion of th ear 
. olhing abnorm 0 
\\'n; ' 0 
th r( p ify 0 
Artion: 
Pas 'cd econd lime 0 ailed U 
iT\\"not pre cOl and hearing ha nOI beeninve ligated in the last year, refer for uudiolllel J If IX I 
pr' ent, arrange for drop and syringing Repeal whi pered voi test I " .. eek after syringi ng 
Repeal whi pered ,'oi 'e test 
Date 
o , '- 3 " S ~ & Ii 10 1 ~ 12 
;\1 nIh ( I I I I I I I I I I I I 
Year Ie: I ~ I' (I s 18 1-1 ~ 19 1 
Pas ed first time 0 Pas 'eeI second lime D 'ail d 0 
rtion: 
Ifpalient till fail and h ring ha nol been inve tigaled in lh lIu t "car , refer for audiom I 
12 "A ~ peopl groll'old r it i, quite flonnal ( ) find tllI!Y . omefimes hal' trouble \l'lIh '"c/I' hl Ii< l I' , 
hOlt'els. I'd Irke /0 ask YOll ,\(III/e qlles(IO/1S about It. " 
12(a) k a ll : Do VOII Her II' f 1'0/11' 'elf if you are IIO/I1h/C 
to J:,'l1110 Ihe 'torl I as soon a ' yoll need to, or when asleep. 
or I .1'011 ollg" or srree=£' '/ 
o 1=1 , 
alhcler 0 
12 b) Ir ye. hOIl oft " doc, till happen? 
L ) If yes. ISl/jll ta fell'drop or more lhallihat? JuSI n fe drop 0 
Mor Ihan thaI 0 -
g( 10 I.. 
, to d) 
ction: If in ontinent of urine (m re than a few drop on e a week or m He, do f ' Ifinfcctcd 
--- 1 refer I learn, ifnot infe led refer to contrnence ad"i or/communi! nllr. 
I ... (d) If catheter. do yOIl hal'e any problem_ wllh 1111. ? ) c B 
~ Ifye , refer to continence ad i orl ornmunil nurse 
h:"C')' 20J 
[lJ] 
• 
Sc'I,1 : 110 1 
Sc;anoinQ bY FomlfC ltd. London, (+44) 0171 9 41 730 
rI l TI . 
• 
• 
13(a) 
I' (b) 
Ask all /)0 YOll el'er sod or mcs YUllr,\c/f) 
If ye ,l1ml of Ie II do you hOI ' 
gl///II~ a eli /ellIs? 
Y e 
o 
More than once or twi e a day 
n e or twice a dav 
Three or mo re t imes a \ e k 
On (' or l\\ i e a '''cck 
Once o r twice a month 
Les than once a mOlllh 
• 
go fo 14 
Action: If3 Of more time a week, refer t team If nce Of f IYI e \\ cek, refer 1 CllO tinencc ad"isNI 
ornmuniry nur e 
J4 ,'\'Iell on ly. WOOlt' 1I go to Q15, 
14(a) 
14(b 
14(c) 
IlIlhe 1t1.!;1 fIlfJlf flt lI ']ve y()/lII,l1Ia/~1' had /() J,:t' llIP 
(0 pas II aiel' dllT/ flg III IIIgh( ) 
If yes, holY oft n pi!r I11ghl ) 
If morr than twirl' , hw 'e you Si!(,11 yOllr do 'lor 
ahoullhls problem infhe Iml m Ollth ? 
..-\ct ion: If 0 , refer to team 
e, lJ 
o D · go 10 (d) 
t ime ' 
14(d) In ,Ire last momh ha\.'c ) '011 had dtjjic7l/~v 111 
passing YOllr II'Cller :) 
dift; ulty 
• orne diffi lIlty 
/\ 1 t of difliclIit 
go to 16 
g to I 
14(c) 
15a 
1 b 
IS 
15d 
• 
If :I 10 1 or difficulty. have YOII seell yo III' doc /or aboul thl5 problem 
mIlle la~'1 month? 
Ye B 
Actio n: If a lot of diiliculty passing wafer lind not seen doctor in the last mornh. rerer to team 
O\:'I~ ' ~&7t19 Wornrn only. Men go to 16. ~_r:JTI 1 1 1 1'0 
HOI! old were .1'011 I1'h II YUII lzad yuJ/r Irsl men Stmal penoJ'J I I I I I I I em I 
o 1 , :!J • ~ ~ 7 " , 
[I I I I I I IID'o 
HOll old ",er e you lihen you had your/asl mens trual pen orP I I I I I I I I I I I' 
D"I VOllr p eriod:. stop IIafllrally , blrcaus oj. 7,rgeIJ', 
or jor . ome ofh r reason? 
Hal' you ew:r been preg7lGIII 
years 
car 
(ill //ldillg mi ttrrta~es and stillhirths) ') go to 16 
HoII' many elllldrell, /II ludillg s tillhirths. hal'£! you had? 
tlal . 110 I 
IJJJJTII T lJIr:::.-l--'-' 
0'23 " S6'89 
l....l I I I I I lTIJ·o 
I I I I I I I I I I II 
P.,. 7 
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Lll J_ 
• 
• • 16 A k a ll pal icnts: 
16(a 
lo(b) 
16 ) 
17(a ) 
I (b) 
17(c) 
18 
19(a) 
19(b) 
In the l(/.~t mOllth hOl'e you het'll mort> Olls lipalt'd 
Iha/1 1IS11O/" 
Ir ye . ha w .1'011 Sl' en y our doctor ahoul 1171.\ i ll Ihe 
la \llIIonth ') 
If no. IS If a problem for YOll ? 
.\('Iion : Ifit i a problem, r fer to team 
In rite Ill.~r I//onrh hal' y ou had rcpea ted mla ks 
0/ diarrhoea '! 
If "c. haFt! VOli seclI 1'0 111' doclOr abullt lh l.\ i ll Ih ' 
lasr 1/10 111 h I ' • 
If 11 0. IS II a proh/cm for YOII 'l 
A('l ion : If it i a problem. refer to team 
I" The /tull1Ionrh hal'(: you had aITcmatfllK alia ks 
o diarrhoea alld cOlIsflpa fioll ,? 
III tlte la~·t mOllth have you hod blood 11/ yO/l/' 1II0 l101IS ? 
If yes. huve yuu :>eell your docfUr ahmil tll1,\ III the 
lasr month ') 
\ ' e. B 
o ' g t 17 
y~~ B·-gO to 17 
YC. 
o B 
Yeo 
o B ,--go to I 
Y s [=1 ; go to I 
10 L 
Yc 
No 
Ye 
No 
r U 
g 
Yes 0 
0 :=1 
, go 10_0 
~ If N , end tool pecimen to laboratory for anaJ; si-, If it i po iti c for bl od, refer t team 
20 a) III the l a,{ t month how' your mot lOllS beeJl Mack? Yeos 0 D ' - g 1021 
20(b) A re YUII taklllK JrolllOblet '7 Ye~ El ·- go to 21 
20( ) I f no, have you J en your doctor about Ihl.l' III Ihl! las/month ) Ye~ El 
J\(' tion : If No, cnd 1001 pecirnen io laboratory for anal, si lfii i po it ive for blood refer to r 
2 1 
/ 
Can you chew seTflS a tOfl~V? 
Action: If 0 , r fer to denti \. 
_2(a l 0 you haFt' t1 probl m wi l" 1I'aIl0l1'l1l '~ 
22(b If yes. hOI'€' you . '('en yOl/r (t lOr abolJt ,hi,\ ') 
( ction : If , refer t team 
r(a 
/-. 
23(b) 
)Ie 
II/. the 1m;, fIIOIlf/r hm 'e you I'(Jmiled blood or 
vomll III ,looks ITke coffee tfro llll i s? 
If yes, hal' y ou , ' ell your do lOr about Ifus 111 Iht: lasl mOlllh ? 
Action : If 1 , r fer t re m 
!)ur\.ey 201 
Ye 
No 
Yc ' EJ o -
c~ EJ 
Yes 0 
10 D 
Ye. 
o 
T [ rrrrmrrrrr .. :::r-=- 01 1 TIT'-- • r . r. 
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go to _ 
go 10 24 
p, 
r l l l . 11 
• 
• 
-'I (a) Ho pe you 'Olll;h d lip b1oocJ ~ 
24(b) If ye ,hmJe you seen your do lor ahou( IhlS ;l1lhe lo'!'( mOIllIr"i 
25(a 
Ac tion: lr Na. refer ta learn 
Do you IISlwlly brlllg up an)' phlegm /rom your 
·he.\lfir I tiling IlIlhe morllllll; III 111 wlIller? 
2 -(b) Do YOIl IJslIallF hrlllg up Of~F phlegm from your 
he\1 dunllg Ihe day - or ullll[!hl - III Ih willler" 
If Ye to 25(a) or 25(b), a k S(c). 1fnot, go to 25(d) 
2~(c) Do yOIl hrmg up phlegm like 1/115 0 11 most days 
lor Il.S mil " G.\ rhree mOlllh:; each year/ 
2S(d) 
I 
1n the IXJsr Illret: ),car.\ , have )'0/1 had a p eriod 0 IIIcr eo.led 
cOl/gh ami phk{!m 10. (//IFf/or IIIr e Heck!; or mot :' 
,P(e) 
5(1) 
f)ot!.s your cllest sOlin Ilih 1': or l1 'hL\I/tng all II/()SI 
day or IIIltht )'! 
/)0 you [le I slum qf hreath walkllTg w"h people (!f 
your 01111 age Oil I vel ground') 
25 g) Are ),011 shorr nfbrearh 011 talkfllg ') 
If ye to Q2 (g), IIm 'e you . eel1 your do tor aholll ihl.I' III Ihl' 
last momh ') 
26(a 
2 (b) 
Artio": 1[;..)0. refer to team. 
! 0 YOIl I1m'l! sw IImg oj y01/I' legs lip f(J 
your ~71 es on g('ffmg lip /II fhe monllllK') 
If ye , hOI'c YOll ell your doctor aholl1 
Ilrls III the 10. 1 momh? 
A('tion: If o. refer to team. 
27 III Ih 10 I o5i\' monrhs, hOI mOllyfall. have 
you had at home? 
"" 
... ~, 
Yes 
N 
Ye 
a 
'\' c . 
No 
Ye 
TO 
Yes 
0 
Yes 
Ye 
a 
Ye 
10 
Ye 
0 
Ye 
0 
Ye 
0 
y 
.~ 
Yes 
' 0 
one 
I 
3 
4 
10 re than 4 
A(' tion: More than 4. refer to team 
2 On!r Ihe last i..t: mmtth.{ ha l you IIlIflced 
IIl1explolJle lweighrloss of more lholl halo . fOliC ? 
~ If Y . refer to learn 
urV1:y • :OJ 
Yes 
0 
mIn [[] [1) [ I I I _ 1.-. IJ..UJ -'-" . I . -1. 
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• B .- go ((l 2S 
B 
G 
B 
6 
§ one peri d 2 r mN p nods 
EJ 
B 
tj go 10 26 
B 
B -- go to 27 
B 
~ 
B 
p.... ~ 
nll • . 111 
-
• 
30 
Compa/" d wllh other people (~r)'olJr 01-1'11 age would YOII say 
Ihm YOllr health IS genera/~v: x ellent, goocl, jalr or P<' or ') 
Excellent 
Vcr~' good 
G od 
Fair 
Poor 
'omfX11"cd I II olhe'r people 0 y Ollr age, wOllltlYOII 
de, cnbe YOllr,\e! as: 
........"." Very physi all. a ti ve 
e--.. Fairly phy ically active 
(a.-,. <; ot vcry phy i , II acti\' 
, Tot at all ph sicallyactive 
• 
31 Here re orne activities \."hich pc pie sometimes find dim lilt For each one ask "D Oll do the 
following by y ur elfor uld you do the following by your elf if you had to') And Ifunable t do it 
alone. do you receive enollgh help"" 
3Ja 
31b 
31c 
31d 
31e 
Jlf 
JIg 
31h 
• 
difficulty 
Cut your own toe nail "., 0 
Dre youLeif including 0 
zips or button ., .. 
oak a hot m al 0 
Do light hOll ewor!;: or 
imple repair ..... ,.. ... .0 
Go up and down tair and 
step (if neces. ary using a 
frame, tripod or lick) .... , 0 
Wa h allover (including -0-
bathing or showering) . 
Walk SO lard down the 
road (if nece ary 1I ing a 
frame, tripod or sti k) .". 0 
Do hopping ........ 0 .. 
orne 
diffi 'ult), 
o 
D 
o 
o 
o 
D 
o 
o 
Action: ny· refer to the appropriate ervice 
urvtl-y . 203 Se tu l : 110 I 
nT1J Jln [TTI . l -'.-. 
nable to do it 
alone but help is 
usually a ailablc 
C 
0 .. 
o 
D 
o 
[] 
[J .. 
o 
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nable to do it 
alone and not enough 
help is avai lable 
o 
o 
o 
.. 0 * 
[ fTJ-'-I .I 
• 
- -
Introduction: 
I am nOIr gomg to ask YOII som questiom)j hi 'h i tll'o/l 'e 111I'n10ry, r adlllf.! and IITlt/l1f.! , 7)<: 
exer L~ " , 
Nurse hlstruction: 
Remember not to Ilrompt thl' p:ltil'f1t . Ask (he que 'tions e net ly lS the art' wrilt(~ n . 
~2 Orientation (Ask the following que ,tion ') 
31a What IS ,he dare TO lay? 
Cad/;' 11 helher datr!. monlh and y,'ar are 'orrc I). 
Lc 
~ 2d rrllm day of thl! IH!~k j ,\ it 1 )Jay? 
It7IGt IS 'he ,1eason ') 2e 
= \"'inter 
'" Winter or Spring 
"'" pqng 
pring or umrn r 
ummer 
umrner or Autumn 
ulu mn 
utumn or Winter 
321' IYhalls the tIC/mil of Ihls p/w;r ? Hher I,S Il localed" 
For home visit ask:, "What is the nil addr ss of Ihl, place?" 
Lg H'hal floor of 1111.1' blll/dlllg ar we on7 
3211 WhaT IS Ihe /lame 0/ tIllS city tOW/1 I'll/age ') 
32i 1-Vhot COl/nly are we In ? 
3kj Whol coulltry are Ire ill ~ 
33 lmmediate Hecall 
Instruction to Patient: 
"/ am 11011' }!oillJ? 10 say three words, Afl'1' r haw! 
lIIished (tVin T all three. J wanl you to repeal them, 
Remember \I hat they are because I am gOing to a.sk 
you TO Jlome: Ihem ill a ell'mlll1lles, 
"pple" "T ble" "Penn ," 
Rate the fir t attempt If any errors or omi sions are 
made on the fir t attempt, repeat all the names unt if 
patient learn all th ree up to a maximum of 5 repeat. , 
34 Attention and Calcuhllion 
3 a 
Dat ' 
Year 
Month 
Day 
' ca 11 
Place 
Floor 
Town 
C )unt ' 
Count! 
pple 
Table 
Penn 
",Now jlt'ollld lik you to take 7 mt'Qyjrom 100", 
"NOll' lake 7 awayfmm (he numher yOIl [:CI", 
'?':ow keep taking 7 (/Iva)' /Jllllif t .ll ),011 to stop", ubtraction I 
2 
Rate as orrect each time the differen e is 7, even if 
a pre\'iou answer was incorrect. Do npt repeat the 
number 'ou were given, 
S ""1 ' 20) ".1 : )IOU 
[11 T rr IJ I11ITITr.-T.- _ []]I LL."":_1L. J . 
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3 
4 
5 
(,'111T1; t In(':1 Wf 'ct 
0 C 
0 0 
0 [J 
0 0 
0 D 
0 0 
0 [] 
0 C 
0 0 
0 0 
Fi r~t Repetit ion 
l 1T~'C1 tn ' IT':'I 
[J 0 
Cl 0 
0 0 
" rrcct In '()JT~'I 
• 34b If 34a is not done, ask 34b. 
NB Only count sco re for 34b ir 34a not do ne. 
sk the subj t to spell the word "world" backwaHI. 
The score i the number fletter. in corre t p sit ion , 
For example, "dlrO\ " i 5, "dlorw" is 3 
35 Hecall 
"II'11a1 1I'1!H: Ihe 11m:/! word5 J asked you 10 repeat 
u /1111 IIhile ago ')" (33) 
36 La ngmlge 
"NOli' I am gOlllg 10 ask YOll 10 do "ome IlImp, . '0 please lislell 
carefully, Some In ~r seem ve( l' ~ /l1lple, hilI I llease bear It '/lh /1\ . " 
If. fo r physical or educati onaJ re;asons, the patient is not able to 
compl e! thi S clion, leave all oding boxes blank and make a nOte 
of the reason for omission. Then go to the end of this se lion 
(Deriving tOlal core). 
Joa Naminl! 
how the subje ( a wrist \ atch and ask. " /1'7101 IS Ih,S called') " 
how a pencil and a k. /f~f'7Iaf i,~ Ihl ' called?" 
n wer is onl correct if obje ! i ae urately named. 
3 b Rel)etitioll 
"! am noll' gOlflg 10 ~ omelhing and / would lik yO/l 10 
repear IT after me".: "No if , {Intis, o~ ~ut.~". , 
Onlv o ne pre -entation LS allowed, 0 It IS es, ntml that ou fead 
th phras learl ' and lowl , enunciating all the s's. 
36c 3-Stagt command 
'" am /lOW gOlllg to g i\'l! YOll a piece ('if paper, 
When 'do, take Ihe paper in your RI(tI'lT haud 
fold fh pap I' ill half wilh BOTH halld and pilI 
fhe paper dOlI'Jl on your lA P" , 
Hand the paper to Ih patient'S midline. 
If the fu ll equence j no! ompleled. repeat the whole 
instruction 
36d Read ing 
Hold up the card which reads " Close your eyes" , so the 
ubjet can see il clearly_ ay, "Plea 'I: reodl,h .l1l ' hal? 
alld do I hal if ,oys". 
Score as correct onl if pat.ient actuall closes eyes. 
SW'v~y • 103 St rlal ; 11081 
• Correct Inc lITl";! 
d ~ I r 0 w 
Correc t In.:,)IT 'c t 
pie 0 0 
Table 0 n 
Penny LJ l_J 
nITe.:! In lIT,',", ! 
Watch 0 0 
P II il 0 0 
Cnll'''':! In ')ll'~-ct 
Repetiti n D D 
• 
Com'ct I II00JlTcct 
Takes paper 
in right hand 0 0 
F Id. paper 0 [J in ha.lf 
PUIS paper [J [] on lap 
D D 
Pat ' 12 
ITIII] J I I InTI rr.T.... t ill J r. _-. . 1-.T11 
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• 
36c 
Writing 
Give the ubject a blank piece of paper and say. 
"Wrlle CI C J/llple/e senfencit on The p lt!ce o!puper " , 
Spell ing and grammar are not important The sentence 
rnu t ha\'e a subject and a verb. 
Copying 
• 
l'O!TCl.:l 1 n . 'n <!Cl 
Wri tes 
. entence o c 
3M ''Her e I. t.I drawing. PI aSI! CO/~)i Ihe drawllIg 0 /'1 Ift l! paper". 
Give inte.rse ting pentagons card 
Correcl In '''!Teet 
Answer i orre t if the two fi ve-sided figures int er. e I to form 
a four- ided figure and if all the angles in the fj e-sided figures 
are preserved, 
Draws 
p >nt agon o o 
Deriving to tal con' 
't, 
Language St~ lion (Q36) c rnpl cted ' 
01'l.~~Je9 i i ' , , [1 , , , ,'0 
Tornl score: I I ' , , ,"TrrrJ' 
a, For patients who did not complete the language section on ph sicalJcdllcational ground , ti k "No" f r 
"language section ompleted" . 
.rive one point for e ery correct answer and fill in the number grid. 
' 8 Only include scores for Q34b (world pelled bad WlIrtJ S) ifQ34:l (s ubtrnction ) lIot 
conducted. 
~ If the total score i, less than 12, refer 10 the Community Psychiatric lIrse r ~ e lllOry 'lill ie 
b For aJl other patient , tick "Ye " for "language se tion completed" urn the total r e rreet an \\cr 
and fi ll in the number grid. 
N 8 Onl:), include score for Q34b (world pelled bllckwards) if Q34n (subtraction) not 
conducted. 
ArtioJl: rf the total score is les than 17, refer 10 the Community Psychiatric j urst' or Memory ' lini 
Comment on MMSE (Q32-36): 
L-__ _ 
Sorve) . 20) POSC : 13 
[1 11 I [ rill ITlTJJ=-J :..... l 1]1 II ."~TII1 . 
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::7 flo, a doc/or ever tnldyou thaI yOIl hod any (?! fhejo/loll'illg? ((ves. was Ihal 
/1/ ,he last year? 
o 
" Pneumonia ......... . 
Emphy erna 
· · .. · ·.· .. ··0 
............. 0 
, A thma ... 0 
. l.r1hriti Rheumatism ........ .0 
Eczema . 0 
tomach ulcer/other digesti e ulcer . 0 
Haemtmhoids or pile " ............ .. o 
High blood pressure ... ....... ......... .. 0 
Heart attack ....... , ... .. . . ... ..... 0 
troke ..... ......... . .......... ··0 
Leg ule r ..................... . 
t.. Varicos veins ....................... ,. 
Gout ......................... .. 
o 
o 
o 
Depres ion nceding treatment ........ D 
Thyroid trouble .......... . ........... 0 
.,' Cataract ..... ..... ... ...... .... .. .......... 0 
Glau oma . ......... .......... ... . 0 
'" Fractured spine . .. ............. . .. 0 
Ye , "'~ t hin Ye,. but before 
la '\ year la t year 
0 0 
0 0 
0 0 
0 0 
0 [J 
0 0 
[] 0 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
0 [] 
0 0 
0 0 
0 D 
0 0 
0 0 I 0 0 0 O .-Site ." 'Fractured hip ........................... 0 ~. Parkin on's di ease ......... ...... .... .... 0 Crulcer (ifye • ask where) .. ' ..... 0 
Infection in bladder or kidneys ...... 0 0 0 I 
Men only 
Trouble wilh Oll r prostate gland ... 0 0 0 
Survey , 203 Setial : )1 011 Pogo 14 
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38a 
38b 
38c 
3 d 
ffa~'e YUII ver be!!11 told hy a doctor Ihal you hm'e "7'gar diabetes? 
When were YOII first /Old you had di(Jhet{'s ~) (}::il 'e yew) 
What /reatmenl are YOIl on/or your dmbeie:;? 
(Tick all that apply) 
1)0 y01/ Ie I YOllr blood/or ,Iugar ~ 
IT yes, ask "hmv often do ),011 dl) this ?" 
3 e Do YOII lest )'Ol~r /ll'illt' jor sligar.' 
If ye , ask "holY oft n do y( /I 10 (his ? t' 
3 f Who do )'OlI lIormally see aboul your diabe tes ') 
(Can be more than one per on) 
38g III th JlI ,~t vear, have ym} had your fect e 'amined? 
"8h {II the Illst rellr, have YOII had your r 'es examined? 
38i !i'/ the last rear, " w 'e you d,scussed your diet with a dietidotl? 
Nurse inst,'uction: 
• 
Ye, 0 
o D go lo 39 
O ': j A ~ leg 
19 ITLTTJTTTIJ '0 
[ I I I I I I I I I I ' 
Diet alone 
Tablet. 
In ulin irtiecri n ' 
o trea ln1l'Ilt 
Yes J () 
o 0 
About once II day 
bout once week 
Aboul once a mOlll h 
Lc 'S lhan 0 11 e j) mo nth 
Yes 0 
0 0 
About on 'C II dll" 
bout o nCl' a week 
Aboll t on e a month 
Les than nee a month 
Famil doctor/GP 
Hospital doctor 
Pra l ie Dist ri t nurse 
o one 
Y es fO 
0 0 
Ye No 
0 
Ye fO 
0 0 
~ 
~ 
DIK 
0 
D/K 
0 
DIK 
0 
Questions (j) and (m) should be asked only to patients on tablrts or insulin, 
Yes o D 
38j Have YOII ever had a low blood slIg"r (0 "Hypo'') 0 o 0 
As k all palients on tablets or insulin Q38k to tn, 
8k If)'Ou have a low blood sugar. should you II1crease 
your diahetes treatment) 
381 If y{)U have a 10111 blood sugar, sholild you lake a 
sugalY drink or ria ,k ? 
38m If you have the 'flll, should ),011 SLOp taking your diabetes 
lablels ill. IIlill? 
SurVt : lOJ 50",1 , 11 0 I 
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Yes 0 D/K 
o 0 0 
Yes 0 D/K 
o 0 0 
Ye 0 D 
DOD 
l l J J_ 
-
• • 
'39. II~olJ/d ftke 10 ask you ome questio/ls aboul your 1101/ mg, 
3 b 
.. 9c 
9d 
3ge 
.?9f 
39g 
39h 
408 
Who do ),011 liFe Jl"llh ? Alone 
pouse 
onfD ought r 
Other relative 
FJ;end 
Other ( peci fy) 
U7ml kllld 0 u.:col11mOdatlOlI do you Ih'e I/"/ ? 1 Coun il rental 
(l Private r Iltal 
Housing AssociHtion 
H ome owner ! . heher~d a c:omm,odation 
Lo 01 Au t.hortlv residential home 
j1ri\'3le residential home ~ Loca.l Authority nursing hom 
Private nur. ing home 
If living in OWII or 1'(' II ted llccomrnodatioll , ask ' 
11/ the 10 '1 year how! you had dl p e1l/ly keepmg YOllr home warm ? 
f 0 yml have celllral heattng? 
If ye , 1/1 1I11/e;' rool1ls? 
1)0 you hOI' all illuoor toilerl 
no you have (I relative, neighhour orfmmd 
whom you can call Oil/or help when reql/l/'ed? 
f . t/Jere OI/yolll! 0l'C111able if you 11 ed help al I/lghl ? 
AClion: JrJ or mor *, refer to 0 ial ervices, 
When you need 10 talk about IJr/I'(lte mo iler or wht!1I 
y OIl aJ'C worried or 'Ire sed, who can you really COIIII' 
Oil or fel! l a l !'Clse wilh '! (May give more than one ansv er , 
Living room 
Bedroom 
.. 
~ L __ 
go t 40 
) 
) 
Yc ( 
o 0 
'.\[I •.. me ne 
B R 8 
Ye. 0 
L] [J* 
Yes 0 
o 0 
y 0 
o 0 * 
o nc 
pou c 
FI;cnd 
eighbour 
Relati e 
H ome H elp/ot her p id h Ip 
Warden 
-lOb Dllrlllg 'he lIst year hm'l! y ou expene/lced~ 
(May give m re than one answer) 
Deat h or separation from a Joved one § §_ 
erious illness in a loved one 
Moving your re idence 
40c l 0 YOII t' l r 17m'l! difficulty III making "lId~' m "f' / meall, 
L 11 difficulf 10 II1d lhe money /() pay your hills? 
40d [, 0 )'(lll have diffi lIlf)' /11 mana g in!! yon,. oWl/finances, I mean 
IhiwI ' likt' po, 'lIIgfor bill , lIorkmg oul 'hallge elc .' 
Action: If2 or more *, refer to Social . ervice 
IT I TrITT rr 
• 
S.ml I 1011 
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e ' No 
* 0 0 
e ' 0 
·0 0 
Pa,.., . I. 
.J 
• • 4 1 I pm /lOW gomg 10 u. k you ,\ome qw:slioll abolll how you've be n f eelillK ova Ihe {Ja.~( (e'll' weeh . 
1-01' each que. lion, please -hoose the answ('r rhal hest applies 10 you. 
41a 
4 1b 
4 Jc 
4 1d 
41e 
41f 
1
41g 
4. 
2a 
42b 
42c 
42d 
42e 
42f 
42g 
4 h 
42i 
142j 
42k 
421 
4201 
42n 
420 
42p 
42q 
42r 
42 
10 1 at all No more Rather more 
than u unl ihan u ual 
HavE! l'OU 10.'" mu IT sleep opel' D o. r--' Horry? . .. . ...... .. ... ..o. .. 
'--
HllI'f! yo/( had dlffi tI':J' 111 slayill),: 
mkep 011 e ),011 are ofF .. .............. 0 0 .. 0 
H(JI )/011 f ell 'ollsta1l1ly /lnder 0 .0 0 ') ,\lrall/ ............. .... ... . .... ..... 
Haw' rOil been f!ellmg edgy and 0 D. 0 had-tempered.') ... .. ... .. . . .. 
/lare )'011 been ~elfin? cored or 0 .0. 0 pallld)i or 110 kood reason '! •• • " ... , •••• * •• " •• 
Hal' YOll fou~ul el'ery lhing gelling 
on TOp (If yOIl . .... .. ... o. . .. .... ...... . 0 0 0 
H C/ I 'e )'01/ b<!e/l fi'c/lJIg nervoll D 0 0 and tnlllg-up all fIll': l ime" ..... ... .... .. . 
. _-_. 
Tlrese qll e. .. riOlI~· are (,bollt holt' YO/l ',·/, been .1i e/illl: over tlu; la.~1 week. 
For each (lueSflOlI, ple(L~e choose the (lIuwer thaf lJeM flPP"C~ (v you. 
Are YOII OCl'Ica11y sa/I ifiei with 1{)1Ir life? 
Have you dropped many of your acflvilies all I illtereSI.' 'J ... 
1 0 you fi ellha( yOllr life isemply . ... .... ... ... . ........ . 
Do )'0/1 often gel bored? 
Much more 
than u unl 
Cl 
D 
,.0 
.. 0 
.0 
0 
Yes 
o 
*0 
*0 
' 0 
re YOII 11/ good spirt IS m osl of til lime? ......................... .. . .... ......... 0 
o · 
o 
o 
o 
o 
o 
O · 
o 
o 
o 
O · 
LJ 
A r.' you afraid that sOl1leLhing bad i . going 10 happen to YOII? *0 
Do you f eel happy 1110 ,11 of th ' lime. .. . ..... .. .... . 
I 0 YOIf often eel helple . ~.? ................. . 
................ 0 
................. {] 
J 0 you prefer (0 fay at home rather thall gOfllg 0111 alld dOlflg lliIlI' thmg. ? .. , .... , . 
Do YOII Je.:." yO/I hal'c more problem:. wirh memory Ihall moM ? . ... 
Do you tlunk il is wOllderful to I e alive II0W ? . . ... , o.. 
I 0 you eel p rell)' worthIes. Ihe way you are Ilmd 
L 0 YOll Je I fil II of en rgy? '" .. , ... . .... 
I 0 you fee l til I your S/(lIallon is hopeless? .. ... ..... ... ....... ..... ..... .. 
Do YOII tlul1k tha/most peoplc ar heller off 1/lan YOII are :) ...... ... .... ......... .......... ... . 
Count the number of asteri ked replies: 
If co re is 7 or less. go to 43 . Total Score: 
If score is more than 7, ask' 
o 
iO' 
0 * 
o 
o 
AT yOIl receIving treatmellt for these feeling!> ? Yes 0 o D '- go to 42s 
Holt' /ollg have YOII 
been havmg this 'reatmellt 6 months or Ie For more than 6 months 0 o 
crion: 
Refer to team if scot more than 7 :md no treatment Q!: more than 6 month. on pre ent treatment 
------- -- - --_._. 
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• 43a Do you !>ftloke Clxarettes (mC/Willl/{ hal/d rafted) C1I presf!m ? 
43b H(m mm~v if,:arell.!s do you smoke a da)'.') 
or holl' maf{r o=s oj lobacco do YOII . moko: a d£1)' '1 
• Yes 
i O EJ .-- go to (c) 
O')34~e,ei 
UTI LLLLIIJ IV 
L 11.LITLLITI ' 
o 1 2 .,,, ~ 1 tI , 
igarette 
go ( 0 ( I) 
[TTr-O] J IJ] , Oz. of 
tobacco 
go to (I 
rc If current non-smoker a k, ha l 'e yO /l c l'er _~moked clf,:(lr elles') Yc 
o 
n b ·-go to 4·1 
C;! : , .. :J tJ 7 tl ~ 
43d HOIl mallY cif,?arelte ' did YOli tIIoke a day ) DlLLI.II.IIJ ,~ ' igcuellcs 
I I I I " I I I I I 
or lum mallY O=S oj tobacco dd )'011 smoke a d lY ? 
4Je Holt' old Ii er e YOII IIhen you slopped "I/oklllg ') YClrs 
, k all rurrC'nt a nd ex-smokers: C'lS.~UI8V CI Iii LID U'~ 
43f HOH old II ere )'0/1 when 0 11 starled smokhlJ.:'l err! I 1 1 I I [J. Year ' 
44a 
44b 
4 c 
44d 
f) lIri llf,? the la1>1 year hare Y OLI (akell 0/1 alcoholic drink ') es 
o B <-go to f) 
r IIr111[' the past week hall' ma~v drinks have ),011 had 0 co h oj Ihe follo\l'm~ 
. • 01?~"!l678$ 
Record number, mcludmg zero. I I I I I LJ I I 1-- '0 
pin t - number of singles U I I I I I I I . 
Wine, Sherry or Pon - number of glas e 
0123 " ~61'~ 
Beer - number of half pints m I I I I I I I J .0 
I I I I I I I I I I I' 
4 e 'ompared Ii IIh 5 years ago, would you say fhaloll 'he whole 
)'011 drlllk mol' . Ie . or ahout the same nowadays ') 
lor n wada I § 
Les. nawada 
44f Jf a nOll-drinker ill k, hal' you always heen 
a non-<.irm.kt!r or dId yOll SlOp drmkillg 
44g 
jor some ,.'asoll ' 
If topped d rinking, why did you stop ' 
(Tic alilhat apply) 
About the nrne 
lway II non-drinker 8 go to 5 
sed to diink but stopped 
nine. . doctor's advi c 
on erned about health 
Too expensi 'e 
Other 
Yes 0 
~ ~ 
If ~Ol.her" . please pecify: ... C_-_____________ ..... _. ____ ._._ .. _._. ___ _ 
[TIT 
-
na l : 11081 
-
• 453 
45b 
45c 
45d 
46 
46 
no )'UII haw! any proh/ell1s wah your eyesl/dll? 
L 0 ),011 H (T,. ~/a. \ ') 
( Ifpatient i \\caring g.las e . don't a k, ju t tick) 
Ir n·s. do \011 It ' or Ih m 
ali rhl! IInie, jor readl/lg only 
or 01" r reaso/l ? 
Wears gla c. all the lime 
Wears glas. es fo r reading only 
Other, plea e pc i 
Ye~ 0 
o [J 
Yes B 
• 
go to (c) 
Cl 
Are you re '1.\1 red as blmd or partially sighu'd'J Blind § 
Partia l! sigi ll ed 
o 
Te t " .. ith patient wearing u ual la ' es -i ng GLasgow han. mea \lr th pati n t '~ \i ion at .l 1\1 Ire . If 
the patient cannot ee the bigge 'tlettcrs. then measure at I metre !\1ca ure both eye jir t , then each l')t' 
ep,rately core, can be plu or minu '. Th greater the secI' , the wor e the "isi n 
Both (' ~' e 
Plu 0 \'1 inu 0 
012345e:"&i 
fll!i IITIl 
UllJ I I I i 1°' [ I ! I I I I '00' 
:L...L..I ...l.1_~.-J,U.:II::! OCXl' 
Mea llred at metre § 
1 asu red at I metre 
Unable to read at I metre 
Len eye 
Plus Cl Minus 0 
o 1 2 3 ~ ~ e : 6 ~ 
; I I I I I lllIJ' 
I I I I I I 
I I I II I 
mill 
i I 10 1 
ill'''' 
I I ! 0001 
1easured at ~ metre § 
MeaslIr -d at I metre 
nable to read at I metre 
night eye 
1)lu 0 1inu n 
1eaSllred at .:; metr s§ ~ ea ured at I metre -
nable to r d at I !\let re 
If a rninu core, or core Ie than 5, go to Q47, If core i 0" r greater, re- tc ·t using pinhole 
46b Pinhole scort': Left eyr Right rye 
('tion: 
Plu 0 Minus 0 
II I I I i II I.TI' 
[! I L[llllJ o, 
I I I I ! I I I i) 00' 
! I I I I I I ITI 000' 
Measured at 3 metre § 
Meruured at 1 metre 
nable to read at I metre .-
I f pinhole re improve to Ie th nO . • refer to the optician 
rf pinhole core i O. or mor ask if inve tigated in the la t year ' 
Ir No, refer to ophtha.lmologisl . 
\lT vt.y • 201 
· ".1 : 11 011 
Plu 0 l1 inu 0 
IT I IIIIIIII' 
U_ILLI I I I 10 ' 
I I I I I I I [Iloo. 
I I I I I I I I I 10 00' 
1ea urcd at 3 metr § 
1ea ured at I metre 
nable to rcad at I metre 
Yes D 00 
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4 a Do Y( /I han' allY h'g or 001 III ers! 
b Arc they f ' 1/ bell/X Ireate,}? 
4 c Ar~' they h If "ealingalflg/II? 
:\aioo: 
If ul er( ) not treat d r n t healing \ ilh pre enl treatment , refer to 
4 a I () ),011 II j 'e all)' o"" :r proM f/I . \I i tll your/eel? 
4 b H " Cd examin feet and 'peci!): ~ Tl k all that appl ) 
Blinj n. 
rns 
Ingrowing l' e nail 
\ 'cry long t nail 
Other problem 
e 
Y 
y. 
J 
omnlUl1It 
Yc 
0 
y s 
H § 
If "Other problem", pi a e ped!): L.L _____________ _ 
Jf ye ,ar you rec I\'1l1g chIT 1)0<1), ') 
Action: Ifno, refer for chiropod 
49a j 0 yo" haFe an)' ul I!f.' or 'ore all}" here 0 11 yOllr lad)'? 
Ye:. 
Yeo 
I 
• 
B olo ·H 
B 
B 
lIr ing ser"i .I!S 
G • - g 10 l 
EJ 
El . go to S( 
Ye, 0 
49b If ve, amine for pre ure re and re ord if pre em a rum ~ ~ Buttock 
Heel 
ther 
1( "Olh r", plea e pt..'Cu; 
-4 c Arc: Ihey Is ir h III/? If a led? 
49d A re 'hey I if" a/mg a/fight.? 
Attion: 
Ye ' 
1 0 
B 
R 
lfu lcer(_) nOI treated r not healing wilh pr ent treatment, refi r to - mmunil ur ing rvic 
o In rhe /asr year have YOIl" d knee pamfor 11I0Si day ' 
(more IhOJl 1-1) 0/ all)' mOllth? 
1111 110.1 
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518 "P/emc ran yon hOl' -me lhe lah/I;'IS or medJ(; /I/(' that yOIl Gre Cllr,.ellt~}' 1()"III~. " For efl h one n. k. 
"Ho I< m a ll)' of these or how 11111 lido ),011 lake' each day ? 
51b 
Any tablct or medi inc sh wn Yes 0 o U 
Print from rontllin('r 
'------:=::=====~ L ..... ____ J 0 IlL .1 
,- JI lDL~D ==============~ ~=========:II J D liD 
~ IL~Q[--~D 
~===========:II 1 D I 1 Cl 
II 101 10 ~=====~II ~DI 10 
~=====~IL 10C 10 
~========I I 10 1 _____ J 0 
1--_ _ 11 101 10 
O'2J'~"&9 
5 I . 'umb r of different medic8ti n I I 1 1 1 I I I I I 1'0 LUll 1 I I I I I' 
5 1 d Check drug Ii t for interactions. 
re there any tUlera lions? 
Action : 
Ifpo sib) drug intera tion, rer r to learn 
rial : 1101 
Yes 0 
o D 
! I I ll llll ! IlD J r .-J . __ UI J J I ••• • r. j • 
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P. 1 1 
[ ll ••• 
• 
• • flit/11k ),011 FCI)! 1II1/('11 for YOllr lIme alld hl!lp, A II/lteed to d) /lUlt I ,' IOke u blood le,)'/ (/1/1/ c/wd 
YO/lr urllle ", 
Take blood an~ tet urine (1\1_ U i[ incontinent and ' 1001 pe irnen if n , e . nry) 
52 mood Trst 
Has the patient been fas ting (not eaten in the last I ~ hours) 
beforeJheblQQ(t arnpl~\\a' Ja~en , ,_. ..... , 
Blood C onstitm'nl 
l / I fa 'mt>g!obm 
\ \ 1m' c -Ill'()llm 
l'!;uckts 
rS11 
Urea 
'/ Crcu,iniuc 
53 
Total proleln 
i\ lhwmn 
'al ' ,um 
Pho1phslC 
B11 1J1lhin 
A1kalmc ph sphata' 
ASl 
Un' ld 
Glu .e 
Protein 
Blood 
I'alienl Res ult 
"UllC1111 
)!Jl 
I'll 
1'1»0111 
iUII 
lUll 
+ ,+ +++ ~++ 
0 0 0 0 
0 0 0 0 
0 0 0 0 
Yes (Fa~lin' 0 :-.Jo C 
I III IlIl'Cliatt· ,\ clio n 
(infol' rn GP) 
Rr~ rIo T eam (within 8 h Oll rs) 
<J 0 > 1(, 
1()(1 r >\)00 
<0 ! tlr " 4 , 16 
>"5 (filliill!(l ( If 
> 12 ( BOI faMlIlf,ll >15 
<129 
<3 ') 
>1 ' 
>250 
< 10 
<200r >27 
>35 
>3.0 
>80 
>0 
ive 
o 
o 
o 
· 12501 -,1 ' . 
>50 
> 120 
Action ir fl!sull is posil i\ e 
Refer 10 team 
M'U 
1. 
54 Where applicable: M tick appropriate box) Tnfe'tcd [] 1 01 illfecleci [1 
lmmediate If grossly infected. plus acute s mptoms. inform GP within 8 hour" 
~ tfinfect d, refer to team 
55 Where ap plicable: Stool specimen 
Report hows pre en eo occult blood 
SUf\ley 2()3 Se"ol : 11 031 
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0 0 
P", 2] 
I-lr . -. · 
• 
• 
. 6a Any other seriou condition which, in the nurse' opinion 
ne d fun her a . cs ment? 
56b lf yes, give d'tail 
re there any a -e .or' omm nt relevant to t.he a , e ment 'l 
5 b If yes, give details ' 
Emenzenc" referral Referral Agencies 
• Yes '0 
o 0 
Ye, 0 
o 0 
l _. (t ick all that patient h:I bft'n I'rfernd (0) 
-----
Hour 
0 1 23'$ 
l\1inu~~s I I I I I I Ie, T I 4/ I 
---------
Vi. it fini h time (24 hour clo k 
-
Scm I : IIO~I 
f]l IT 1 _ _ - _ I _ L. 
ur e 
I' : lJ l11 ___ 
• 
Variables used to derive the large and abridged version of the 
CHS FI using the BWHHS study cohort 
Large CHS FI (51 variables) 
1. Low Haemoglobin 
2. High cholesterol 
3. Low albumin 
4. High creatinine 
5. High glucose 
6. Low 8MI 
7. High BMI 
8. Waist hip ratio 
9. High blood pressure (measured) 
10. Orthostatic hypotension (measured) 
11. Sinus Tachycardia (>100 bpm) 
12. Eye sight trouble 
13. Hearing trouble 
14. Cataract 
15. Glaucoma 
16. Asthma 
17. Arthritis 
18. Angina 
19. Ankle oedema 
20. Bronchitis 
21. Cancer 
22. Cerebrovascular disease 
23. Anxious or depressed 
24. Depression 
25. Diabetes Mellitus 
26. Gout 
27. High blood pressure (self report of 
diagnosed) 
Abridged CHS FI (36 variables) 
1. BMI 
2. Waist hip ratio 
3. High blood pressure (measured) 
4. Orthostatic hypotension (measured) 
5. Sinus Tachycardia (>100 bpm) 
6. Eye sight trouble 
7. Hearing trouble 
8. Cataract 
9. Glaucoma 
10. Asthma 
11. Arthritis 
12. Angina 
13. Bronchitis 
14. Cancer 
15. Anxious or depressed 
16. Depression 
17. Diabetes Mellitus 
18. High blood pressure (self report of 
diagnosed) 
19. Falls 
20. Memory problems/dementia 
28. Falls 
29. Hip fracture 
30. Memory problems/dementia 
31. Myocardial infarction 
32. Stroke 
33. Thyroid disease 
34. Ulcers 
35. Unable to walk out of house/difficulty in 
going out 
36. Difficulty in walking about 
37. Difficulty walking 400 yards 
38. Difficulty going up and down stairs 
39. Difficulty doing household chores 
40. Difficulty washing and dressing oneself 
41. Status activity level 
42. Shortness of breath 
43. Increased cough 
44. Increased and often wheeze 
45. Morning phlegm 
46. Most days phlegm 
47. Ever had chest pain 
48. Chest discomfort 
49. Chest pain 
50. On level pain 
51. On uphill pain 
21. Myocardial infarction 
22. Stroke 
23. Thyroid disease 
24. Ulcers 
25. Unable to walk out of 
house/difficulty in going out 
26. Difficulty in walking about 
27. Difficulty going up and down stairs 
28. Difficulty doing household chores 
29. Difficulty washing and dreSSing 
oneself 
30. Status activity level 
31. Shortness of breath 
32. Increased cough 
33. Increased and often wheeze 
34. Morning phlegm 
35. Ever had chest pain 
36. Chest discomfort 
Variables used to derive the large and abridged version of the 
CHS FI using the MRC assessment study cohort 
Large CHS FI (44 variables) 
1. Low Haemoglobin 
2. High cholesterol 
3. Low albumin 
4. High creatinine 
5. High glucose 
6. Low 8MI 
7. High 8MI 
8. Waist hip ratio 
9. High blood pressure (measured) 
10. Orthostatic hypotension 
(measured) 
11. Sinus Tachycardia (> 1 00 bpm) 
12. Eye sight trouble 
13. Hearing trouble 
14. Cataract 
15. Glaucoma 
16. Asthma 
17. Arthritis 
18. Emphysema 
19. Cancer 
20. Anxious or depressed 
21. Depression 
22. Diabetes Mellitus 
23. Hip fracture 
24. High blood pressure (self report of 
diagnosed) 
Abridged CHS FI (35 variables) 
1. BMI 
2. Waist hip ratio 
3. High blood pressure (measured) 
4. Orthostatic hypotension (measured) 
5. Sinus Tachycardia (>100 bpm) 
6. Eye sight trouble 
7. Hearing trouble 
8. Cataract 
9. Glaucoma 
10. Asthma 
11. Arthritis 
12. Angina 
13. Bronchitis 
14. Cancer 
15. Anxious or depressed 
16. Depression 
17. Diabetes Mellitus 
18. High blood pressure (self report of 
diagnosed) 
19. Falls 
20. Memory problems/dementia 
25. Falls 
26. Memory problems/dementia 
27. Myocardial infarction 
28. Stroke 
29. Thyroid disease 
30. Ulcers 
31. Unable to walk out of 
house/difficulty in going out 
32. Difficulty going up and down stairs 
33. Difficulty doing household chores 
34. Difficulty washing and dressing 
oneself 
35. Status activity level 
36. Shortness of breath 
37. Increased cough 
38. Increased and often wheeze 
39. Morning phlegm 
40. Most days phlegm 
41. EVer had chest pain 
42. Chest discomfort 
43. On level pain 
44. On uphill pain 
21. Myocardial infarction 
22. Stroke 
23. Thyroid disease 
24. Ulcers 
25. Unable to walk out of 
house/difficulty in going out 
26. Difficulty in walking about 
27. Difficulty going up and down stairs 
28. Difficulty doing household chores 
29. Difficulty washing and dressing 
oneself 
30. Status activity level 
31. Shortness of breath 
32. Increased cough 
33. Morning phlegm 
34. EVer had chest pain 
35. Chest discomfort 
